data_1aps_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1aps _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--O 1.239 0.548 0 CA-C-O 123.03 1.179 . . . . 0.0 114.124 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.63 106.83 10.42 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.576 2.351 . . . . 0.0 107.348 173.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -107.06 112.11 24.89 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.878 -166.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 p -85.1 104.64 15.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.833 167.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.75 143.57 19.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 110.221 -3.172 . . . . 0.0 108.028 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -109.05 142.17 40.13 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.976 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -120.33 159.58 24.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.351 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -144.76 116.82 8.34 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.945 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.48 121.74 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 112.467 -2.151 . . . . 0.0 107.054 170.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.31 71.51 10.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.74 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.27 73.15 2.56 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.453 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -33.02 -59.1 0.36 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.78 1.632 . . . . 0.0 115.358 -174.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 t -125.62 72.92 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.664 0.745 . . . . 0.0 109.259 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . 0.252 12.9 mt-30 53.33 -139.14 1.05 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.4 -37.73 1.82 Allowed Glycine 0 N--CA 1.474 1.21 0 N-CA-C 116.527 1.371 . . . . 0.0 116.527 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.1 m -54.13 99.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 126.681 1.992 . . . . 0.0 115.718 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.6 m -94.76 75.3 3.66 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 112.396 -2.184 . . . . 0.0 108.519 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -78.78 -29.92 45.28 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 111.103 -2.771 . . . . 0.0 113.106 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 mmm-85 -50.38 155.73 0.98 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.528 1.531 . . . . 0.0 113.82 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 63.9 -57.19 0.21 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.932 2.093 . . . . 0.0 114.968 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -46.26 -55.17 7.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.06 2.144 . . . . 0.0 111.049 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.1 -68.96 0.13 Allowed 'General case' 0 C--N 1.323 -0.58 0 O-C-N 125.167 1.542 . . . . 0.0 112.432 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -38.92 -63.55 0.52 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.575 1.95 . . . . 0.0 114.987 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.3 -52.15 63.16 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.876 1.67 . . . . 0.0 113.489 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.29 -36.66 77.26 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -41.39 99.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.864 0.865 . . . . 0.0 112.818 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -53.07 -51.69 60.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.778 0.831 . . . . 0.0 110.884 168.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -61.27 -40.04 92.65 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.65 -34.04 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.883 1.273 . . . . 0.0 111.55 172.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.3 36.88 4.23 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 125.082 1.325 . . . . 0.0 113.119 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.0 m -123.0 158.56 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 124.37 2.033 . . . . 0.0 115.005 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -126.2 155.61 36.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 110.856 -2.883 . . . . 0.0 109.434 -172.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.47 -144.67 13.99 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.108 0.861 . . . . 0.0 111.695 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -166.0 168.16 15.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.356 1.614 . . . . 0.0 115.356 -173.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.3 t -107.47 136.46 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 112.395 -2.184 . . . . 0.0 108.572 177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -115.12 114.28 25.11 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.639 1.576 . . . . 0.0 109.293 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -93.46 119.23 32.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 112.312 -2.222 . . . . 0.0 109.752 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 p -98.67 179.78 4.56 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.893 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.6 p -58.02 -52.66 64.6 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 113.906 -1.497 . . . . 0.0 113.25 171.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.08 49.44 0.84 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.48 3.29 2.89 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 119.576 2.59 . . . . 0.0 119.576 165.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.9 p -64.83 83.52 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 123.0 1.381 . . . . 0.0 111.355 168.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.2 t -75.25 93.98 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 112.277 -2.238 . . . . 0.0 109.234 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.5 t -102.61 -169.52 1.67 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 109.987 -3.279 . . . . 0.0 109.69 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.6 -163.99 24.93 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.123 1.344 . . . . 0.0 113.47 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -123.73 131.09 53.53 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 112.021 -2.09 . . . . 0.0 112.646 -168.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.88 108.74 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.229 1.812 . . . . 0.0 107.342 172.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.01 131.35 55.46 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 170.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -168.18 158.77 31.7 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.306 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -59.84 142.64 99.0 Favored 'Trans proline' 0 C--N 1.325 -0.705 0 C-N-CA 121.839 1.692 . . . . 0.0 110.541 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -33.06 -65.95 0.15 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -36.42 48.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -72.74 -41.83 64.74 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.449 1.1 . . . . 0.0 112.487 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . 0.303 8.6 m -65.19 -33.92 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 172.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -57.11 -47.56 80.79 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.16 0.984 . . . . 0.0 112.932 169.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.4 t -60.18 -45.02 94.53 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.815 1.246 . . . . 0.0 112.593 174.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -40.88 85.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.403 1.481 . . . . 0.0 113.937 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.61 -40.23 88.72 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 171.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.8 m -58.49 -41.93 86.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.699 0.761 . . . . 0.0 111.093 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -76.23 179.06 5.97 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.447 1.499 . . . . 0.0 110.597 164.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.8 mt 71.01 -36.74 0.37 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.469 2.307 . . . . 0.0 114.965 -173.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.7 p -78.85 -42.08 28.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.711 2.004 . . . . 0.0 109.342 162.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.73 99.64 0.12 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 158.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.3 m -108.26 91.41 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 111.426 -2.625 . . . . 0.0 114.53 -169.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.39 158.73 19.91 Favored Glycine 0 N--CA 1.478 1.487 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.583 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.1 t -126.59 139.94 36.09 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 -163.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -102.12 8.21 0.47 Allowed 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 122.342 2.028 . . . . 0.0 116.026 158.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.2 m -178.66 -68.55 0.01 OUTLIER 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.587 2.355 . . . . 0.0 112.187 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 p -114.65 173.07 6.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.635 1.174 . . . . 0.0 113.86 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.449 ' CZ ' ' H ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -78.39 129.07 34.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.093 172.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mp -75.2 85.22 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -76.6 91.16 3.38 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 113.788 -1.551 . . . . 0.0 113.456 -171.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 68.39 112.87 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 111.194 -2.73 . . . . 0.0 113.878 172.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.4 m -117.28 117.06 28.51 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.306 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -102.26 140.41 36.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.219 -2.264 . . . . 0.0 109.086 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -115.91 99.06 7.01 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.539 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.9 p -137.74 156.91 47.47 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.492 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 69.44 90.35 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.58 1.552 . . . . 0.0 110.749 -165.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -118.25 111.67 19.09 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.641 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -137.61 110.45 7.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.606 -1.179 . . . . 0.0 113.948 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -68.48 123.42 20.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.919 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 pt -126.07 -159.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.977 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 t -132.03 143.67 50.22 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.482 0.713 . . . . 0.0 109.921 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 59.01 157.34 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.2 mt -97.32 92.73 6.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.856 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -83.04 34.55 0.46 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -168.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -155.64 150.44 26.34 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.887 0.875 . . . . 0.0 111.858 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 p -78.25 85.78 4.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.824 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.6 m120 59.83 176.66 0.09 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 112.65 -2.068 . . . . 0.0 114.19 -176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -78.72 112.48 15.89 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 122.612 1.196 . . . . 0.0 109.06 164.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.7 p -108.7 -139.53 0.38 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 111.68 -2.509 . . . . 0.0 114.978 -163.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.7 m -104.19 -170.81 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.38 1.872 . . . . 0.0 112.162 -164.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -76.77 126.03 30.28 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.717 177.143 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 N--CA 1.47 0.112 0 N-CA-C 116.465 1.679 . . . . 0.0 116.465 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.5 tp -166.64 38.49 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 129.101 2.96 . . . . 0.0 107.108 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -104.37 79.51 1.59 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.896 1.814 . . . . 0.0 115.896 -153.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.1 t -58.53 128.67 38.32 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.935 -176.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.8 m -114.94 142.0 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 126.169 2.168 . . . . 0.0 112.344 -173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.06 120.45 42.56 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.802 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -104.34 124.41 49.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.603 -2.089 . . . . 0.0 112.698 -173.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -100.91 113.61 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.522 168.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.1 t -71.34 121.67 21.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 112.313 -2.221 . . . . 0.0 111.12 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -132.43 150.4 52.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.499 166.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.613 ' H ' ' NH2' ' A' ' 74' ' ' ARG . . . -176.15 -146.07 5.82 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -98.64 -79.82 0.47 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.422 -0.889 . . . . 0.0 111.363 -170.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.35 120.33 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.858 1.263 . . . . 0.0 109.736 -173.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.439 HE22 ' CZ ' ' A' ' 74' ' ' ARG . 93.3 mm-40 -66.76 137.34 56.58 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.897 -172.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.94 94.8 1.96 Allowed Glycine 0 N--CA 1.479 1.535 0 CA-C-N 113.37 -1.741 . . . . 0.0 112.936 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.285 2.6 t -27.91 -71.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 127.898 2.479 . . . . 0.0 117.218 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.7 t 64.44 -27.54 0.09 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 119.429 3.122 . . . . 0.0 119.429 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.97 20.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 118.4 2.741 . . . . 0.0 118.4 -177.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -62.86 -73.38 0.11 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.193 1.797 . . . . 0.0 113.452 -166.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.6 mmt -50.21 -46.81 54.87 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -45.88 -58.46 3.51 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.148 1.379 . . . . 0.0 112.872 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.98 75.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.244 1.418 . . . . 0.0 112.976 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -55.36 -58.46 7.62 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.081 1.353 . . . . 0.0 112.841 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -57.09 -52.82 63.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.607 -1.633 . . . . 0.0 112.228 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -57.99 -57.68 11.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.492 0.717 . . . . 0.0 111.835 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 -45.75 75.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 64.9 mtt-85 -53.9 -55.85 23.08 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.524 1.13 . . . . 0.0 111.559 174.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -58.74 -35.02 72.04 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.217 -1.356 . . . . 0.0 113.972 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.6 pt -107.45 34.98 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.53 33.51 81.96 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 168.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.4 t -124.51 118.78 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.51 164.46 28.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 114.529 -1.214 . . . . 0.0 114.182 -173.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.58 -120.99 1.3 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.698 1.618 . . . . 0.0 111.013 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -164.04 163.15 23.38 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.38 135.58 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.043 1.737 . . . . 0.0 107.01 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -138.51 137.0 36.68 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.41 0.684 . . . . 0.0 111.592 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -88.0 140.81 29.11 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.181 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.0 p -77.76 37.22 0.23 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 128.059 2.544 . . . . 0.0 110.892 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . 0.262 25.1 p 65.0 -50.99 0.34 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 128.682 2.793 . . . . 0.0 113.477 -154.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -134.88 132.58 38.71 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -167.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.72 -65.62 3.67 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 114.122 -1.399 . . . . 0.0 116.228 166.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.5 p -90.51 157.71 17.4 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.436 1.894 . . . . 0.0 113.707 -176.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.15 131.64 72.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 171.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 p -107.8 104.4 13.88 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 110.944 -2.844 . . . . 0.0 107.41 166.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -120.18 176.27 16.14 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.734 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -129.9 132.81 46.52 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.3 t -116.09 119.16 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.884 2.874 . . . . 0.0 108.209 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -53.69 157.41 2.27 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.434 1.894 . . . . 0.0 112.738 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -18.91 96.51 0.01 OUTLIER Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.001 2.238 . . . . 0.0 116.665 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.3 86.85 0.09 OUTLIER 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.552 2.168 . . . . 0.0 112.559 164.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.41 101.3 7.54 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 111.015 -2.811 . . . . 0.0 109.419 171.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.445 0.4 OUTLIER 55.53 -88.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 112.209 -2.269 . . . . 0.0 116.766 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -49.25 -50.82 37.01 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.719 1.608 . . . . 0.0 112.404 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -56.05 -36.57 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.844 1.658 . . . . 0.0 111.821 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -56.61 -35.35 68.19 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.0 p -61.56 -32.81 72.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -67.23 -28.79 68.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.344 1.058 . . . . 0.0 112.94 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -61.73 -37.92 86.02 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.3 m -54.88 -49.21 71.75 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.864 0.866 . . . . 0.0 111.176 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -53.15 -59.22 4.83 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.531 1.533 . . . . 0.0 112.79 171.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.6 mt -59.99 -17.41 38.2 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.8 p -92.92 -53.83 3.99 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 172.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -71.98 -42.96 65.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -170.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.37 113.86 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 -165.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.74 80.91 0.52 Allowed Glycine 0 CA--C 1.532 1.104 0 CA-C-N 113.323 -1.762 . . . . 0.0 110.777 166.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.2 m -63.87 -45.09 80.95 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-O 117.769 -1.11 . . . . 0.0 113.404 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -91.77 102.53 0.22 Allowed 'Trans proline' 0 CA--C 1.53 0.313 0 N-CA-C 106.554 -2.133 . . . . 0.0 106.554 155.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.8 m 67.85 124.04 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.5 p -83.14 53.31 2.42 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.185 -1.825 . . . . 0.0 114.416 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.613 ' NH2' ' H ' ' A' ' 15' ' ' GLY . 1.7 tpm_? -87.47 -10.99 50.3 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.027 -1.897 . . . . 0.0 110.205 165.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.46 96.09 4.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -134.74 -48.79 0.75 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 112.58 -2.1 . . . . 0.0 111.838 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.567 ' NH1' HD22 ' A' ' 79' ' ' ASN . 52.6 ttt-85 -123.27 88.48 2.93 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.389 1.476 . . . . 0.0 108.261 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.9 m -104.63 124.8 49.97 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 123.708 1.718 . . . . 0.0 112.117 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.567 HD22 ' NH1' ' A' ' 77' ' ' ARG . 1.4 m-80 -87.81 86.9 7.22 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 110.841 -2.89 . . . . 0.0 112.545 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -74.44 88.66 2.11 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.141 -1.845 . . . . 0.0 110.731 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.4 t -120.61 -165.7 1.24 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.144 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 t30 47.67 74.06 0.18 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.112 2.165 . . . . 0.0 110.75 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -101.31 102.71 13.61 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.783 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.53 113.04 21.42 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 112.147 -2.297 . . . . 0.0 112.718 -177.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.5 p -65.53 102.05 0.67 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.755 1.264 . . . . 0.0 113.872 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.3 pt -85.11 77.48 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 112.206 -2.27 . . . . 0.0 113.326 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.2 m -50.09 -34.98 23.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 112.692 -2.049 . . . . 0.0 112.92 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -113.84 108.08 16.58 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 166.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 70.3 tp -67.38 76.94 0.16 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 124.283 1.992 . . . . 0.0 109.513 170.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -96.34 59.29 1.86 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 112.468 -2.151 . . . . 0.0 114.609 -171.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.5 131.27 0.09 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 128.574 2.75 . . . . 0.0 109.143 174.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.2 p -132.69 65.14 1.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 123.182 1.468 . . . . 0.0 109.469 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -174.85 134.7 0.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 111.43 -2.623 . . . . 0.0 109.129 -168.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -111.31 94.33 4.92 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 168.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.9 t -98.03 165.37 11.94 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 118.215 2.672 . . . . 0.0 118.215 -153.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.11 141.06 7.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 127.874 2.47 . . . . 0.0 115.276 -170.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -59.63 104.5 0.28 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.885 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 N--CA 1.477 0.881 0 CA-C-N 113.148 -1.842 . . . . 0.0 112.948 -179.557 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo . . . . . 0 CA--C 1.536 0.582 0 N-CA-C 119.342 2.786 . . . . 0.0 119.342 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.95 117.01 33.65 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.944 1.354 . . . . 0.0 111.273 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -85.28 121.5 28.1 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.555 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.5 t -107.87 93.32 4.47 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 123.589 1.662 . . . . 0.0 108.565 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.252 8.0 p -98.3 107.38 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 112.728 -2.033 . . . . 0.0 112.137 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -85.73 94.18 9.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 112.468 -2.151 . . . . 0.0 110.143 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -70.79 166.61 20.6 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 112.185 -2.28 . . . . 0.0 113.044 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -136.35 113.03 10.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.752 1.621 . . . . 0.0 110.764 167.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.8 124.67 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.35 1.06 . . . . 0.0 113.81 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.58 91.81 3.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 123.085 1.421 . . . . 0.0 108.394 164.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.81 87.11 0.25 Allowed Glycine 0 CA--C 1.54 1.597 0 CA-C-N 112.665 -2.061 . . . . 0.0 112.539 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -53.17 -55.72 22.02 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.835 1.254 . . . . 0.0 113.713 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 p -108.75 129.2 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 123.751 0.657 . . . . 0.0 109.824 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 71.84 -30.86 0.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.022 2.129 . . . . 0.0 116.081 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -22.33 -64.16 0.03 OUTLIER Glycine 0 CA--C 1.53 1.02 0 C-N-CA 129.054 3.216 . . . . 0.0 117.408 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.0 m -70.39 63.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.8 t -149.04 -85.56 0.09 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.396 1.878 . . . . 0.0 110.104 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . 0.364 34.2 p90 58.14 -46.91 0.05 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 119.528 3.158 . . . . 0.0 119.528 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -12.05 -81.11 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.939 2.895 . . . . 0.0 117.298 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -44.04 -55.51 4.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.057 1.343 . . . . 0.0 114.004 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -57.61 -58.51 7.99 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.828 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.76 -53.03 62.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.477 1.111 . . . . 0.0 113.602 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.3 -54.78 27.08 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.864 2.466 . . . . 0.0 113.725 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -56.72 -52.66 64.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.328 1.051 . . . . 0.0 111.851 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -66.17 -47.57 73.55 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.737 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.04 -47.68 74.47 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -55.9 -50.76 69.78 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.776 0.83 . . . . 0.0 112.522 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -58.12 -37.04 73.82 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.08 1.352 . . . . 0.0 114.274 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.7 mm -76.13 -36.34 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.981 0.912 . . . . 0.0 111.979 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.27 67.85 1.21 Allowed Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.876 1.227 . . . . 0.0 110.56 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.3 p -158.34 154.64 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.757 1.623 . . . . 0.0 111.62 -173.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . 0.473 3.7 p 65.15 152.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 128.929 2.892 . . . . 0.0 115.416 170.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.97 -89.29 1.53 Allowed Glycine 0 N--CA 1.477 1.422 0 CA-C-N 112.802 -1.999 . . . . 0.0 113.191 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -135.17 159.69 40.73 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 t -109.66 136.23 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 113.004 -1.907 . . . . 0.0 108.074 173.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -118.19 133.01 56.28 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.46 1.904 . . . . 0.0 112.224 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -75.18 146.47 41.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 112.027 -2.351 . . . . 0.0 112.766 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.0 p -123.15 161.47 24.39 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.328 168.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 p -64.57 -22.02 66.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 113.286 -1.779 . . . . 0.0 113.932 169.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -101.8 11.46 38.68 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -168.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.66 -35.94 1.2 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.096 0.855 . . . . 0.0 114.082 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.0 p -61.16 79.97 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.291 2.236 . . . . 0.0 111.728 172.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.51 141.0 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 111.854 -2.43 . . . . 0.0 111.254 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.5 t -113.31 131.64 55.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 113.436 -1.711 . . . . 0.0 111.832 -173.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -133.85 143.03 14.6 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.296 -175.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -98.21 86.94 3.78 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 112.914 -1.643 . . . . 0.0 112.468 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.9 t -86.74 82.75 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 111.86 -2.427 . . . . 0.0 110.534 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.584 HE21 ' CD1' ' A' ' 86' ' ' ILE . 40.3 tt0 -88.03 115.87 25.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.962 -1.927 . . . . 0.0 109.875 173.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 157.89 -82.35 0.15 Allowed Glycine 0 N--CA 1.468 0.827 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.698 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -15.18 82.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.327 -0.58 1 C-N-CA 125.343 4.029 . . . . 0.0 118.35 -158.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.501 ' H ' ' CG1' ' A' ' 58' ' ' VAL . 66.9 tt0 -129.24 107.63 9.7 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.467 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 57.91 -88.29 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.487 2.315 . . . . 0.0 114.569 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -57.1 -43.5 82.32 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.299 0.639 . . . . 0.0 111.935 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.501 ' CG1' ' H ' ' A' ' 55' ' ' GLU 0.33 14.8 p -84.83 2.17 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -60.49 -35.45 75.94 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.487 -0.758 . . . . 0.0 111.517 164.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -51.23 -38.57 53.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.127 1.371 . . . . 0.0 114.023 173.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -53.23 60.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.052 0.541 . . . . 0.0 111.28 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -54.5 -51.62 64.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.728 1.211 . . . . 0.0 112.858 173.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.4 t -57.57 -31.12 65.83 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.051 1.74 . . . . 0.0 115.293 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -76.9 -50.8 12.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.205 1.802 . . . . 0.0 114.467 170.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.1 tp -51.4 -26.86 8.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.163 2.185 . . . . 0.0 115.482 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.7 p -53.82 -60.3 3.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.158 2.183 . . . . 0.0 113.967 170.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -127.17 70.82 1.31 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.768 2.427 . . . . 0.0 109.5 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -54.95 -29.04 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.83 -84.5 0.48 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.691 171.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.9 t -128.28 -74.68 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -44.12 102.39 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 124.213 3.275 . . . . 0.0 114.173 -154.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.8 p 42.25 45.91 3.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.655 -2.521 . . . . 0.0 115.303 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.1 p -155.38 -66.35 0.12 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 68.4 -61.52 0.4 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.894 2.078 . . . . 0.0 114.158 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.6 mt 32.05 110.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 128.963 2.905 . . . . 0.0 113.74 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -67.71 -32.28 72.81 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -163.49 110.71 1.17 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.065 0.946 . . . . 0.0 111.686 171.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.7 m -88.75 101.11 13.68 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.448 1.594 . . . . 0.0 109.471 166.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -68.24 98.92 0.85 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 111.602 -2.545 . . . . 0.0 111.155 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -79.31 78.72 5.79 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 124.041 1.877 . . . . 0.0 112.42 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.5 p -92.67 -69.17 0.76 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 110.977 -2.829 . . . . 0.0 115.302 -169.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -80.75 75.75 7.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 123.686 1.707 . . . . 0.0 110.955 -175.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -87.44 83.41 7.3 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 111.885 -2.416 . . . . 0.0 111.235 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -96.92 91.85 5.83 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.143 -1.844 . . . . 0.0 109.218 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.1 p -74.6 115.21 13.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.255 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.584 ' CD1' HE21 ' A' ' 52' ' ' GLN . 2.6 pp -122.01 149.49 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 110.618 -2.992 . . . . 0.0 111.658 -174.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.0 p -82.32 101.72 10.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 113.703 -1.589 . . . . 0.0 112.083 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.292 33.8 mmtp 98.55 149.05 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.538 2.335 . . . . 0.0 116.343 168.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.6 tp -103.22 130.29 50.41 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.304 -173.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -119.99 -44.32 2.51 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.192 -1.367 . . . . 0.0 112.587 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -73.95 95.16 2.44 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.885 1.274 . . . . 0.0 113.987 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.9 p -86.21 -22.2 27.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 111.546 -2.57 . . . . 0.0 115.811 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -137.5 108.47 6.72 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.898 0.749 . . . . 0.0 112.539 -162.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.65 125.79 26.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.815 171.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.4 t -149.97 111.28 4.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.31 25.6 m 48.39 -178.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 120.195 3.405 . . . . 0.0 120.195 161.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -105.97 139.38 40.61 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.841 -1.527 . . . . 0.0 113.662 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 C--O 1.246 0.88 0 CA-C-N 112.4 -2.182 . . . . 0.0 113.446 -179.776 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo . . . . . 0 CA--C 1.539 0.75 0 N-CA-C 114.556 0.944 . . . . 0.0 114.556 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 mp -114.18 97.25 6.24 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -98.88 113.64 25.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.976 -161.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 t -103.33 101.88 11.81 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.248 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -116.1 142.14 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 112.821 -1.99 . . . . 0.0 112.077 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -100.24 121.79 42.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 123.33 1.538 . . . . 0.0 110.353 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -103.02 148.76 25.29 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 111.933 -2.394 . . . . 0.0 111.863 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -124.15 85.94 2.49 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 111.821 -2.445 . . . . 0.0 109.51 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.66 110.38 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 123.104 1.43 . . . . 0.0 110.521 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -93.84 77.77 4.2 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 111.126 -2.761 . . . . 0.0 106.855 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.66 54.31 0.55 Allowed Glycine 0 N--CA 1.479 1.503 0 CA-C-N 112.015 -2.357 . . . . 0.0 109.991 173.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -36.06 79.25 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -174.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.1 m -80.22 52.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 52.68 -110.89 0.55 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 127.012 2.125 . . . . 0.0 112.484 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.75 -56.39 0.35 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 119.087 2.395 . . . . 0.0 119.087 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 m -77.14 100.24 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -171.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.43 64.98 1.02 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 124.582 2.135 . . . . 0.0 107.634 162.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.96 -31.43 50.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 111.702 -2.499 . . . . 0.0 113.709 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -32.7 -59.72 0.32 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.909 2.083 . . . . 0.0 115.538 170.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.1 tpt -54.9 -38.24 67.33 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -73.36 -53.48 10.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.915 1.686 . . . . 0.0 111.284 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.25 -37.35 64.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.283 1.433 . . . . 0.0 113.143 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.28 -83.42 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.594 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -63.97 -59.62 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.005 1.322 . . . . 0.0 114.209 -170.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.24 -43.88 90.0 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.12 -43.38 98.58 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.5 ttp-105 -52.35 -55.72 19.65 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.732 0.813 . . . . 0.0 110.866 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -57.63 -40.78 79.98 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.017 1.727 . . . . 0.0 114.794 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.8 mm -71.11 -29.76 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.105 0.962 . . . . 0.0 113.418 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.1 38.67 4.77 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 124.568 1.08 . . . . 0.0 112.702 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.3 t -110.62 141.45 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 123.77 1.748 . . . . 0.0 111.736 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 t -126.47 156.18 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 111.002 -2.817 . . . . 0.0 111.125 -172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.89 -149.61 20.73 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.074 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -153.46 146.36 24.44 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.328 1.451 . . . . 0.0 111.084 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.99 144.52 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.979 0.912 . . . . 0.0 109.583 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -132.52 137.49 47.18 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.493 0.717 . . . . 0.0 112.298 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -94.97 93.35 7.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 122.676 1.227 . . . . 0.0 110.281 168.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.7 t -80.53 163.43 23.73 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -168.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.2 p -54.02 -35.03 61.49 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.126 -1.852 . . . . 0.0 113.911 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -66.3 -1.76 3.72 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.46 -41.08 2.62 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 124.952 1.263 . . . . 0.0 111.612 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.93 140.66 24.06 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.981 2.112 . . . . 0.0 113.804 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.0 t -92.01 103.36 14.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 123.986 1.851 . . . . 0.0 107.278 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.7 t -109.77 -164.26 0.92 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 111.738 -2.483 . . . . 0.0 110.156 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.26 -173.79 15.69 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 126.378 1.942 . . . . 0.0 110.89 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -125.74 134.34 51.79 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 112.257 -1.972 . . . . 0.0 111.91 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.41 117.02 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 111.278 -2.692 . . . . 0.0 109.942 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.15 130.11 48.7 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 112.619 -2.082 . . . . 0.0 107.6 171.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.5 149.05 17.41 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.626 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -65.99 145.84 80.82 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 121.554 1.503 . . . . 0.0 109.822 166.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -17.83 -61.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.09 -39.97 91.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -65.92 -39.31 90.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.238 1.015 . . . . 0.0 111.718 174.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.2 t -61.69 -42.63 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.244 1.018 . . . . 0.0 112.286 175.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -55.33 -46.54 76.33 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.7 p -69.02 -47.22 65.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.578 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -49.98 -52.58 32.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.695 1.598 . . . . 0.0 114.19 176.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -59.17 -38.15 79.08 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.9 m -63.98 -57.69 8.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.055 170.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -46.61 -46.06 19.43 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 127.781 2.432 . . . . 0.0 115.262 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.6 mt -90.1 13.1 15.84 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . 0.265 53.4 p -101.64 -109.23 0.23 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -110.22 75.61 0.94 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.222 2.209 . . . . 0.0 107.911 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.09 -52.1 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 112.426 -2.17 . . . . 0.0 114.698 -166.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.13 -56.8 3.62 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 115.792 1.077 . . . . 0.0 115.792 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.6 m -41.58 145.49 0.66 Allowed Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 127.415 2.286 . . . . 0.0 115.932 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.92 -27.36 8.46 Favored 'Cis proline' 0 CA--C 1.535 0.569 0 N-CA-C 117.774 2.182 . . . . 0.0 117.774 -10.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.5 p -131.19 -43.83 1.04 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.0 m -97.27 121.98 39.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.713 2.005 . . . . 0.0 112.818 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.84 86.37 0.51 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -172.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.43 91.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 114.055 -1.429 . . . . 0.0 107.765 167.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.55 -55.25 14.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 110.708 -2.951 . . . . 0.0 115.838 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.54 145.6 9.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.745 0.818 . . . . 0.0 110.007 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.3 m -152.22 138.15 18.1 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -98.18 140.23 32.79 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.214 -2.721 . . . . 0.0 109.184 167.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -114.37 109.82 18.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.68 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.49 167.67 13.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 113.219 -1.809 . . . . 0.0 111.986 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 53.82 84.89 0.06 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.909 1.284 . . . . 0.0 113.264 172.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.2 111.76 24.51 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 123.057 1.408 . . . . 0.0 113.728 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -100.03 91.14 4.65 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 111.63 -2.532 . . . . 0.0 107.069 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 p -74.28 84.31 1.9 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 123.107 1.432 . . . . 0.0 109.034 172.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.1 pt -112.34 154.35 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 112.98 -1.918 . . . . 0.0 114.333 -165.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.1 t -59.15 132.41 53.92 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.229 -1.805 . . . . 0.0 111.864 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp 61.56 149.9 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.8 mt -85.51 97.58 10.13 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 113.782 -1.554 . . . . 0.0 111.07 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -84.16 82.03 8.54 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.492 -173.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 154.19 150.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 129.97 3.308 . . . . 0.0 111.965 167.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.3 p -82.07 88.42 6.43 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.504 1.145 . . . . 0.0 110.293 169.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.2 m120 61.42 172.14 0.11 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 111.211 -2.722 . . . . 0.0 113.209 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -73.56 69.59 1.25 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.245 1.497 . . . . 0.0 110.807 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.5 110.42 15.95 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 112.585 -2.098 . . . . 0.0 116.078 -166.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.258 27.2 m 54.95 163.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 110.768 -2.924 . . . . 0.0 117.035 165.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -111.66 113.15 25.35 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.215 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 . . . . . 0 C--O 1.246 0.873 0 CA-C-N 111.519 -2.582 . . . . 0.0 111.717 -177.373 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 CA--C 1.534 0.515 0 N-CA-C 115.434 1.282 . . . . 0.0 115.434 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.08 127.22 41.06 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 164.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -97.16 115.6 27.84 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.199 1.0 . . . . 0.0 111.598 -163.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.9 t -107.24 122.98 47.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.127 -1.851 . . . . 0.0 110.36 166.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 t -112.98 108.03 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 111.314 -2.675 . . . . 0.0 108.262 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -88.24 97.36 10.98 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 113.106 -1.861 . . . . 0.0 107.715 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -94.79 150.68 19.95 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 109.122 -3.672 . . . . 0.0 112.56 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -127.8 97.52 4.86 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.008 166.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.6 t -68.78 126.58 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.005 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -127.94 137.0 52.1 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.545 0.528 . . . . 0.0 111.515 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -105.52 121.08 6.68 Favored Glycine 0 N--CA 1.476 1.352 0 O-C-N 124.819 1.324 . . . . 0.0 112.313 -175.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -38.68 -43.56 0.91 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 172.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -121.84 146.98 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.581 163.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -52.83 168.65 0.11 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.6 -78.5 0.28 Allowed Glycine 0 N--CA 1.477 1.377 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.655 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 t 66.98 -72.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 128.277 2.631 . . . . 0.0 111.234 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.7 m 42.05 38.83 1.16 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.391 1.876 . . . . 0.0 115.316 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -63.02 -27.9 69.73 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 112.722 -2.036 . . . . 0.0 113.754 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -21.03 -73.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 174.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 67.7 mtm -60.67 -40.59 92.69 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -62.91 -46.89 85.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.894 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.7 -56.86 10.0 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 125.001 1.438 . . . . 0.0 111.925 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -51.43 -60.0 3.62 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.669 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.23 -53.14 61.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.195 1.398 . . . . 0.0 113.468 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -65.51 -38.61 90.2 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.549 0.74 . . . . 0.0 112.203 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.9 -47.53 77.27 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.017 0.927 . . . . 0.0 112.985 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -52.23 -49.89 63.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.796 1.238 . . . . 0.0 111.196 173.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.97 -51.67 68.26 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.272 1.429 . . . . 0.0 114.444 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mm -67.8 -25.69 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.4 1.08 . . . . 0.0 112.705 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.28 53.85 1.67 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.33 0.966 . . . . 0.0 111.788 -174.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -116.6 140.13 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 123.41 1.576 . . . . 0.0 109.58 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.5 m -119.98 166.74 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 111.982 -2.372 . . . . 0.0 111.048 173.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.1 -135.3 7.41 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.5 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -162.1 151.07 15.45 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 113.456 -1.372 . . . . 0.0 111.367 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.7 p -114.91 136.4 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.681 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -117.01 123.3 46.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.202 1.477 . . . . 0.0 112.508 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -64.93 114.73 4.74 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 111.399 -2.637 . . . . 0.0 109.161 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.0 -130.17 0.26 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.995 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.6 m -107.4 108.38 19.7 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.897 -1.127 . . . . 0.0 110.623 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp 49.76 85.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.95 -31.3 1.08 Allowed Glycine 0 N--CA 1.473 1.115 0 CA-C-N 113.086 -1.87 . . . . 0.0 116.319 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.8 p -59.87 147.49 38.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.375 1.07 . . . . 0.0 112.076 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.64 124.92 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 112.163 -2.289 . . . . 0.0 113.575 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -92.23 -171.91 2.96 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 109.26 -3.609 . . . . 0.0 109.896 159.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 129.5 -155.84 21.04 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.698 2.094 . . . . 0.0 111.191 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -130.94 109.6 10.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.362 1.465 . . . . 0.0 112.659 -173.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 t -94.33 97.65 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.376 171.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -100.77 107.68 19.31 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.592 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.19 150.87 20.32 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 114.429 -1.26 . . . . 0.0 113.673 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.93 153.14 52.68 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.142 1.894 . . . . 0.0 111.147 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -39.84 -49.06 2.36 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -173.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -63.19 -62.91 1.38 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.037 0.381 . . . . 0.0 111.547 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -59.56 -31.34 69.34 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . 0.287 1.7 p -55.78 -35.41 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.57 -41.07 66.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.9 t -67.55 -54.35 20.65 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.669 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 20.1 ptp -58.13 -36.77 73.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -52.38 -61.63 2.15 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.088 1.355 . . . . 0.0 111.737 171.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.3 m -54.04 -43.5 70.23 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -58.11 -53.99 51.99 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 mt -51.57 -29.58 17.69 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -80.02 -69.93 0.55 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.916 -1.493 . . . . 0.0 114.777 167.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -63.86 -27.16 68.97 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.357 8.1 p 62.01 -70.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 129.394 3.078 . . . . 0.0 118.548 172.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.94 -111.67 2.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.88 1.228 . . . . 0.0 111.687 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.1 p -73.18 -30.96 1.33 Allowed Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 118.952 2.945 . . . . 0.0 118.952 -170.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -56.95 109.93 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 CA-C-N 123.075 2.134 . . . . 0.0 112.846 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -43.2 -30.79 0.51 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.222 2.609 . . . . 0.0 114.174 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -49.63 -23.93 1.95 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 74.1 -33.04 0.24 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 127.941 2.496 . . . . 0.0 116.505 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . 0.337 4.1 mp 58.37 -84.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.723 2.009 . . . . 0.0 112.044 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.31 2.6 p30 57.76 -41.37 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 128.313 2.645 . . . . 0.0 117.928 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.48 ' NH1' HD22 ' A' ' 79' ' ' ASN . 38.9 ttt-85 -110.58 101.69 10.33 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 123.313 1.53 . . . . 0.0 111.116 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.7 m -118.17 127.9 54.2 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 112.784 -2.007 . . . . 0.0 111.584 172.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASN . . . . . 0.48 HD22 ' NH1' ' A' ' 77' ' ' ARG . 2.4 m-80 -82.73 83.57 7.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 111.484 -2.598 . . . . 0.0 110.861 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -72.27 37.8 0.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.682 -2.053 . . . . 0.0 112.953 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 m -59.78 -36.39 76.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.063 2.145 . . . . 0.0 115.887 -163.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -116.17 88.38 2.88 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.05 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -92.95 102.88 15.24 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.844 169.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -108.47 119.99 41.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 111.462 -2.608 . . . . 0.0 110.31 -173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.6 p -82.8 92.17 7.19 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 123.756 1.741 . . . . 0.0 111.934 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.5 pt -80.64 140.42 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 111.166 -2.743 . . . . 0.0 114.052 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.4 m -73.33 87.36 1.51 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.808 -1.996 . . . . 0.0 111.289 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 73.08 156.32 0.17 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-N 112.247 -2.251 . . . . 0.0 112.42 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.25 111.15 10.2 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.949 0.881 . . . . 0.0 111.113 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.7 13.58 8.47 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -162.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -148.51 155.21 40.86 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.328 1.051 . . . . 0.0 111.751 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.6 p -68.62 -46.69 68.6 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.519 -1.219 . . . . 0.0 114.056 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -156.54 172.93 17.69 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.429 1.492 . . . . 0.0 111.101 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -72.93 94.98 1.91 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.789 1.28 . . . . 0.0 110.586 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.4 m -63.06 142.96 58.18 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.305 -2.225 . . . . 0.0 114.496 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 85.3 t -63.75 143.14 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 110.792 -2.913 . . . . 0.0 110.032 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.1 ptt85 -6.63 123.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 120.306 3.446 . . . . 0.0 120.306 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 112.066 -2.334 . . . . 0.0 112.514 165.995 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.502 ' H2 ' ' NH2' ' A' ' 4' ' ' ARG . 10.0 p . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.5 p -50.38 -33.06 19.24 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.9 -23.34 4.79 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . 0.502 ' NH2' ' H2 ' ' A' ' 1' ' ' SER . 1.2 mpp_? -96.5 119.19 64.5 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.541 1.136 . . . . 0.0 111.294 176.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -71.92 59.97 2.93 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 123.428 2.752 . . . . 0.0 114.124 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -124.63 106.83 10.42 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.576 2.351 . . . . 0.0 107.348 173.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -107.06 112.11 24.89 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.878 -166.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 4.4 p -85.1 104.64 15.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.833 167.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 93.0 t -109.75 143.57 19.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 110.221 -3.172 . . . . 0.0 108.028 -177.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -109.05 142.17 40.13 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.976 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -120.33 159.58 24.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.351 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -144.76 116.82 8.34 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.945 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.48 121.74 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 112.467 -2.151 . . . . 0.0 107.054 170.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.31 71.51 10.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.74 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.27 73.15 2.56 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.453 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -33.02 -59.1 0.36 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.78 1.632 . . . . 0.0 115.358 -174.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 t -125.62 72.92 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.664 0.745 . . . . 0.0 109.259 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . 0.252 12.9 mt-30 53.33 -139.14 1.05 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 176.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.4 -37.73 1.82 Allowed Glycine 0 N--CA 1.474 1.21 0 N-CA-C 116.527 1.371 . . . . 0.0 116.527 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.1 m -54.13 99.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 126.681 1.992 . . . . 0.0 115.718 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.6 m -94.76 75.3 3.66 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 112.396 -2.184 . . . . 0.0 108.519 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -78.78 -29.92 45.28 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 111.103 -2.771 . . . . 0.0 113.106 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.8 mmm-85 -50.38 155.73 0.98 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.528 1.531 . . . . 0.0 113.82 176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 63.9 -57.19 0.21 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.932 2.093 . . . . 0.0 114.968 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -46.26 -55.17 7.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.06 2.144 . . . . 0.0 111.049 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.1 -68.96 0.13 Allowed 'General case' 0 C--N 1.323 -0.58 0 O-C-N 125.167 1.542 . . . . 0.0 112.432 172.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -38.92 -63.55 0.52 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.575 1.95 . . . . 0.0 114.987 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -63.3 -52.15 63.16 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.876 1.67 . . . . 0.0 113.489 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.29 -36.66 77.26 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -62.64 -41.39 99.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.864 0.865 . . . . 0.0 112.818 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -53.07 -51.69 60.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.778 0.831 . . . . 0.0 110.884 168.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -61.27 -40.04 92.65 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.3 mm -61.65 -34.04 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.883 1.273 . . . . 0.0 111.55 172.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.3 36.88 4.23 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 125.082 1.325 . . . . 0.0 113.119 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 29.0 m -123.0 158.56 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 124.37 2.033 . . . . 0.0 115.005 -179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -126.2 155.61 36.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 110.856 -2.883 . . . . 0.0 109.434 -172.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.47 -144.67 13.99 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.108 0.861 . . . . 0.0 111.695 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -166.0 168.16 15.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.356 1.614 . . . . 0.0 115.356 -173.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 83.3 t -107.47 136.46 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 112.395 -2.184 . . . . 0.0 108.572 177.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -115.12 114.28 25.11 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.639 1.576 . . . . 0.0 109.293 173.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -93.46 119.23 32.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 112.312 -2.222 . . . . 0.0 109.752 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 p -98.67 179.78 4.56 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.893 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.6 p -58.02 -52.66 64.6 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 113.906 -1.497 . . . . 0.0 113.25 171.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.08 49.44 0.84 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.48 3.29 2.89 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 119.576 2.59 . . . . 0.0 119.576 165.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.9 p -64.83 83.52 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 123.0 1.381 . . . . 0.0 111.355 168.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.2 t -75.25 93.98 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 112.277 -2.238 . . . . 0.0 109.234 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.5 t -102.61 -169.52 1.67 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 109.987 -3.279 . . . . 0.0 109.69 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.6 -163.99 24.93 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.123 1.344 . . . . 0.0 113.47 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -123.73 131.09 53.53 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 112.021 -2.09 . . . . 0.0 112.646 -168.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.88 108.74 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.229 1.812 . . . . 0.0 107.342 172.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -112.01 131.35 55.46 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 170.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -168.18 158.77 31.7 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.306 178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -59.84 142.64 99.0 Favored 'Trans proline' 0 C--N 1.325 -0.705 0 C-N-CA 121.839 1.692 . . . . 0.0 110.541 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -33.06 -65.95 0.15 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -36.42 48.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -72.74 -41.83 64.74 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.449 1.1 . . . . 0.0 112.487 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . 0.303 8.6 m -65.19 -33.92 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 172.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -57.11 -47.56 80.79 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.16 0.984 . . . . 0.0 112.932 169.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.4 t -60.18 -45.02 94.53 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.815 1.246 . . . . 0.0 112.593 174.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -40.88 85.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.403 1.481 . . . . 0.0 113.937 175.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.61 -40.23 88.72 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 171.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.8 m -58.49 -41.93 86.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.699 0.761 . . . . 0.0 111.093 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 24.0 t90 -76.23 179.06 5.97 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.447 1.499 . . . . 0.0 110.597 164.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.8 mt 71.01 -36.74 0.37 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.469 2.307 . . . . 0.0 114.965 -173.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.7 p -78.85 -42.08 28.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.711 2.004 . . . . 0.0 109.342 162.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.73 99.64 0.12 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 158.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.3 m -108.26 91.41 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 111.426 -2.625 . . . . 0.0 114.53 -169.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.39 158.73 19.91 Favored Glycine 0 N--CA 1.478 1.487 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.583 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.1 t -126.59 139.94 36.09 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 -163.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -102.12 8.21 0.47 Allowed 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 122.342 2.028 . . . . 0.0 116.026 158.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.2 m -178.66 -68.55 0.01 OUTLIER 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.587 2.355 . . . . 0.0 112.187 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 p -114.65 173.07 6.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.635 1.174 . . . . 0.0 113.86 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.449 ' CZ ' ' H ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -78.39 129.07 34.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.093 172.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mp -75.2 85.22 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -76.6 91.16 3.38 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 113.788 -1.551 . . . . 0.0 113.456 -171.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 68.39 112.87 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 111.194 -2.73 . . . . 0.0 113.878 172.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.4 m -117.28 117.06 28.51 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.306 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -102.26 140.41 36.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.219 -2.264 . . . . 0.0 109.086 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -115.91 99.06 7.01 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.539 -177.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.9 p -137.74 156.91 47.47 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.492 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 69.44 90.35 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.58 1.552 . . . . 0.0 110.749 -165.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -118.25 111.67 19.09 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.641 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -137.61 110.45 7.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.606 -1.179 . . . . 0.0 113.948 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -68.48 123.42 20.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.919 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 pt -126.07 -159.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.977 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 t -132.03 143.67 50.22 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.482 0.713 . . . . 0.0 109.921 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 59.01 157.34 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.2 mt -97.32 92.73 6.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.856 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -83.04 34.55 0.46 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -168.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -155.64 150.44 26.34 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.887 0.875 . . . . 0.0 111.858 179.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 p -78.25 85.78 4.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.824 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.6 m120 59.83 176.66 0.09 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 112.65 -2.068 . . . . 0.0 114.19 -176.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -78.72 112.48 15.89 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 122.612 1.196 . . . . 0.0 109.06 164.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.7 p -108.7 -139.53 0.38 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 111.68 -2.509 . . . . 0.0 114.978 -163.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.7 m -104.19 -170.81 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.38 1.872 . . . . 0.0 112.162 -164.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 11.8 ptt180 -76.77 126.03 30.28 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 174.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.717 177.143 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 122.383 1.087 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . 0.307 28.7 p 59.75 -43.82 0.09 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.572 2.749 . . . . 0.0 118.062 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.41 -36.83 0.35 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 119.785 3.254 . . . . 0.0 119.785 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -56.1 144.11 60.69 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.125 1.37 . . . . 0.0 112.005 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.82 72.89 2.5 Favored 'Trans proline' 0 C--N 1.334 -0.19 0 C-N-CA 123.092 2.528 . . . . 0.0 116.465 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.5 tp -166.64 38.49 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 129.101 2.96 . . . . 0.0 107.108 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -104.37 79.51 1.59 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.896 1.814 . . . . 0.0 115.896 -153.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 39.1 t -58.53 128.67 38.32 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.935 -176.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.8 m -114.94 142.0 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 126.169 2.168 . . . . 0.0 112.344 -173.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.06 120.45 42.56 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.802 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -104.34 124.41 49.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.603 -2.089 . . . . 0.0 112.698 -173.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -100.91 113.61 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.522 168.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.1 t -71.34 121.67 21.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 112.313 -2.221 . . . . 0.0 111.12 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -132.43 150.4 52.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.499 166.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.613 ' H ' ' NH2' ' A' ' 74' ' ' ARG . . . -176.15 -146.07 5.82 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -98.64 -79.82 0.47 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.422 -0.889 . . . . 0.0 111.363 -170.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.35 120.33 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.858 1.263 . . . . 0.0 109.736 -173.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.439 HE22 ' CZ ' ' A' ' 74' ' ' ARG . 93.3 mm-40 -66.76 137.34 56.58 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.897 -172.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.94 94.8 1.96 Allowed Glycine 0 N--CA 1.479 1.535 0 CA-C-N 113.37 -1.741 . . . . 0.0 112.936 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . 0.285 2.6 t -27.91 -71.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 127.898 2.479 . . . . 0.0 117.218 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.7 t 64.44 -27.54 0.09 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 119.429 3.122 . . . . 0.0 119.429 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.97 20.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 118.4 2.741 . . . . 0.0 118.4 -177.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -62.86 -73.38 0.11 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.193 1.797 . . . . 0.0 113.452 -166.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.6 mmt -50.21 -46.81 54.87 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -45.88 -58.46 3.51 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.148 1.379 . . . . 0.0 112.872 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.09 -49.98 75.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.244 1.418 . . . . 0.0 112.976 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 85.8 mt-10 -55.36 -58.46 7.62 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.081 1.353 . . . . 0.0 112.841 -178.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -57.09 -52.82 63.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.607 -1.633 . . . . 0.0 112.228 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -57.99 -57.68 11.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.492 0.717 . . . . 0.0 111.835 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 -45.75 75.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 64.9 mtt-85 -53.9 -55.85 23.08 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.524 1.13 . . . . 0.0 111.559 174.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -58.74 -35.02 72.04 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.217 -1.356 . . . . 0.0 113.972 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.6 pt -107.45 34.98 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -178.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.53 33.51 81.96 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 168.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.4 t -124.51 118.78 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 15.1 m -127.51 164.46 28.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 114.529 -1.214 . . . . 0.0 114.182 -173.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.58 -120.99 1.3 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.698 1.618 . . . . 0.0 111.013 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -164.04 163.15 23.38 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.38 135.58 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.043 1.737 . . . . 0.0 107.01 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -138.51 137.0 36.68 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.41 0.684 . . . . 0.0 111.592 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.8 p-10 -88.0 140.81 29.11 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.181 172.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.0 p -77.76 37.22 0.23 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 128.059 2.544 . . . . 0.0 110.892 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . 0.262 25.1 p 65.0 -50.99 0.34 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 128.682 2.793 . . . . 0.0 113.477 -154.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -134.88 132.58 38.71 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -167.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.72 -65.62 3.67 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 114.122 -1.399 . . . . 0.0 116.228 166.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.5 p -90.51 157.71 17.4 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.436 1.894 . . . . 0.0 113.707 -176.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.15 131.64 72.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 171.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 p -107.8 104.4 13.88 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 110.944 -2.844 . . . . 0.0 107.41 166.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -120.18 176.27 16.14 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.734 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -129.9 132.81 46.52 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.3 t -116.09 119.16 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.884 2.874 . . . . 0.0 108.209 175.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -53.69 157.41 2.27 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.434 1.894 . . . . 0.0 112.738 175.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -18.91 96.51 0.01 OUTLIER Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.001 2.238 . . . . 0.0 116.665 -178.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.3 86.85 0.09 OUTLIER 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.552 2.168 . . . . 0.0 112.559 164.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.41 101.3 7.54 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 111.015 -2.811 . . . . 0.0 109.419 171.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.445 0.4 OUTLIER 55.53 -88.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 112.209 -2.269 . . . . 0.0 116.766 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -49.25 -50.82 37.01 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.719 1.608 . . . . 0.0 112.404 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 59.0 t -56.05 -36.57 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.844 1.658 . . . . 0.0 111.821 -177.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -56.61 -35.35 68.19 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.0 p -61.56 -32.81 72.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -67.23 -28.79 68.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.344 1.058 . . . . 0.0 112.94 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -61.73 -37.92 86.02 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.3 m -54.88 -49.21 71.75 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.864 0.866 . . . . 0.0 111.176 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -53.15 -59.22 4.83 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.531 1.533 . . . . 0.0 112.79 171.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.6 mt -59.99 -17.41 38.2 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 96.8 p -92.92 -53.83 3.99 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 172.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -71.98 -42.96 65.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -170.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.37 113.86 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 -165.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.74 80.91 0.52 Allowed Glycine 0 CA--C 1.532 1.104 0 CA-C-N 113.323 -1.762 . . . . 0.0 110.777 166.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.2 m -63.87 -45.09 80.95 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-O 117.769 -1.11 . . . . 0.0 113.404 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -91.77 102.53 0.22 Allowed 'Trans proline' 0 CA--C 1.53 0.313 0 N-CA-C 106.554 -2.133 . . . . 0.0 106.554 155.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.8 m 67.85 124.04 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.5 p -83.14 53.31 2.42 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.185 -1.825 . . . . 0.0 114.416 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.613 ' NH2' ' H ' ' A' ' 15' ' ' GLY . 1.7 tpm_? -87.47 -10.99 50.3 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.027 -1.897 . . . . 0.0 110.205 165.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.46 96.09 4.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -134.74 -48.79 0.75 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 112.58 -2.1 . . . . 0.0 111.838 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.567 ' NH1' HD22 ' A' ' 79' ' ' ASN . 52.6 ttt-85 -123.27 88.48 2.93 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.389 1.476 . . . . 0.0 108.261 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.9 m -104.63 124.8 49.97 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 123.708 1.718 . . . . 0.0 112.117 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.567 HD22 ' NH1' ' A' ' 77' ' ' ARG . 1.4 m-80 -87.81 86.9 7.22 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 110.841 -2.89 . . . . 0.0 112.545 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -74.44 88.66 2.11 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.141 -1.845 . . . . 0.0 110.731 175.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.4 t -120.61 -165.7 1.24 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.144 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 7.3 t30 47.67 74.06 0.18 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.112 2.165 . . . . 0.0 110.75 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -101.31 102.71 13.61 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.783 -171.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.53 113.04 21.42 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 112.147 -2.297 . . . . 0.0 112.718 -177.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.5 p -65.53 102.05 0.67 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.755 1.264 . . . . 0.0 113.872 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.3 pt -85.11 77.48 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 112.206 -2.27 . . . . 0.0 113.326 -174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.2 m -50.09 -34.98 23.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 112.692 -2.049 . . . . 0.0 112.92 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -113.84 108.08 16.58 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 166.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 70.3 tp -67.38 76.94 0.16 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 124.283 1.992 . . . . 0.0 109.513 170.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -96.34 59.29 1.86 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 112.468 -2.151 . . . . 0.0 114.609 -171.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.5 131.27 0.09 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 128.574 2.75 . . . . 0.0 109.143 174.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.2 p -132.69 65.14 1.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 123.182 1.468 . . . . 0.0 109.469 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -174.85 134.7 0.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 111.43 -2.623 . . . . 0.0 109.129 -168.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 30.1 t80 -111.31 94.33 4.92 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 168.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 5.9 t -98.03 165.37 11.94 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 118.215 2.672 . . . . 0.0 118.215 -153.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 7.7 p -53.11 141.06 7.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 127.874 2.47 . . . . 0.0 115.276 -170.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 35.4 ttp180 -59.63 104.5 0.28 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.885 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 N--CA 1.477 0.881 0 CA-C-N 113.148 -1.842 . . . . 0.0 112.948 -179.557 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.42 46.57 0.35 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 112.205 -2.27 . . . . 0.0 115.674 174.165 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.91 -51.92 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 121.091 3.737 . . . . 0.0 121.091 170.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 86.1 mtm180 -45.16 127.87 5.69 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 127.74 2.416 . . . . 0.0 115.965 -166.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -52.03 -31.35 43.86 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 125.294 3.996 . . . . 0.0 119.342 -161.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.95 117.01 33.65 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.944 1.354 . . . . 0.0 111.273 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -85.28 121.5 28.1 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.555 -175.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.5 t -107.87 93.32 4.47 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 123.589 1.662 . . . . 0.0 108.565 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.252 8.0 p -98.3 107.38 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 112.728 -2.033 . . . . 0.0 112.137 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -85.73 94.18 9.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 112.468 -2.151 . . . . 0.0 110.143 172.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -70.79 166.61 20.6 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 112.185 -2.28 . . . . 0.0 113.044 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -136.35 113.03 10.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.752 1.621 . . . . 0.0 110.764 167.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.8 124.67 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.35 1.06 . . . . 0.0 113.81 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.58 91.81 3.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 123.085 1.421 . . . . 0.0 108.394 164.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -134.81 87.11 0.25 Allowed Glycine 0 CA--C 1.54 1.597 0 CA-C-N 112.665 -2.061 . . . . 0.0 112.539 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -53.17 -55.72 22.02 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.835 1.254 . . . . 0.0 113.713 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 p -108.75 129.2 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 123.751 0.657 . . . . 0.0 109.824 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 71.84 -30.86 0.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.022 2.129 . . . . 0.0 116.081 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -22.33 -64.16 0.03 OUTLIER Glycine 0 CA--C 1.53 1.02 0 C-N-CA 129.054 3.216 . . . . 0.0 117.408 -178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.0 m -70.39 63.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.8 t -149.04 -85.56 0.09 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.396 1.878 . . . . 0.0 110.104 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . 0.364 34.2 p90 58.14 -46.91 0.05 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 119.528 3.158 . . . . 0.0 119.528 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -12.05 -81.11 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.939 2.895 . . . . 0.0 117.298 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -44.04 -55.51 4.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.057 1.343 . . . . 0.0 114.004 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -57.61 -58.51 7.99 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.828 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.76 -53.03 62.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.477 1.111 . . . . 0.0 113.602 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -52.3 -54.78 27.08 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.864 2.466 . . . . 0.0 113.725 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -56.72 -52.66 64.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.328 1.051 . . . . 0.0 111.851 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -66.17 -47.57 73.55 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.737 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.04 -47.68 74.47 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -55.9 -50.76 69.78 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.776 0.83 . . . . 0.0 112.522 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -58.12 -37.04 73.82 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.08 1.352 . . . . 0.0 114.274 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.7 mm -76.13 -36.34 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.981 0.912 . . . . 0.0 111.979 177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.27 67.85 1.21 Allowed Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.876 1.227 . . . . 0.0 110.56 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 12.3 p -158.34 154.64 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.757 1.623 . . . . 0.0 111.62 -173.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . 0.473 3.7 p 65.15 152.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 128.929 2.892 . . . . 0.0 115.416 170.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.97 -89.29 1.53 Allowed Glycine 0 N--CA 1.477 1.422 0 CA-C-N 112.802 -1.999 . . . . 0.0 113.191 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -135.17 159.69 40.73 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 1.9 t -109.66 136.23 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 113.004 -1.907 . . . . 0.0 108.074 173.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.7 pttp -118.19 133.01 56.28 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.46 1.904 . . . . 0.0 112.224 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -75.18 146.47 41.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 112.027 -2.351 . . . . 0.0 112.766 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.0 p -123.15 161.47 24.39 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.328 168.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 p -64.57 -22.02 66.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 113.286 -1.779 . . . . 0.0 113.932 169.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -101.8 11.46 38.68 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -168.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.66 -35.94 1.2 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.096 0.855 . . . . 0.0 114.082 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.0 p -61.16 79.97 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.291 2.236 . . . . 0.0 111.728 172.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.51 141.0 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 111.854 -2.43 . . . . 0.0 111.254 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.5 t -113.31 131.64 55.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 113.436 -1.711 . . . . 0.0 111.832 -173.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -133.85 143.03 14.6 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.296 -175.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -98.21 86.94 3.78 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 112.914 -1.643 . . . . 0.0 112.468 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.9 t -86.74 82.75 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 111.86 -2.427 . . . . 0.0 110.534 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.584 HE21 ' CD1' ' A' ' 86' ' ' ILE . 40.3 tt0 -88.03 115.87 25.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.962 -1.927 . . . . 0.0 109.875 173.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 157.89 -82.35 0.15 Allowed Glycine 0 N--CA 1.468 0.827 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.698 -176.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_exo -15.18 82.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.327 -0.58 1 C-N-CA 125.343 4.029 . . . . 0.0 118.35 -158.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.501 ' H ' ' CG1' ' A' ' 58' ' ' VAL . 66.9 tt0 -129.24 107.63 9.7 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.467 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 57.91 -88.29 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.487 2.315 . . . . 0.0 114.569 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -57.1 -43.5 82.32 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.299 0.639 . . . . 0.0 111.935 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.501 ' CG1' ' H ' ' A' ' 55' ' ' GLU 0.33 14.8 p -84.83 2.17 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -60.49 -35.45 75.94 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.487 -0.758 . . . . 0.0 111.517 164.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -51.23 -38.57 53.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.127 1.371 . . . . 0.0 114.023 173.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -53.23 60.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.052 0.541 . . . . 0.0 111.28 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.8 ttpt -54.5 -51.62 64.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.728 1.211 . . . . 0.0 112.858 173.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.4 t -57.57 -31.12 65.83 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.051 1.74 . . . . 0.0 115.293 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -76.9 -50.8 12.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.205 1.802 . . . . 0.0 114.467 170.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.1 tp -51.4 -26.86 8.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.163 2.185 . . . . 0.0 115.482 -174.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.7 p -53.82 -60.3 3.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.158 2.183 . . . . 0.0 113.967 170.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -127.17 70.82 1.31 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.768 2.427 . . . . 0.0 109.5 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -54.95 -29.04 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -177.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.83 -84.5 0.48 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.691 171.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.9 t -128.28 -74.68 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -44.12 102.39 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 124.213 3.275 . . . . 0.0 114.173 -154.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.8 p 42.25 45.91 3.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.655 -2.521 . . . . 0.0 115.303 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 66.1 p -155.38 -66.35 0.12 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 68.4 -61.52 0.4 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.894 2.078 . . . . 0.0 114.158 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.6 mt 32.05 110.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 128.963 2.905 . . . . 0.0 113.74 -178.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -67.71 -32.28 72.81 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -163.49 110.71 1.17 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.065 0.946 . . . . 0.0 111.686 171.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 63.7 m -88.75 101.11 13.68 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.448 1.594 . . . . 0.0 109.471 166.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -68.24 98.92 0.85 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 111.602 -2.545 . . . . 0.0 111.155 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -79.31 78.72 5.79 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 124.041 1.877 . . . . 0.0 112.42 175.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.5 p -92.67 -69.17 0.76 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 110.977 -2.829 . . . . 0.0 115.302 -169.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -80.75 75.75 7.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 123.686 1.707 . . . . 0.0 110.955 -175.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -87.44 83.41 7.3 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 111.885 -2.416 . . . . 0.0 111.235 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -96.92 91.85 5.83 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.143 -1.844 . . . . 0.0 109.218 -174.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.1 p -74.6 115.21 13.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.255 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.584 ' CD1' HE21 ' A' ' 52' ' ' GLN . 2.6 pp -122.01 149.49 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 110.618 -2.992 . . . . 0.0 111.658 -174.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.0 p -82.32 101.72 10.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 113.703 -1.589 . . . . 0.0 112.083 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . 0.292 33.8 mmtp 98.55 149.05 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.538 2.335 . . . . 0.0 116.343 168.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.6 tp -103.22 130.29 50.41 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.304 -173.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -119.99 -44.32 2.51 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.192 -1.367 . . . . 0.0 112.587 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -73.95 95.16 2.44 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.885 1.274 . . . . 0.0 113.987 179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.9 p -86.21 -22.2 27.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 111.546 -2.57 . . . . 0.0 115.811 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -137.5 108.47 6.72 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.898 0.749 . . . . 0.0 112.539 -162.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.65 125.79 26.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.815 171.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.4 t -149.97 111.28 4.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.31 25.6 m 48.39 -178.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 120.195 3.405 . . . . 0.0 120.195 161.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.6 mtt180 -105.97 139.38 40.61 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.841 -1.527 . . . . 0.0 113.662 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 C--O 1.246 0.88 0 CA-C-N 112.4 -2.182 . . . . 0.0 113.446 -179.776 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.9 p . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.7 p -67.37 -31.34 71.51 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 112.592 -2.094 . . . . 0.0 116.024 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.91 69.29 0.95 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 123.255 1.502 . . . . 0.0 110.912 170.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -145.83 125.18 6.76 Favored Pre-proline 0 N--CA 1.471 0.594 0 CA-C-N 113.265 -1.788 . . . . 0.0 112.207 -176.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.71 33.62 0.43 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.145 2.563 . . . . 0.0 114.556 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.9 mp -114.18 97.25 6.24 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -98.88 113.64 25.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.976 -161.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 t -103.33 101.88 11.81 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.248 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -116.1 142.14 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 112.821 -1.99 . . . . 0.0 112.077 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -100.24 121.79 42.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 123.33 1.538 . . . . 0.0 110.353 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -103.02 148.76 25.29 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 111.933 -2.394 . . . . 0.0 111.863 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -124.15 85.94 2.49 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 111.821 -2.445 . . . . 0.0 109.51 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.66 110.38 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 123.104 1.43 . . . . 0.0 110.521 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -93.84 77.77 4.2 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 111.126 -2.761 . . . . 0.0 106.855 177.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.66 54.31 0.55 Allowed Glycine 0 N--CA 1.479 1.503 0 CA-C-N 112.015 -2.357 . . . . 0.0 109.991 173.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -36.06 79.25 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -174.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.1 m -80.22 52.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 52.68 -110.89 0.55 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 127.012 2.125 . . . . 0.0 112.484 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.75 -56.39 0.35 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 119.087 2.395 . . . . 0.0 119.087 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 m -77.14 100.24 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -171.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.43 64.98 1.02 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 124.582 2.135 . . . . 0.0 107.634 162.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.96 -31.43 50.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 111.702 -2.499 . . . . 0.0 113.709 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -32.7 -59.72 0.32 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.909 2.083 . . . . 0.0 115.538 170.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.1 tpt -54.9 -38.24 67.33 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 2.5 m-30 -73.36 -53.48 10.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.915 1.686 . . . . 0.0 111.284 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -54.25 -37.35 64.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.283 1.433 . . . . 0.0 113.143 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.28 -83.42 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.594 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -63.97 -59.62 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.005 1.322 . . . . 0.0 114.209 -170.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -65.24 -43.88 90.0 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -63.12 -43.38 98.58 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 178.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.5 ttp-105 -52.35 -55.72 19.65 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.732 0.813 . . . . 0.0 110.866 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -57.63 -40.78 79.98 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.017 1.727 . . . . 0.0 114.794 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 31.8 mm -71.11 -29.76 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.105 0.962 . . . . 0.0 113.418 176.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.1 38.67 4.77 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 124.568 1.08 . . . . 0.0 112.702 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.3 t -110.62 141.45 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 123.77 1.748 . . . . 0.0 111.736 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.8 t -126.47 156.18 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 111.002 -2.817 . . . . 0.0 111.125 -172.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.89 -149.61 20.73 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.074 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 55.7 p-90 -153.46 146.36 24.44 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.328 1.451 . . . . 0.0 111.084 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 t -117.99 144.52 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.979 0.912 . . . . 0.0 109.583 -176.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.4 tttt -132.52 137.49 47.18 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.493 0.717 . . . . 0.0 112.298 175.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -94.97 93.35 7.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 122.676 1.227 . . . . 0.0 110.281 168.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 5.7 t -80.53 163.43 23.73 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -168.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.2 p -54.02 -35.03 61.49 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.126 -1.852 . . . . 0.0 113.911 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -66.3 -1.76 3.72 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.46 -41.08 2.62 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 124.952 1.263 . . . . 0.0 111.612 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.93 140.66 24.06 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.981 2.112 . . . . 0.0 113.804 -178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 96.0 t -92.01 103.36 14.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 123.986 1.851 . . . . 0.0 107.278 169.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.7 t -109.77 -164.26 0.92 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 111.738 -2.483 . . . . 0.0 110.156 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.26 -173.79 15.69 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 126.378 1.942 . . . . 0.0 110.89 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -125.74 134.34 51.79 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 112.257 -1.972 . . . . 0.0 111.91 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.5 p -117.41 117.02 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 111.278 -2.692 . . . . 0.0 109.942 177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -102.15 130.11 48.7 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 112.619 -2.082 . . . . 0.0 107.6 171.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.5 149.05 17.41 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.626 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -65.99 145.84 80.82 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 121.554 1.503 . . . . 0.0 109.822 166.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -17.83 -61.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -61.09 -39.97 91.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -65.92 -39.31 90.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.238 1.015 . . . . 0.0 111.718 174.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 49.2 t -61.69 -42.63 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.244 1.018 . . . . 0.0 112.286 175.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.2 m120 -55.33 -46.54 76.33 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.7 p -69.02 -47.22 65.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.578 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -49.98 -52.58 32.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.695 1.598 . . . . 0.0 114.19 176.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 65.5 pttt -59.17 -38.15 79.08 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.9 m -63.98 -57.69 8.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.055 170.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 13.9 t90 -46.61 -46.06 19.43 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 127.781 2.432 . . . . 0.0 115.262 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.6 mt -90.1 13.1 15.84 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . 0.265 53.4 p -101.64 -109.23 0.23 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -110.22 75.61 0.94 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.222 2.209 . . . . 0.0 107.911 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.09 -52.1 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 112.426 -2.17 . . . . 0.0 114.698 -166.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.13 -56.8 3.62 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 115.792 1.077 . . . . 0.0 115.792 -173.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.6 m -41.58 145.49 0.66 Allowed Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 127.415 2.286 . . . . 0.0 115.932 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.92 -27.36 8.46 Favored 'Cis proline' 0 CA--C 1.535 0.569 0 N-CA-C 117.774 2.182 . . . . 0.0 117.774 -10.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.5 p -131.19 -43.83 1.04 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.0 m -97.27 121.98 39.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.713 2.005 . . . . 0.0 112.818 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.84 86.37 0.51 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -172.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -75.43 91.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 114.055 -1.429 . . . . 0.0 107.765 167.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.55 -55.25 14.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 110.708 -2.951 . . . . 0.0 115.838 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.54 145.6 9.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.745 0.818 . . . . 0.0 110.007 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 90.3 m -152.22 138.15 18.1 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -98.18 140.23 32.79 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.214 -2.721 . . . . 0.0 109.184 167.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -114.37 109.82 18.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.68 176.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.49 167.67 13.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 113.219 -1.809 . . . . 0.0 111.986 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 53.82 84.89 0.06 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.909 1.284 . . . . 0.0 113.264 172.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.2 111.76 24.51 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 123.057 1.408 . . . . 0.0 113.728 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -100.03 91.14 4.65 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 111.63 -2.532 . . . . 0.0 107.069 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.1 p -74.28 84.31 1.9 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 123.107 1.432 . . . . 0.0 109.034 172.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.1 pt -112.34 154.35 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 112.98 -1.918 . . . . 0.0 114.333 -165.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.1 t -59.15 132.41 53.92 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.229 -1.805 . . . . 0.0 111.864 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp 61.56 149.9 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 90.8 mt -85.51 97.58 10.13 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 113.782 -1.554 . . . . 0.0 111.07 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -84.16 82.03 8.54 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.492 -173.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 154.19 150.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 129.97 3.308 . . . . 0.0 111.965 167.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.3 p -82.07 88.42 6.43 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.504 1.145 . . . . 0.0 110.293 169.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.2 m120 61.42 172.14 0.11 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 111.211 -2.722 . . . . 0.0 113.209 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -73.56 69.59 1.25 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.245 1.497 . . . . 0.0 110.807 177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.5 110.42 15.95 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 112.585 -2.098 . . . . 0.0 116.078 -166.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.258 27.2 m 54.95 163.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 110.768 -2.924 . . . . 0.0 117.035 165.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 52.6 ttp180 -111.66 113.15 25.35 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.215 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 . . . . . 0 C--O 1.246 0.873 0 CA-C-N 111.519 -2.582 . . . . 0.0 111.717 -177.373 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.5 t . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.2 p -133.74 -82.13 0.46 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.924 1.289 . . . . 0.0 112.344 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -122.63 -139.54 0.31 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.097 1.359 . . . . 0.0 111.034 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -48.81 132.01 14.5 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 125.7 1.6 . . . . 0.0 115.113 -171.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -68.14 72.8 0.8 Allowed 'Trans proline' 0 C--N 1.328 -0.522 0 C-N-CA 123.134 2.556 . . . . 0.0 115.434 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.08 127.22 41.06 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 164.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -97.16 115.6 27.84 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.199 1.0 . . . . 0.0 111.598 -163.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.9 t -107.24 122.98 47.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.127 -1.851 . . . . 0.0 110.36 166.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 t -112.98 108.03 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 111.314 -2.675 . . . . 0.0 108.262 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -88.24 97.36 10.98 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 113.106 -1.861 . . . . 0.0 107.715 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -94.79 150.68 19.95 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 109.122 -3.672 . . . . 0.0 112.56 -171.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 mp0 -127.8 97.52 4.86 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.008 166.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 94.6 t -68.78 126.58 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.005 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -127.94 137.0 52.1 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.545 0.528 . . . . 0.0 111.515 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -105.52 121.08 6.68 Favored Glycine 0 N--CA 1.476 1.352 0 O-C-N 124.819 1.324 . . . . 0.0 112.313 -175.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -38.68 -43.56 0.91 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 172.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -121.84 146.98 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.581 163.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -52.83 168.65 0.11 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.6 -78.5 0.28 Allowed Glycine 0 N--CA 1.477 1.377 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.655 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 t 66.98 -72.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 128.277 2.631 . . . . 0.0 111.234 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.7 m 42.05 38.83 1.16 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.391 1.876 . . . . 0.0 115.316 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.3 t80 -63.02 -27.9 69.73 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 112.722 -2.036 . . . . 0.0 113.754 -168.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 -21.03 -73.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 174.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 67.7 mtm -60.67 -40.59 92.69 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -62.91 -46.89 85.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.894 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -50.7 -56.86 10.0 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 125.001 1.438 . . . . 0.0 111.925 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -51.43 -60.0 3.62 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.669 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.23 -53.14 61.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.195 1.398 . . . . 0.0 113.468 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -65.51 -38.61 90.2 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.549 0.74 . . . . 0.0 112.203 -178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.9 -47.53 77.27 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.017 0.927 . . . . 0.0 112.985 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -52.23 -49.89 63.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.796 1.238 . . . . 0.0 111.196 173.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.97 -51.67 68.26 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.272 1.429 . . . . 0.0 114.444 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.7 mm -67.8 -25.69 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.4 1.08 . . . . 0.0 112.705 -176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.28 53.85 1.67 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.33 0.966 . . . . 0.0 111.788 -174.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.6 t -116.6 140.13 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 123.41 1.576 . . . . 0.0 109.58 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 33.5 m -119.98 166.74 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 111.982 -2.372 . . . . 0.0 111.048 173.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.1 -135.3 7.41 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.5 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 39.8 p-90 -162.1 151.07 15.45 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 113.456 -1.372 . . . . 0.0 111.367 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.7 p -114.91 136.4 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.681 -178.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -117.01 123.3 46.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.202 1.477 . . . . 0.0 112.508 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -64.93 114.73 4.74 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 111.399 -2.637 . . . . 0.0 109.161 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.0 -130.17 0.26 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.995 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.6 m -107.4 108.38 19.7 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.897 -1.127 . . . . 0.0 110.623 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp 49.76 85.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.95 -31.3 1.08 Allowed Glycine 0 N--CA 1.473 1.115 0 CA-C-N 113.086 -1.87 . . . . 0.0 116.319 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.8 p -59.87 147.49 38.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.375 1.07 . . . . 0.0 112.076 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.1 m -133.64 124.92 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 112.163 -2.289 . . . . 0.0 113.575 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -92.23 -171.91 2.96 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 109.26 -3.609 . . . . 0.0 109.896 159.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 129.5 -155.84 21.04 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.698 2.094 . . . . 0.0 111.191 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -130.94 109.6 10.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.362 1.465 . . . . 0.0 112.659 -173.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 t -94.33 97.65 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.376 171.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -100.77 107.68 19.31 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.592 -178.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.19 150.87 20.32 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 114.429 -1.26 . . . . 0.0 113.673 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -72.93 153.14 52.68 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.142 1.894 . . . . 0.0 111.147 175.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -39.84 -49.06 2.36 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -173.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -63.19 -62.91 1.38 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.037 0.381 . . . . 0.0 111.547 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -59.56 -31.34 69.34 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . 0.287 1.7 p -55.78 -35.41 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -177.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.57 -41.07 66.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.9 t -67.55 -54.35 20.65 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.669 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 20.1 ptp -58.13 -36.77 73.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -52.38 -61.63 2.15 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.088 1.355 . . . . 0.0 111.737 171.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.3 m -54.04 -43.5 70.23 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 3.5 t90 -58.11 -53.99 51.99 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 mt -51.57 -29.58 17.69 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -80.02 -69.93 0.55 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.916 -1.493 . . . . 0.0 114.777 167.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -63.86 -27.16 68.97 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . 0.357 8.1 p 62.01 -70.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 129.394 3.078 . . . . 0.0 118.548 172.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.94 -111.67 2.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.88 1.228 . . . . 0.0 111.687 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.1 p -73.18 -30.96 1.33 Allowed Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 118.952 2.945 . . . . 0.0 118.952 -170.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -56.95 109.93 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 CA-C-N 123.075 2.134 . . . . 0.0 112.846 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -43.2 -30.79 0.51 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.222 2.609 . . . . 0.0 114.174 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -49.63 -23.93 1.95 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 74.1 -33.04 0.24 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 127.941 2.496 . . . . 0.0 116.505 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . 0.337 4.1 mp 58.37 -84.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.723 2.009 . . . . 0.0 112.044 178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.31 2.6 p30 57.76 -41.37 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 128.313 2.645 . . . . 0.0 117.928 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.48 ' NH1' HD22 ' A' ' 79' ' ' ASN . 38.9 ttt-85 -110.58 101.69 10.33 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 123.313 1.53 . . . . 0.0 111.116 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.7 m -118.17 127.9 54.2 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 112.784 -2.007 . . . . 0.0 111.584 172.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.48 HD22 ' NH1' ' A' ' 77' ' ' ARG . 2.4 m-80 -82.73 83.57 7.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 111.484 -2.598 . . . . 0.0 110.861 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -72.27 37.8 0.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.682 -2.053 . . . . 0.0 112.953 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 m -59.78 -36.39 76.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.063 2.145 . . . . 0.0 115.887 -163.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -116.17 88.38 2.88 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.05 177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -92.95 102.88 15.24 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.844 169.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -108.47 119.99 41.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 111.462 -2.608 . . . . 0.0 110.31 -173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.6 p -82.8 92.17 7.19 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 123.756 1.741 . . . . 0.0 111.934 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.5 pt -80.64 140.42 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 111.166 -2.743 . . . . 0.0 114.052 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.4 m -73.33 87.36 1.51 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.808 -1.996 . . . . 0.0 111.289 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 73.08 156.32 0.17 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-N 112.247 -2.251 . . . . 0.0 112.42 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.25 111.15 10.2 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.949 0.881 . . . . 0.0 111.113 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.7 13.58 8.47 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -162.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -148.51 155.21 40.86 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.328 1.051 . . . . 0.0 111.751 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.6 p -68.62 -46.69 68.6 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.519 -1.219 . . . . 0.0 114.056 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -156.54 172.93 17.69 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.429 1.492 . . . . 0.0 111.101 174.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -72.93 94.98 1.91 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.789 1.28 . . . . 0.0 110.586 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 42.4 m -63.06 142.96 58.18 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.305 -2.225 . . . . 0.0 114.496 -173.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 85.3 t -63.75 143.14 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 110.792 -2.913 . . . . 0.0 110.032 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 46.1 ptt85 -6.63 123.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 120.306 3.446 . . . . 0.0 120.306 178.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 112.066 -2.334 . . . . 0.0 112.514 165.995 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--O 1.239 0.548 0 CA-C-O 123.03 1.179 . . . . 0.0 114.124 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.888 ' HB3' HE22 ' A' ' 52' ' ' GLN . 5.2 mp -124.63 106.83 10.42 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.576 2.351 . . . . 0.0 107.348 173.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.671 ' HE2' ' HB3' ' A' ' 83' ' ' GLU . 47.9 tttt -107.06 112.11 24.89 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.878 -166.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.612 ' HB3' ' HG2' ' A' ' 52' ' ' GLN . 4.4 p -85.1 104.64 15.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.833 167.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.438 HG22 ' HG3' ' A' ' 83' ' ' GLU . 93.0 t -109.75 143.57 19.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 110.221 -3.172 . . . . 0.0 108.028 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 9.8 m-20 -109.05 142.17 40.13 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.976 171.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -120.33 159.58 24.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.351 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -144.76 116.82 8.34 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.945 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.48 121.74 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 112.467 -2.151 . . . . 0.0 107.054 170.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.31 71.51 10.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.74 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.27 73.15 2.56 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.453 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -33.02 -59.1 0.36 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.78 1.632 . . . . 0.0 115.358 -174.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 t -125.62 72.92 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.664 0.745 . . . . 0.0 109.259 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.468 ' HB3' ' H ' ' A' ' 19' ' ' GLY 0.252 12.9 mt-30 53.33 -139.14 1.05 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 176.72 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.468 ' H ' ' HB3' ' A' ' 18' ' ' GLN . . . 78.4 -37.73 1.82 Allowed Glycine 0 N--CA 1.474 1.21 0 N-CA-C 116.527 1.371 . . . . 0.0 116.527 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.1 m -54.13 99.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 126.681 1.992 . . . . 0.0 115.718 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.6 m -94.76 75.3 3.66 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 112.396 -2.184 . . . . 0.0 108.519 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -78.78 -29.92 45.28 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 111.103 -2.771 . . . . 0.0 113.106 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.453 ' NH1' ' HG2' ' A' ' 97' ' ' ARG . 53.8 mmm-85 -50.38 155.73 0.98 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.528 1.531 . . . . 0.0 113.82 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 63.9 -57.19 0.21 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.932 2.093 . . . . 0.0 114.968 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -46.26 -55.17 7.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.06 2.144 . . . . 0.0 111.049 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.419 ' HA ' ' HH2' ' A' ' 64' ' ' TRP . . . -53.1 -68.96 0.13 Allowed 'General case' 0 C--N 1.323 -0.58 0 O-C-N 125.167 1.542 . . . . 0.0 112.432 172.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -38.92 -63.55 0.52 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.575 1.95 . . . . 0.0 114.987 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.2 m-20 -63.3 -52.15 63.16 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.876 1.67 . . . . 0.0 113.489 -174.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 33' ' ' ILE . 58.8 mt-10 -69.29 -36.66 77.26 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.517 ' HB1' HG23 ' A' ' 35' ' ' VAL . . . -62.64 -41.39 99.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.864 0.865 . . . . 0.0 112.818 175.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -53.07 -51.69 60.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.778 0.831 . . . . 0.0 110.884 168.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 28' ' ' ASP . 44.8 mmtm -61.27 -40.04 92.65 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 29' ' ' GLU . 37.3 mm -61.65 -34.04 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.883 1.273 . . . . 0.0 111.55 172.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.3 36.88 4.23 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 125.082 1.325 . . . . 0.0 113.119 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.716 HG21 ' HG3' ' A' ' 61' ' ' MET . 29.0 m -123.0 158.56 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 124.37 2.033 . . . . 0.0 115.005 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 93' ' ' ASN . 3.1 t -126.2 155.61 36.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 110.856 -2.883 . . . . 0.0 109.434 -172.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.47 -144.67 13.99 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.108 0.861 . . . . 0.0 111.695 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.492 ' CZ3' ' HB2' ' A' ' 40' ' ' LYS . 65.5 p-90 -166.0 168.16 15.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.356 1.614 . . . . 0.0 115.356 -173.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 47' ' ' VAL . 83.3 t -107.47 136.46 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 112.395 -2.184 . . . . 0.0 108.572 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.637 ' HB3' HG23 ' A' ' 48' ' ' THR . 59.2 tttp -115.12 114.28 25.11 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.639 1.576 . . . . 0.0 109.293 173.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -93.46 119.23 32.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 112.312 -2.222 . . . . 0.0 109.752 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 p -98.67 179.78 4.56 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.893 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.6 p -58.02 -52.66 64.6 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 113.906 -1.497 . . . . 0.0 113.25 171.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.08 49.44 0.84 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.48 3.29 2.89 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 119.576 2.59 . . . . 0.0 119.576 165.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.9 p -64.83 83.52 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 123.0 1.381 . . . . 0.0 111.355 168.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 39' ' ' VAL . 63.2 t -75.25 93.98 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 112.277 -2.238 . . . . 0.0 109.234 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.637 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.5 t -102.61 -169.52 1.67 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 109.987 -3.279 . . . . 0.0 109.69 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.6 -163.99 24.93 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.123 1.344 . . . . 0.0 113.47 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -123.73 131.09 53.53 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 112.021 -2.09 . . . . 0.0 112.646 -168.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.88 108.74 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.229 1.812 . . . . 0.0 107.342 172.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.888 HE22 ' HB3' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -112.01 131.35 55.46 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 170.447 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.701 ' HA3' HG12 ' A' ' 35' ' ' VAL . . . -168.18 158.77 31.7 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.306 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -59.84 142.64 99.0 Favored 'Trans proline' 0 C--N 1.325 -0.705 0 C-N-CA 121.839 1.692 . . . . 0.0 110.541 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -33.06 -65.95 0.15 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -36.42 48.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -72.74 -41.83 64.74 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.449 1.1 . . . . 0.0 112.487 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 7' ' ' LYS 0.303 8.6 m -65.19 -33.92 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 172.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -57.11 -47.56 80.79 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.16 0.984 . . . . 0.0 112.932 169.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.4 t -60.18 -45.02 94.53 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.815 1.246 . . . . 0.0 112.593 174.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.716 ' HG3' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -58.81 -40.88 85.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.403 1.481 . . . . 0.0 113.937 175.036 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.61 -40.23 88.72 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 171.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.8 m -58.49 -41.93 86.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.699 0.761 . . . . 0.0 111.093 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.588 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 24.0 t90 -76.23 179.06 5.97 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.447 1.499 . . . . 0.0 110.597 164.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.571 HD12 ' HE1' ' A' ' 80' ' ' PHE . 50.8 mt 71.01 -36.74 0.37 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.469 2.307 . . . . 0.0 114.965 -173.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.7 p -78.85 -42.08 28.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.711 2.004 . . . . 0.0 109.342 162.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 64' ' ' TRP . 0.1 OUTLIER -61.73 99.64 0.12 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 158.404 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.3 m -108.26 91.41 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 111.426 -2.625 . . . . 0.0 114.53 -169.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.39 158.73 19.91 Favored Glycine 0 N--CA 1.478 1.487 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.583 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.1 t -126.59 139.94 36.09 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 -163.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -102.12 8.21 0.47 Allowed 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 122.342 2.028 . . . . 0.0 116.026 158.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.2 m -178.66 -68.55 0.01 OUTLIER 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.587 2.355 . . . . 0.0 112.187 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 p -114.65 173.07 6.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.635 1.174 . . . . 0.0 113.86 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.469 ' H ' ' CZ ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -78.39 129.07 34.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.093 172.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mp -75.2 85.22 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -76.6 91.16 3.38 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 113.788 -1.551 . . . . 0.0 113.456 -171.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.405 ' CZ ' ' HA ' ' A' ' 77' ' ' ARG . 0.6 OUTLIER 68.39 112.87 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 111.194 -2.73 . . . . 0.0 113.878 172.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.4 m -117.28 117.06 28.51 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.306 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -102.26 140.41 36.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.219 -2.264 . . . . 0.0 109.086 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.571 ' HE1' HD12 ' A' ' 65' ' ' LEU . 68.6 m-85 -115.91 99.06 7.01 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.539 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.9 p -137.74 156.91 47.47 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.492 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 47.0 m-80 69.44 90.35 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.58 1.552 . . . . 0.0 110.749 -165.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.671 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 11.8 mp0 -118.25 111.67 19.09 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.641 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -137.61 110.45 7.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.606 -1.179 . . . . 0.0 113.948 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -68.48 123.42 20.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.919 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 pt -126.07 -159.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.977 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 t -132.03 143.67 50.22 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.482 0.713 . . . . 0.0 109.921 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 59.01 157.34 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.2 mt -97.32 92.73 6.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.856 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -83.04 34.55 0.46 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -168.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.421 ' HB2' HG13 ' A' ' 36' ' ' VAL . 80.2 m-85 -155.64 150.44 26.34 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.887 0.875 . . . . 0.0 111.858 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 p -78.25 85.78 4.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.824 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.424 ' HA ' HG22 ' A' ' 36' ' ' VAL . 3.6 m120 59.83 176.66 0.09 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 112.65 -2.068 . . . . 0.0 114.19 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -78.72 112.48 15.89 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 122.612 1.196 . . . . 0.0 109.06 164.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.7 p -108.7 -139.53 0.38 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 111.68 -2.509 . . . . 0.0 114.978 -163.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.7 m -104.19 -170.81 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.38 1.872 . . . . 0.0 112.162 -164.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.453 ' HG2' ' NH1' ' A' ' 23' ' ' ARG . 11.8 ptt180 -76.77 126.03 30.28 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 174.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.717 177.143 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 N--CA 1.47 0.112 0 N-CA-C 116.465 1.679 . . . . 0.0 116.465 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.5 tp -166.64 38.49 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 129.101 2.96 . . . . 0.0 107.108 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.617 ' O ' ' HD2' ' A' ' 54' ' ' PRO . 20.2 ptmt -104.37 79.51 1.59 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.896 1.814 . . . . 0.0 115.896 -153.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . 0.458 ' HB3' ' HG3' ' A' ' 84' ' ' LYS . 39.1 t -58.53 128.67 38.32 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.935 -176.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.608 HG12 ' HG2' ' A' ' 83' ' ' GLU . 25.8 m -114.94 142.0 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 126.169 2.168 . . . . 0.0 112.344 -173.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.06 120.45 42.56 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.802 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 51.4 p90 -104.34 124.41 49.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.603 -2.089 . . . . 0.0 112.698 -173.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -100.91 113.61 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.522 168.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.1 t -71.34 121.67 21.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 112.313 -2.221 . . . . 0.0 111.12 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -132.43 150.4 52.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.499 166.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.638 ' H ' ' NH2' ' A' ' 74' ' ' ARG . . . -176.15 -146.07 5.82 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -98.64 -79.82 0.47 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.422 -0.889 . . . . 0.0 111.363 -170.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.35 120.33 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.858 1.263 . . . . 0.0 109.736 -173.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -66.76 137.34 56.58 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.897 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.94 94.8 1.96 Allowed Glycine 0 N--CA 1.479 1.535 0 CA-C-N 113.37 -1.741 . . . . 0.0 112.936 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.475 HG21 HG22 ' A' ' 47' ' ' VAL 0.285 2.6 t -27.91 -71.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 127.898 2.479 . . . . 0.0 117.218 -177.945 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.7 t 64.44 -27.54 0.09 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 119.429 3.122 . . . . 0.0 119.429 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.97 20.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 118.4 2.741 . . . . 0.0 118.4 -177.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -62.86 -73.38 0.11 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.193 1.797 . . . . 0.0 113.452 -166.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.6 mmt -50.21 -46.81 54.87 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -45.88 -58.46 3.51 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.148 1.379 . . . . 0.0 112.872 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HA ' ' HZ2' ' A' ' 64' ' ' TRP . . . -59.09 -49.98 75.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.244 1.418 . . . . 0.0 112.976 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.587 ' HA ' ' HD2' ' A' ' 94' ' ' PHE . 85.8 mt-10 -55.36 -58.46 7.62 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.081 1.353 . . . . 0.0 112.841 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -57.09 -52.82 63.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.607 -1.633 . . . . 0.0 112.228 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.604 ' O ' HG12 ' A' ' 33' ' ' ILE . 47.5 mt-10 -57.99 -57.68 11.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.492 0.717 . . . . 0.0 111.835 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 -45.75 75.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . 0.463 HH21 ' HA ' ' A' ' 95' ' ' SER . 64.9 mtt-85 -53.9 -55.85 23.08 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.524 1.13 . . . . 0.0 111.559 174.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -58.74 -35.02 72.04 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.217 -1.356 . . . . 0.0 113.972 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 29' ' ' GLU . 26.6 pt -107.45 34.98 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.53 33.51 81.96 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 168.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.635 HG22 HG13 ' A' ' 58' ' ' VAL . 89.4 t -124.51 118.78 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 52' ' ' GLN . 15.1 m -127.51 164.46 28.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 114.529 -1.214 . . . . 0.0 114.182 -173.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.58 -120.99 1.3 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.698 1.618 . . . . 0.0 111.013 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -164.04 163.15 23.38 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.38 135.58 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.043 1.737 . . . . 0.0 107.01 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -138.51 137.0 36.68 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.41 0.684 . . . . 0.0 111.592 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.459 ' OD1' ' HG2' ' A' ' 97' ' ' ARG . 5.8 p-10 -88.0 140.81 29.11 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.181 172.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.0 p -77.76 37.22 0.23 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 128.059 2.544 . . . . 0.0 110.892 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . 0.262 25.1 p 65.0 -50.99 0.34 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 128.682 2.793 . . . . 0.0 113.477 -154.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -134.88 132.58 38.71 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -167.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.72 -65.62 3.67 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 114.122 -1.399 . . . . 0.0 116.228 166.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.5 p -90.51 157.71 17.4 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.436 1.894 . . . . 0.0 113.707 -176.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 20' ' ' VAL . 17.7 m -125.15 131.64 72.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 171.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 p -107.8 104.4 13.88 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 110.944 -2.844 . . . . 0.0 107.41 166.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -120.18 176.27 16.14 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.734 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -129.9 132.81 46.52 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 35' ' ' VAL . 15.3 t -116.09 119.16 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.884 2.874 . . . . 0.0 108.209 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HG2' HG22 ' A' ' 36' ' ' VAL . 2.0 pp0? -53.69 157.41 2.27 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.434 1.894 . . . . 0.0 112.738 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.601 ' H ' HD11 ' A' ' 86' ' ' ILE . . . -18.91 96.51 0.01 OUTLIER Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.001 2.238 . . . . 0.0 116.665 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' A' ' 7' ' ' LYS . 33.6 Cg_exo -61.3 86.85 0.09 OUTLIER 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.552 2.168 . . . . 0.0 112.559 164.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.41 101.3 7.54 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 111.015 -2.811 . . . . 0.0 109.419 171.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.445 0.4 OUTLIER 55.53 -88.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 112.209 -2.269 . . . . 0.0 116.766 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -49.25 -50.82 37.01 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.719 1.608 . . . . 0.0 112.404 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.635 HG13 HG22 ' A' ' 35' ' ' VAL . 59.0 t -56.05 -36.57 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.844 1.658 . . . . 0.0 111.821 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -56.61 -35.35 68.19 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.0 p -61.56 -32.81 72.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -67.23 -28.79 68.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.344 1.058 . . . . 0.0 112.94 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -61.73 -37.92 86.02 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.3 m -54.88 -49.21 71.75 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.864 0.866 . . . . 0.0 111.176 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.428 ' HZ2' ' HA ' ' A' ' 26' ' ' ALA . 3.3 t90 -53.15 -59.22 4.83 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.531 1.533 . . . . 0.0 112.79 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 51' ' ' VAL . 14.6 mt -59.99 -17.41 38.2 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.563 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 96.8 p -92.92 -53.83 3.99 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 172.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -71.98 -42.96 65.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -170.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.37 113.86 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 -165.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.74 80.91 0.52 Allowed Glycine 0 CA--C 1.532 1.104 0 CA-C-N 113.323 -1.762 . . . . 0.0 110.777 166.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.581 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 2.2 m -63.87 -45.09 80.95 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-O 117.769 -1.11 . . . . 0.0 113.404 -174.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 22.8 Cg_exo -91.77 102.53 0.22 Allowed 'Trans proline' 0 CA--C 1.53 0.313 0 N-CA-C 106.554 -2.133 . . . . 0.0 106.554 155.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.8 m 67.85 124.04 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.5 p -83.14 53.31 2.42 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.185 -1.825 . . . . 0.0 114.416 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.638 ' NH2' ' H ' ' A' ' 15' ' ' GLY . 1.7 tpm_? -87.47 -10.99 50.3 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.027 -1.897 . . . . 0.0 110.205 165.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.46 96.09 4.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -134.74 -48.79 0.75 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 112.58 -2.1 . . . . 0.0 111.838 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -123.27 88.48 2.93 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.389 1.476 . . . . 0.0 108.261 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.9 m -104.63 124.8 49.97 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 123.708 1.718 . . . . 0.0 112.117 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 3.7 m120 -87.81 86.9 7.22 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 110.841 -2.89 . . . . 0.0 112.545 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.563 ' HE2' ' HB3' ' A' ' 66' ' ' SER . 75.0 m-85 -74.44 88.66 2.11 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.141 -1.845 . . . . 0.0 110.731 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.4 t -120.61 -165.7 1.24 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.144 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 47.67 74.06 0.18 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.112 2.165 . . . . 0.0 110.75 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.608 ' HG2' HG12 ' A' ' 9' ' ' VAL . 17.7 mt-10 -101.31 102.71 13.61 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.783 -171.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.458 ' HG3' ' HB3' ' A' ' 8' ' ' SER . 0.1 OUTLIER -117.53 113.04 21.42 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 112.147 -2.297 . . . . 0.0 112.718 -177.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.5 p -65.53 102.05 0.67 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.755 1.264 . . . . 0.0 113.872 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.601 HD11 ' H ' ' A' ' 53' ' ' GLY . 11.3 pt -85.11 77.48 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 112.206 -2.27 . . . . 0.0 113.326 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.2 m -50.09 -34.98 23.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 112.692 -2.049 . . . . 0.0 112.92 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -113.84 108.08 16.58 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 166.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 70.3 tp -67.38 76.94 0.16 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 124.283 1.992 . . . . 0.0 109.513 170.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -96.34 59.29 1.86 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 112.468 -2.151 . . . . 0.0 114.609 -171.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.5 131.27 0.09 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 128.574 2.75 . . . . 0.0 109.143 174.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.2 p -132.69 65.14 1.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 123.182 1.468 . . . . 0.0 109.469 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -174.85 134.7 0.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 111.43 -2.623 . . . . 0.0 109.129 -168.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.587 ' HD2' ' HA ' ' A' ' 27' ' ' GLU . 30.1 t80 -111.31 94.33 4.92 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 168.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.463 ' HA ' HH21 ' A' ' 31' ' ' ARG . 5.9 t -98.03 165.37 11.94 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 118.215 2.672 . . . . 0.0 118.215 -153.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.522 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 7.7 p -53.11 141.06 7.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 127.874 2.47 . . . . 0.0 115.276 -170.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.459 ' HG2' ' OD1' ' A' ' 41' ' ' ASN . 35.4 ttp180 -59.63 104.5 0.28 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.885 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 N--CA 1.477 0.881 0 CA-C-N 113.148 -1.842 . . . . 0.0 112.948 -179.557 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo . . . . . 0 CA--C 1.536 0.582 0 N-CA-C 119.342 2.786 . . . . 0.0 119.342 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.95 117.01 33.65 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.944 1.354 . . . . 0.0 111.273 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.474 ' HZ3' ' HD2' ' A' ' 62' ' ' LYS . 82.2 tttt -85.28 121.5 28.1 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.555 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.5 t -107.87 93.32 4.47 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 123.589 1.662 . . . . 0.0 108.565 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.252 8.0 p -98.3 107.38 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 112.728 -2.033 . . . . 0.0 112.137 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.571 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 11.3 m-20 -85.73 94.18 9.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 112.468 -2.151 . . . . 0.0 110.143 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -70.79 166.61 20.6 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 112.185 -2.28 . . . . 0.0 113.044 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -136.35 113.03 10.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.752 1.621 . . . . 0.0 110.764 167.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.8 124.67 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.35 1.06 . . . . 0.0 113.81 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.58 91.81 3.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 123.085 1.421 . . . . 0.0 108.394 164.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -134.81 87.11 0.25 Allowed Glycine 0 CA--C 1.54 1.597 0 CA-C-N 112.665 -2.061 . . . . 0.0 112.539 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -53.17 -55.72 22.02 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.835 1.254 . . . . 0.0 113.713 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 p -108.75 129.2 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 123.751 0.657 . . . . 0.0 109.824 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 71.84 -30.86 0.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.022 2.129 . . . . 0.0 116.081 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 15' ' ' GLY . . . -22.33 -64.16 0.03 OUTLIER Glycine 0 CA--C 1.53 1.02 0 C-N-CA 129.054 3.216 . . . . 0.0 117.408 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.4 ' C ' HH22 ' A' ' 97' ' ' ARG . 10.0 m -70.39 63.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.8 t -149.04 -85.56 0.09 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.396 1.878 . . . . 0.0 110.104 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.5 ' HA ' ' HB3' ' A' ' 73' ' ' SER 0.364 34.2 p90 58.14 -46.91 0.05 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 119.528 3.158 . . . . 0.0 119.528 179.148 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -12.05 -81.11 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.939 2.895 . . . . 0.0 117.298 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -44.04 -55.51 4.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.057 1.343 . . . . 0.0 114.004 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -57.61 -58.51 7.99 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.828 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.615 ' HA ' ' HH2' ' A' ' 64' ' ' TRP . . . -59.76 -53.03 62.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.477 1.111 . . . . 0.0 113.602 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -52.3 -54.78 27.08 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.864 2.466 . . . . 0.0 113.725 -178.133 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -56.72 -52.66 64.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.328 1.051 . . . . 0.0 111.851 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 33' ' ' ILE . 1.4 mp0 -66.17 -47.57 73.55 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.737 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.04 -47.68 74.47 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -55.9 -50.76 69.78 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.776 0.83 . . . . 0.0 112.522 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -58.12 -37.04 73.82 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.08 1.352 . . . . 0.0 114.274 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 29' ' ' GLU . 24.7 mm -76.13 -36.34 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.981 0.912 . . . . 0.0 111.979 177.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.27 67.85 1.21 Allowed Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.876 1.227 . . . . 0.0 110.56 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.683 HG23 ' HA3' ' A' ' 53' ' ' GLY . 12.3 p -158.34 154.64 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.757 1.623 . . . . 0.0 111.62 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.696 HG13 ' HB2' ' A' ' 94' ' ' PHE 0.473 3.7 p 65.15 152.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 128.929 2.892 . . . . 0.0 115.416 170.271 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.97 -89.29 1.53 Allowed Glycine 0 N--CA 1.477 1.422 0 CA-C-N 112.802 -1.999 . . . . 0.0 113.191 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -135.17 159.69 40.73 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HB ' ' HG2' ' A' ' 97' ' ' ARG . 1.9 t -109.66 136.23 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 113.004 -1.907 . . . . 0.0 108.074 173.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.794 ' HG3' HG23 ' A' ' 48' ' ' THR . 10.7 pttp -118.19 133.01 56.28 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.46 1.904 . . . . 0.0 112.224 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -75.18 146.47 41.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 112.027 -2.351 . . . . 0.0 112.766 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.0 p -123.15 161.47 24.39 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.328 168.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 p -64.57 -22.02 66.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 113.286 -1.779 . . . . 0.0 113.932 169.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -101.8 11.46 38.68 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -168.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.66 -35.94 1.2 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.096 0.855 . . . . 0.0 114.082 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.0 p -61.16 79.97 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.291 2.236 . . . . 0.0 111.728 172.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.51 141.0 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 111.854 -2.43 . . . . 0.0 111.254 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.794 HG23 ' HG3' ' A' ' 40' ' ' LYS . 7.5 t -113.31 131.64 55.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 113.436 -1.711 . . . . 0.0 111.832 -173.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 10' ' ' ASP . . . -133.85 143.03 14.6 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.296 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -98.21 86.94 3.78 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 112.914 -1.643 . . . . 0.0 112.468 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.9 t -86.74 82.75 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 111.86 -2.427 . . . . 0.0 110.534 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.561 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 40.3 tt0 -88.03 115.87 25.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.962 -1.927 . . . . 0.0 109.875 173.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.683 ' HA3' HG23 ' A' ' 35' ' ' VAL . . . 157.89 -82.35 0.15 Allowed Glycine 0 N--CA 1.468 0.827 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.698 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.49 ' HA ' HG13 ' A' ' 58' ' ' VAL . 8.8 Cg_exo -15.18 82.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.327 -0.58 1 C-N-CA 125.343 4.029 . . . . 0.0 118.35 -158.123 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.706 ' H ' HG13 ' A' ' 58' ' ' VAL . 66.9 tt0 -129.24 107.63 9.7 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.467 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 57.91 -88.29 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.487 2.315 . . . . 0.0 114.569 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -57.1 -43.5 82.32 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.299 0.639 . . . . 0.0 111.935 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.706 HG13 ' H ' ' A' ' 55' ' ' GLU 0.33 14.8 p -84.83 2.17 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -60.49 -35.45 75.94 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.487 -0.758 . . . . 0.0 111.517 164.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -51.23 -38.57 53.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.127 1.371 . . . . 0.0 114.023 173.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -53.23 60.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.052 0.541 . . . . 0.0 111.28 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.474 ' HD2' ' HZ3' ' A' ' 7' ' ' LYS . 30.8 ttpt -54.5 -51.62 64.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.728 1.211 . . . . 0.0 112.858 173.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.4 t -57.57 -31.12 65.83 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.051 1.74 . . . . 0.0 115.293 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.615 ' HH2' ' HA ' ' A' ' 26' ' ' ALA . 5.3 t90 -76.9 -50.8 12.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.205 1.802 . . . . 0.0 114.467 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.595 ' HB3' ' HZ ' ' A' ' 80' ' ' PHE . 14.1 tp -51.4 -26.86 8.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.163 2.185 . . . . 0.0 115.482 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.447 ' HA ' ' HB ' ' A' ' 78' ' ' THR . 13.7 p -53.82 -60.3 3.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.158 2.183 . . . . 0.0 113.967 170.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -127.17 70.82 1.31 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.768 2.427 . . . . 0.0 109.5 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -54.95 -29.04 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -177.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.83 -84.5 0.48 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.691 171.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.9 t -128.28 -74.68 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -44.12 102.39 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 124.213 3.275 . . . . 0.0 114.173 -154.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.8 p 42.25 45.91 3.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.655 -2.521 . . . . 0.0 115.303 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 66.1 p -155.38 -66.35 0.12 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 68.4 -61.52 0.4 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.894 2.078 . . . . 0.0 114.158 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.475 HG21 ' OG1' ' A' ' 78' ' ' THR . 14.6 mt 32.05 110.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 128.963 2.905 . . . . 0.0 113.74 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -67.71 -32.28 72.81 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -163.49 110.71 1.17 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.065 0.946 . . . . 0.0 111.686 171.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.475 ' OG1' HG21 ' A' ' 75' ' ' ILE . 63.7 m -88.75 101.11 13.68 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.448 1.594 . . . . 0.0 109.471 166.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -68.24 98.92 0.85 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 111.602 -2.545 . . . . 0.0 111.155 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.595 ' HZ ' ' HB3' ' A' ' 65' ' ' LEU . 58.4 m-85 -79.31 78.72 5.79 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 124.041 1.877 . . . . 0.0 112.42 175.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.5 p -92.67 -69.17 0.76 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 110.977 -2.829 . . . . 0.0 115.302 -169.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.617 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 15.3 m120 -80.75 75.75 7.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 123.686 1.707 . . . . 0.0 110.955 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -87.44 83.41 7.3 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 111.885 -2.416 . . . . 0.0 111.235 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.617 ' HE3' ' HB3' ' A' ' 82' ' ' ASN . 87.9 mttt -96.92 91.85 5.83 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.143 -1.844 . . . . 0.0 109.218 -174.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.1 p -74.6 115.21 13.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.255 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.499 ' CD1' HE21 ' A' ' 52' ' ' GLN . 2.6 pp -122.01 149.49 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 110.618 -2.992 . . . . 0.0 111.658 -174.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.0 p -82.32 101.72 10.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 113.703 -1.589 . . . . 0.0 112.083 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 88' ' ' LYS 0.292 33.8 mmtp 98.55 149.05 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.538 2.335 . . . . 0.0 116.343 168.871 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.6 tp -103.22 130.29 50.41 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.304 -173.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -119.99 -44.32 2.51 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.192 -1.367 . . . . 0.0 112.587 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' TYR . . . . . 0.561 ' HB2' ' HB3' ' A' ' 52' ' ' GLN . 20.5 m-85 -73.95 95.16 2.44 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.885 1.274 . . . . 0.0 113.987 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.9 p -86.21 -22.2 27.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 111.546 -2.57 . . . . 0.0 115.811 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -137.5 108.47 6.72 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.898 0.749 . . . . 0.0 112.539 -162.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.696 ' HB2' HG13 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -66.65 125.79 26.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.815 171.028 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.4 t -149.97 111.28 4.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 97' ' ' ARG 0.31 25.6 m 48.39 -178.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 120.195 3.405 . . . . 0.0 120.195 161.649 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.475 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 46.6 mtt180 -105.97 139.38 40.61 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.841 -1.527 . . . . 0.0 113.662 -176.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 C--O 1.246 0.88 0 CA-C-N 112.4 -2.182 . . . . 0.0 113.446 -179.776 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo . . . . . 0 CA--C 1.539 0.75 0 N-CA-C 114.556 0.944 . . . . 0.0 114.556 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.55 ' HB3' HE22 ' A' ' 52' ' ' GLN . 9.9 mp -114.18 97.25 6.24 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.747 ' HG2' HG22 ' A' ' 85' ' ' THR . 63.0 mttm -98.88 113.64 25.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.976 -161.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 t -103.33 101.88 11.81 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.248 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -116.1 142.14 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 112.821 -1.99 . . . . 0.0 112.077 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -100.24 121.79 42.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 123.33 1.538 . . . . 0.0 110.353 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.454 ' HD1' HG23 ' A' ' 13' ' ' VAL . 30.8 p90 -103.02 148.76 25.29 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 111.933 -2.394 . . . . 0.0 111.863 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -124.15 85.94 2.49 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 111.821 -2.445 . . . . 0.0 109.51 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 48.7 t -80.66 110.38 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 123.104 1.43 . . . . 0.0 110.521 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.586 ' HB3' ' HE ' ' A' ' 16' ' ' ARG . 13.6 m-85 -93.84 77.77 4.2 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 111.126 -2.761 . . . . 0.0 106.855 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.66 54.31 0.55 Allowed Glycine 0 N--CA 1.479 1.503 0 CA-C-N 112.015 -2.357 . . . . 0.0 109.991 173.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.586 ' HE ' ' HB3' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -61.4 -36.06 79.25 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -174.236 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.1 m -80.22 52.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 52.68 -110.89 0.55 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 127.012 2.125 . . . . 0.0 112.484 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.75 -56.39 0.35 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 119.087 2.395 . . . . 0.0 119.087 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 m -77.14 100.24 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -171.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.43 64.98 1.02 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 124.582 2.135 . . . . 0.0 107.634 162.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.96 -31.43 50.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 111.702 -2.499 . . . . 0.0 113.709 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -32.7 -59.72 0.32 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.909 2.083 . . . . 0.0 115.538 170.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.1 tpt -54.9 -38.24 67.33 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TYR . . . . . 0.726 ' HB3' ' HZ2' ' A' ' 64' ' ' TRP . 2.5 m-30 -73.36 -53.48 10.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.915 1.686 . . . . 0.0 111.284 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 94' ' ' PHE . . . -54.25 -37.35 64.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.283 1.433 . . . . 0.0 113.143 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.28 -83.42 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.594 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -63.97 -59.62 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.005 1.322 . . . . 0.0 114.209 -170.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 33' ' ' ILE . 43.5 mt-10 -65.24 -43.88 90.0 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 26' ' ' ALA . . . -63.12 -43.38 98.58 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.5 ttp-105 -52.35 -55.72 19.65 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.732 0.813 . . . . 0.0 110.866 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -57.63 -40.78 79.98 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.017 1.727 . . . . 0.0 114.794 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 29' ' ' GLU . 31.8 mm -71.11 -29.76 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.105 0.962 . . . . 0.0 113.418 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.1 38.67 4.77 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 124.568 1.08 . . . . 0.0 112.702 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.3 t -110.62 141.45 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 123.77 1.748 . . . . 0.0 111.736 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 89' ' ' LEU . 3.8 t -126.47 156.18 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 111.002 -2.817 . . . . 0.0 111.125 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.89 -149.61 20.73 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.074 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.604 ' HZ3' ' HB2' ' A' ' 40' ' ' LYS . 55.7 p-90 -153.46 146.36 24.44 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.328 1.451 . . . . 0.0 111.084 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' HD1' ' A' ' 98' ' ' TYR . 2.6 t -117.99 144.52 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.979 0.912 . . . . 0.0 109.583 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.604 ' HB2' ' HZ3' ' A' ' 38' ' ' TRP . 60.4 tttt -132.52 137.49 47.18 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.493 0.717 . . . . 0.0 112.298 175.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . 0.475 ' OD1' ' HG2' ' A' ' 97' ' ' ARG . 1.9 p-10 -94.97 93.35 7.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 122.676 1.227 . . . . 0.0 110.281 168.095 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 46' ' ' THR . 5.7 t -80.53 163.43 23.73 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -168.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.2 p -54.02 -35.03 61.49 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.126 -1.852 . . . . 0.0 113.911 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -66.3 -1.76 3.72 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.46 -41.08 2.62 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 124.952 1.263 . . . . 0.0 111.612 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.55 ' O ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -52.93 140.66 24.06 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.981 2.112 . . . . 0.0 113.804 -178.229 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 13' ' ' VAL . 96.0 t -92.01 103.36 14.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 123.986 1.851 . . . . 0.0 107.278 169.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.7 t -109.77 -164.26 0.92 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 111.738 -2.483 . . . . 0.0 110.156 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.26 -173.79 15.69 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 126.378 1.942 . . . . 0.0 110.89 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -125.74 134.34 51.79 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 112.257 -1.972 . . . . 0.0 111.91 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.454 HG21 ' HG3' ' A' ' 61' ' ' MET . 7.5 p -117.41 117.02 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 111.278 -2.692 . . . . 0.0 109.942 177.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.55 HE22 ' HB3' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -102.15 130.11 48.7 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 112.619 -2.082 . . . . 0.0 107.6 171.443 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.5 149.05 17.41 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.626 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -65.99 145.84 80.82 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 121.554 1.503 . . . . 0.0 109.822 166.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -17.83 -61.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.547 ' HG2' ' HD2' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -61.09 -39.97 91.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HD2' ' HG2' ' A' ' 56' ' ' GLU . 2.7 mptp? -65.92 -39.31 90.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.238 1.015 . . . . 0.0 111.718 174.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.667 HG21 ' HB2' ' A' ' 7' ' ' LYS . 49.2 t -61.69 -42.63 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.244 1.018 . . . . 0.0 112.286 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.594 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 25.2 m120 -55.33 -46.54 76.33 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.7 p -69.02 -47.22 65.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.578 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.655 ' HA ' ' HE3' ' A' ' 64' ' ' TRP . 13.8 tmm? -49.98 -52.58 32.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.695 1.598 . . . . 0.0 114.19 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 59' ' ' ASN . 65.5 pttt -59.17 -38.15 79.08 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.9 m -63.98 -57.69 8.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.055 170.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.726 ' HZ2' ' HB3' ' A' ' 25' ' ' TYR . 13.9 t90 -46.61 -46.06 19.43 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 127.781 2.432 . . . . 0.0 115.262 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.447 ' HB2' ' HZ ' ' A' ' 80' ' ' PHE . 64.6 mt -90.1 13.1 15.84 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 -175.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . 0.265 53.4 p -101.64 -109.23 0.23 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -110.22 75.61 0.94 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.222 2.209 . . . . 0.0 107.911 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.09 -52.1 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 112.426 -2.17 . . . . 0.0 114.698 -166.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.715 ' HA2' ' HA ' ' A' ' 74' ' ' ARG . . . 77.13 -56.8 3.62 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 115.792 1.077 . . . . 0.0 115.792 -173.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.6 m -41.58 145.49 0.66 Allowed Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 127.415 2.286 . . . . 0.0 115.932 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.92 -27.36 8.46 Favored 'Cis proline' 0 CA--C 1.535 0.569 0 N-CA-C 117.774 2.182 . . . . 0.0 117.774 -10.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.5 p -131.19 -43.83 1.04 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.0 m -97.27 121.98 39.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.713 2.005 . . . . 0.0 112.818 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.715 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.84 86.37 0.51 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -172.963 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.652 HD11 ' HE2' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -75.43 91.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 114.055 -1.429 . . . . 0.0 107.765 167.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.55 -55.25 14.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 110.708 -2.951 . . . . 0.0 115.838 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HD2' ' H ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -163.54 145.6 9.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.745 0.818 . . . . 0.0 110.007 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.44 ' H ' ' HD2' ' A' ' 77' ' ' ARG . 90.3 m -152.22 138.15 18.1 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -98.18 140.23 32.79 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.214 -2.721 . . . . 0.0 109.184 167.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.447 ' HZ ' ' HB2' ' A' ' 65' ' ' LEU . 87.7 m-85 -114.37 109.82 18.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.68 176.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.49 167.67 13.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 113.219 -1.809 . . . . 0.0 111.986 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.7 m120 53.82 84.89 0.06 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.909 1.284 . . . . 0.0 113.264 172.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.2 111.76 24.51 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 123.057 1.408 . . . . 0.0 113.728 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -100.03 91.14 4.65 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 111.63 -2.532 . . . . 0.0 107.069 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.747 HG22 ' HG2' ' A' ' 7' ' ' LYS . 12.1 p -74.28 84.31 1.9 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 123.107 1.432 . . . . 0.0 109.034 172.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.1 pt -112.34 154.35 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 112.98 -1.918 . . . . 0.0 114.333 -165.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.1 t -59.15 132.41 53.92 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.229 -1.805 . . . . 0.0 111.864 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp 61.56 149.9 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.468 ' HB3' HG11 ' A' ' 36' ' ' VAL . 90.8 mt -85.51 97.58 10.13 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 113.782 -1.554 . . . . 0.0 111.07 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -84.16 82.03 8.54 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.492 -173.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 154.19 150.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 129.97 3.308 . . . . 0.0 111.965 167.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.3 p -82.07 88.42 6.43 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.504 1.145 . . . . 0.0 110.293 169.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 61.42 172.14 0.11 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 111.211 -2.722 . . . . 0.0 113.209 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 8.3 t80 -73.56 69.59 1.25 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.245 1.497 . . . . 0.0 110.807 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.5 110.42 15.95 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 112.585 -2.098 . . . . 0.0 116.078 -166.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.258 27.2 m 54.95 163.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 110.768 -2.924 . . . . 0.0 117.035 165.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.475 ' HG2' ' OD1' ' A' ' 41' ' ' ASN . 52.6 ttp180 -111.66 113.15 25.35 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.215 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.442 ' HD1' ' O ' ' A' ' 39' ' ' VAL . 83.5 m-85 . . . . . 0 C--O 1.246 0.873 0 CA-C-N 111.519 -2.582 . . . . 0.0 111.717 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 CA--C 1.534 0.515 0 N-CA-C 115.434 1.282 . . . . 0.0 115.434 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.08 127.22 41.06 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 164.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.606 ' HB2' HG21 ' A' ' 58' ' ' VAL . 33.3 mmtp -97.16 115.6 27.84 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.199 1.0 . . . . 0.0 111.598 -163.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.9 t -107.24 122.98 47.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.127 -1.851 . . . . 0.0 110.36 166.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 t -112.98 108.03 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 111.314 -2.675 . . . . 0.0 108.262 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.0 t0 -88.24 97.36 10.98 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 113.106 -1.861 . . . . 0.0 107.715 173.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.461 ' HD2' HG23 ' A' ' 13' ' ' VAL . 33.7 p90 -94.79 150.68 19.95 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 109.122 -3.672 . . . . 0.0 112.56 -171.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 6.0 mp0 -127.8 97.52 4.86 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.008 166.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.461 HG23 ' HD2' ' A' ' 11' ' ' TYR . 94.6 t -68.78 126.58 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.005 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -127.94 137.0 52.1 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.545 0.528 . . . . 0.0 111.515 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 75' ' ' ILE . . . -105.52 121.08 6.68 Favored Glycine 0 N--CA 1.476 1.352 0 O-C-N 124.819 1.324 . . . . 0.0 112.313 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -38.68 -43.56 0.91 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 172.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -121.84 146.98 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.581 163.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -52.83 168.65 0.11 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.6 -78.5 0.28 Allowed Glycine 0 N--CA 1.477 1.377 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.655 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' A' ' 22' ' ' PHE . 12.5 t 66.98 -72.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 128.277 2.631 . . . . 0.0 111.234 175.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.7 m 42.05 38.83 1.16 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.391 1.876 . . . . 0.0 115.316 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.561 ' HB3' HG22 ' A' ' 47' ' ' VAL . 17.3 t80 -63.02 -27.9 69.73 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 112.722 -2.036 . . . . 0.0 113.754 -168.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.517 ' NE ' ' HB3' ' A' ' 97' ' ' ARG . 8.6 mmm180 -21.03 -73.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 67.7 mtm -60.67 -40.59 92.69 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -62.91 -46.89 85.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.894 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.495 ' HA ' ' HZ2' ' A' ' 64' ' ' TRP . . . -50.7 -56.86 10.0 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 125.001 1.438 . . . . 0.0 111.925 173.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.425 ' OE1' HG22 ' A' ' 96' ' ' VAL . 33.0 tt0 -51.43 -60.0 3.62 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.669 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.23 -53.14 61.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.195 1.398 . . . . 0.0 113.468 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.475 ' O ' HG12 ' A' ' 33' ' ' ILE . 1.9 tp10 -65.51 -38.61 90.2 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.549 0.74 . . . . 0.0 112.203 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -55.9 -47.53 77.27 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.017 0.927 . . . . 0.0 112.985 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -52.23 -49.89 63.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.796 1.238 . . . . 0.0 111.196 173.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.97 -51.67 68.26 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.272 1.429 . . . . 0.0 114.444 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 29' ' ' GLU . 29.7 mm -67.8 -25.69 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.4 1.08 . . . . 0.0 112.705 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.28 53.85 1.67 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.33 0.966 . . . . 0.0 111.788 -174.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.546 HG22 ' CE ' ' A' ' 61' ' ' MET . 2.6 t -116.6 140.13 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 123.41 1.576 . . . . 0.0 109.58 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 52' ' ' GLN . 33.5 m -119.98 166.74 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 111.982 -2.372 . . . . 0.0 111.048 173.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.1 -135.3 7.41 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.5 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.434 ' CZ3' ' HB2' ' A' ' 40' ' ' LYS . 39.8 p-90 -162.1 151.07 15.45 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 113.456 -1.372 . . . . 0.0 111.367 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 95' ' ' SER . 10.7 p -114.91 136.4 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.681 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.703 ' HB3' HG23 ' A' ' 48' ' ' THR . 83.8 tttt -117.01 123.3 46.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.202 1.477 . . . . 0.0 112.508 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -64.93 114.73 4.74 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 111.399 -2.637 . . . . 0.0 109.161 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.507 ' OG1' HG22 ' A' ' 48' ' ' THR . 0.2 OUTLIER -104.0 -130.17 0.26 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.995 -175.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.6 m -107.4 108.38 19.7 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.897 -1.127 . . . . 0.0 110.623 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp 49.76 85.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.95 -31.3 1.08 Allowed Glycine 0 N--CA 1.473 1.115 0 CA-C-N 113.086 -1.87 . . . . 0.0 116.319 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.8 p -59.87 147.49 38.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.375 1.07 . . . . 0.0 112.076 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.561 HG22 ' HB3' ' A' ' 22' ' ' PHE . 16.1 m -133.64 124.92 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 112.163 -2.289 . . . . 0.0 113.575 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.703 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.9 t -92.23 -171.91 2.96 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 109.26 -3.609 . . . . 0.0 109.896 159.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 129.5 -155.84 21.04 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.698 2.094 . . . . 0.0 111.191 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -130.94 109.6 10.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.362 1.465 . . . . 0.0 112.659 -173.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 t -94.33 97.65 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.376 171.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.518 ' HB2' HG23 ' A' ' 36' ' ' VAL . 67.7 mt-30 -100.77 107.68 19.31 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.592 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.19 150.87 20.32 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 114.429 -1.26 . . . . 0.0 113.673 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HD3' HD11 ' A' ' 89' ' ' LEU . 74.3 Cg_endo -72.93 153.14 52.68 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.142 1.894 . . . . 0.0 111.147 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.575 ' O ' HG12 ' A' ' 58' ' ' VAL . 40.0 mt-10 -39.84 -49.06 2.36 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -173.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -63.19 -62.91 1.38 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.037 0.381 . . . . 0.0 111.547 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -59.56 -31.34 69.34 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.606 HG21 ' HB2' ' A' ' 7' ' ' LYS 0.287 1.7 p -55.78 -35.41 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -177.368 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.57 -41.07 66.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.9 t -67.55 -54.35 20.65 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.669 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.546 ' CE ' HG22 ' A' ' 35' ' ' VAL . 20.1 ptp -58.13 -36.77 73.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HE3' HG22 ' A' ' 58' ' ' VAL . 88.1 mttt -52.38 -61.63 2.15 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.088 1.355 . . . . 0.0 111.737 171.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.3 m -54.04 -43.5 70.23 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . 0.495 ' HZ2' ' HA ' ' A' ' 26' ' ' ALA . 3.5 t90 -58.11 -53.99 51.99 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 mt -51.57 -29.58 17.69 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -80.02 -69.93 0.55 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.916 -1.493 . . . . 0.0 114.777 167.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -63.86 -27.16 68.97 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.514 HG22 ' HD2' ' A' ' 71' ' ' PRO 0.357 8.1 p 62.01 -70.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 129.394 3.078 . . . . 0.0 118.548 172.376 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.94 -111.67 2.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.88 1.228 . . . . 0.0 111.687 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.1 p -73.18 -30.96 1.33 Allowed Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 118.952 2.945 . . . . 0.0 118.952 -170.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' A' ' 68' ' ' VAL . 38.7 Cg_exo -56.95 109.93 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 CA-C-N 123.075 2.134 . . . . 0.0 112.846 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -43.2 -30.79 0.51 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.222 2.609 . . . . 0.0 114.174 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -49.63 -23.93 1.95 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 74.1 -33.04 0.24 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 127.941 2.496 . . . . 0.0 116.505 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.629 ' HA ' ' HA2' ' A' ' 15' ' ' GLY 0.337 4.1 mp 58.37 -84.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.723 2.009 . . . . 0.0 112.044 178.113 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.31 2.6 p30 57.76 -41.37 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 128.313 2.645 . . . . 0.0 117.928 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 -110.58 101.69 10.33 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 123.313 1.53 . . . . 0.0 111.116 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.7 m -118.17 127.9 54.2 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 112.784 -2.007 . . . . 0.0 111.584 172.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . 6.4 m120 -82.73 83.57 7.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 111.484 -2.598 . . . . 0.0 110.861 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -72.27 37.8 0.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.682 -2.053 . . . . 0.0 112.953 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 m -59.78 -36.39 76.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.063 2.145 . . . . 0.0 115.887 -163.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.558 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 24.6 t-20 -116.17 88.38 2.88 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.05 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -92.95 102.88 15.24 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.844 169.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -108.47 119.99 41.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 111.462 -2.608 . . . . 0.0 110.31 -173.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.6 p -82.8 92.17 7.19 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 123.756 1.741 . . . . 0.0 111.934 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.5 pt -80.64 140.42 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 111.166 -2.743 . . . . 0.0 114.052 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.4 m -73.33 87.36 1.51 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.808 -1.996 . . . . 0.0 111.289 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 73.08 156.32 0.17 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-N 112.247 -2.251 . . . . 0.0 112.42 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.469 HD11 ' HD3' ' A' ' 54' ' ' PRO . 88.5 mt -75.25 111.15 10.2 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.949 0.881 . . . . 0.0 111.113 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.7 13.58 8.47 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -162.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -148.51 155.21 40.86 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.328 1.051 . . . . 0.0 111.751 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.6 p -68.62 -46.69 68.6 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.519 -1.219 . . . . 0.0 114.056 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.479 ' HA ' HG12 ' A' ' 36' ' ' VAL . 1.9 t-20 -156.54 172.93 17.69 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.429 1.492 . . . . 0.0 111.101 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -72.93 94.98 1.91 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.789 1.28 . . . . 0.0 110.586 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . 0.495 ' O ' HG12 ' A' ' 39' ' ' VAL . 42.4 m -63.06 142.96 58.18 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.305 -2.225 . . . . 0.0 114.496 -173.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . 0.425 HG22 ' OE1' ' A' ' 27' ' ' GLU . 85.3 t -63.75 143.14 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 110.792 -2.913 . . . . 0.0 110.032 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.517 ' HB3' ' NE ' ' A' ' 23' ' ' ARG . 46.1 ptt85 -6.63 123.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 120.306 3.446 . . . . 0.0 120.306 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 112.066 -2.334 . . . . 0.0 112.514 165.995 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.5 p -50.38 -33.06 19.24 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.9 -23.34 4.79 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -96.5 119.19 64.5 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.541 1.136 . . . . 0.0 111.294 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -71.92 59.97 2.93 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 123.428 2.752 . . . . 0.0 114.124 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.888 ' HB3' HE22 ' A' ' 52' ' ' GLN . 5.2 mp -124.63 106.83 10.42 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.576 2.351 . . . . 0.0 107.348 173.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.671 ' HE2' ' HB3' ' A' ' 83' ' ' GLU . 47.9 tttt -107.06 112.11 24.89 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.878 -166.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.612 ' HB3' ' HG2' ' A' ' 52' ' ' GLN . 4.4 p -85.1 104.64 15.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.833 167.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.438 HG22 ' HG3' ' A' ' 83' ' ' GLU . 93.0 t -109.75 143.57 19.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 110.221 -3.172 . . . . 0.0 108.028 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 9.8 m-20 -109.05 142.17 40.13 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.976 171.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -120.33 159.58 24.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.351 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -144.76 116.82 8.34 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.945 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.48 121.74 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 112.467 -2.151 . . . . 0.0 107.054 170.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.31 71.51 10.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.74 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.27 73.15 2.56 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.453 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -33.02 -59.1 0.36 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.78 1.632 . . . . 0.0 115.358 -174.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 t -125.62 72.92 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.664 0.745 . . . . 0.0 109.259 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.468 ' HB3' ' H ' ' A' ' 19' ' ' GLY 0.252 12.9 mt-30 53.33 -139.14 1.05 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 176.72 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.468 ' H ' ' HB3' ' A' ' 18' ' ' GLN . . . 78.4 -37.73 1.82 Allowed Glycine 0 N--CA 1.474 1.21 0 N-CA-C 116.527 1.371 . . . . 0.0 116.527 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.1 m -54.13 99.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 126.681 1.992 . . . . 0.0 115.718 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.6 m -94.76 75.3 3.66 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 112.396 -2.184 . . . . 0.0 108.519 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -78.78 -29.92 45.28 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 111.103 -2.771 . . . . 0.0 113.106 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.453 ' NH1' ' HG2' ' A' ' 97' ' ' ARG . 53.8 mmm-85 -50.38 155.73 0.98 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.528 1.531 . . . . 0.0 113.82 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 63.9 -57.19 0.21 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.932 2.093 . . . . 0.0 114.968 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -46.26 -55.17 7.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.06 2.144 . . . . 0.0 111.049 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.419 ' HA ' ' HH2' ' A' ' 64' ' ' TRP . . . -53.1 -68.96 0.13 Allowed 'General case' 0 C--N 1.323 -0.58 0 O-C-N 125.167 1.542 . . . . 0.0 112.432 172.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -38.92 -63.55 0.52 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.575 1.95 . . . . 0.0 114.987 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.2 m-20 -63.3 -52.15 63.16 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.876 1.67 . . . . 0.0 113.489 -174.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 33' ' ' ILE . 58.8 mt-10 -69.29 -36.66 77.26 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.517 ' HB1' HG23 ' A' ' 35' ' ' VAL . . . -62.64 -41.39 99.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.864 0.865 . . . . 0.0 112.818 175.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -53.07 -51.69 60.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.778 0.831 . . . . 0.0 110.884 168.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 28' ' ' ASP . 44.8 mmtm -61.27 -40.04 92.65 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 29' ' ' GLU . 37.3 mm -61.65 -34.04 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.883 1.273 . . . . 0.0 111.55 172.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.3 36.88 4.23 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 125.082 1.325 . . . . 0.0 113.119 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.716 HG21 ' HG3' ' A' ' 61' ' ' MET . 29.0 m -123.0 158.56 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 124.37 2.033 . . . . 0.0 115.005 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 93' ' ' ASN . 3.1 t -126.2 155.61 36.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 110.856 -2.883 . . . . 0.0 109.434 -172.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.47 -144.67 13.99 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.108 0.861 . . . . 0.0 111.695 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.492 ' CZ3' ' HB2' ' A' ' 40' ' ' LYS . 65.5 p-90 -166.0 168.16 15.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.356 1.614 . . . . 0.0 115.356 -173.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 47' ' ' VAL . 83.3 t -107.47 136.46 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 112.395 -2.184 . . . . 0.0 108.572 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.637 ' HB3' HG23 ' A' ' 48' ' ' THR . 59.2 tttp -115.12 114.28 25.11 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.639 1.576 . . . . 0.0 109.293 173.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -93.46 119.23 32.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 112.312 -2.222 . . . . 0.0 109.752 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 p -98.67 179.78 4.56 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.893 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.6 p -58.02 -52.66 64.6 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 113.906 -1.497 . . . . 0.0 113.25 171.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.08 49.44 0.84 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.48 3.29 2.89 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 119.576 2.59 . . . . 0.0 119.576 165.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.9 p -64.83 83.52 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 123.0 1.381 . . . . 0.0 111.355 168.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 39' ' ' VAL . 63.2 t -75.25 93.98 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 112.277 -2.238 . . . . 0.0 109.234 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.637 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.5 t -102.61 -169.52 1.67 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 109.987 -3.279 . . . . 0.0 109.69 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.6 -163.99 24.93 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.123 1.344 . . . . 0.0 113.47 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -123.73 131.09 53.53 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 112.021 -2.09 . . . . 0.0 112.646 -168.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.88 108.74 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.229 1.812 . . . . 0.0 107.342 172.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.888 HE22 ' HB3' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -112.01 131.35 55.46 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 170.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.701 ' HA3' HG12 ' A' ' 35' ' ' VAL . . . -168.18 158.77 31.7 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.306 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -59.84 142.64 99.0 Favored 'Trans proline' 0 C--N 1.325 -0.705 0 C-N-CA 121.839 1.692 . . . . 0.0 110.541 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -33.06 -65.95 0.15 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -36.42 48.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -72.74 -41.83 64.74 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.449 1.1 . . . . 0.0 112.487 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 7' ' ' LYS 0.303 8.6 m -65.19 -33.92 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 172.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -57.11 -47.56 80.79 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.16 0.984 . . . . 0.0 112.932 169.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.4 t -60.18 -45.02 94.53 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.815 1.246 . . . . 0.0 112.593 174.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.716 ' HG3' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -58.81 -40.88 85.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.403 1.481 . . . . 0.0 113.937 175.036 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.61 -40.23 88.72 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 171.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.8 m -58.49 -41.93 86.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.699 0.761 . . . . 0.0 111.093 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.588 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 24.0 t90 -76.23 179.06 5.97 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.447 1.499 . . . . 0.0 110.597 164.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.571 HD12 ' HE1' ' A' ' 80' ' ' PHE . 50.8 mt 71.01 -36.74 0.37 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.469 2.307 . . . . 0.0 114.965 -173.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.7 p -78.85 -42.08 28.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.711 2.004 . . . . 0.0 109.342 162.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 64' ' ' TRP . 0.1 OUTLIER -61.73 99.64 0.12 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 158.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.3 m -108.26 91.41 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 111.426 -2.625 . . . . 0.0 114.53 -169.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.39 158.73 19.91 Favored Glycine 0 N--CA 1.478 1.487 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.583 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.1 t -126.59 139.94 36.09 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 -163.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -102.12 8.21 0.47 Allowed 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 122.342 2.028 . . . . 0.0 116.026 158.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.2 m -178.66 -68.55 0.01 OUTLIER 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.587 2.355 . . . . 0.0 112.187 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 p -114.65 173.07 6.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.635 1.174 . . . . 0.0 113.86 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.469 ' H ' ' CZ ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -78.39 129.07 34.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.093 172.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mp -75.2 85.22 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -76.6 91.16 3.38 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 113.788 -1.551 . . . . 0.0 113.456 -171.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.405 ' CZ ' ' HA ' ' A' ' 77' ' ' ARG . 0.6 OUTLIER 68.39 112.87 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 111.194 -2.73 . . . . 0.0 113.878 172.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.4 m -117.28 117.06 28.51 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.306 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -102.26 140.41 36.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.219 -2.264 . . . . 0.0 109.086 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.571 ' HE1' HD12 ' A' ' 65' ' ' LEU . 68.6 m-85 -115.91 99.06 7.01 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.539 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.9 p -137.74 156.91 47.47 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.492 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 47.0 m-80 69.44 90.35 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.58 1.552 . . . . 0.0 110.749 -165.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.671 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 11.8 mp0 -118.25 111.67 19.09 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.641 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -137.61 110.45 7.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.606 -1.179 . . . . 0.0 113.948 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -68.48 123.42 20.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.919 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 pt -126.07 -159.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.977 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 t -132.03 143.67 50.22 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.482 0.713 . . . . 0.0 109.921 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 59.01 157.34 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.2 mt -97.32 92.73 6.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.856 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -83.04 34.55 0.46 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -168.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.421 ' HB2' HG13 ' A' ' 36' ' ' VAL . 80.2 m-85 -155.64 150.44 26.34 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.887 0.875 . . . . 0.0 111.858 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 p -78.25 85.78 4.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.824 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.424 ' HA ' HG22 ' A' ' 36' ' ' VAL . 3.6 m120 59.83 176.66 0.09 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 112.65 -2.068 . . . . 0.0 114.19 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -78.72 112.48 15.89 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 122.612 1.196 . . . . 0.0 109.06 164.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.7 p -108.7 -139.53 0.38 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 111.68 -2.509 . . . . 0.0 114.978 -163.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.7 m -104.19 -170.81 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.38 1.872 . . . . 0.0 112.162 -164.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.453 ' HG2' ' NH1' ' A' ' 23' ' ' ARG . 11.8 ptt180 -76.77 126.03 30.28 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 174.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.717 177.143 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 122.383 1.087 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . 0.307 28.7 p 59.75 -43.82 0.09 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.572 2.749 . . . . 0.0 118.062 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.41 -36.83 0.35 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 119.785 3.254 . . . . 0.0 119.785 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.668 ' HB2' HG21 ' A' ' 85' ' ' THR . 16.6 mmm180 -56.1 144.11 60.69 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.125 1.37 . . . . 0.0 112.005 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.82 72.89 2.5 Favored 'Trans proline' 0 C--N 1.334 -0.19 0 C-N-CA 123.092 2.528 . . . . 0.0 116.465 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.5 tp -166.64 38.49 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 129.101 2.96 . . . . 0.0 107.108 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.617 ' O ' ' HD2' ' A' ' 54' ' ' PRO . 20.2 ptmt -104.37 79.51 1.59 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.896 1.814 . . . . 0.0 115.896 -153.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.458 ' HB3' ' HG3' ' A' ' 84' ' ' LYS . 39.1 t -58.53 128.67 38.32 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.935 -176.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.608 HG12 ' HG2' ' A' ' 83' ' ' GLU . 25.8 m -114.94 142.0 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 126.169 2.168 . . . . 0.0 112.344 -173.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.06 120.45 42.56 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.802 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 51.4 p90 -104.34 124.41 49.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.603 -2.089 . . . . 0.0 112.698 -173.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -100.91 113.61 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.522 168.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.1 t -71.34 121.67 21.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 112.313 -2.221 . . . . 0.0 111.12 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -132.43 150.4 52.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.499 166.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.638 ' H ' ' NH2' ' A' ' 74' ' ' ARG . . . -176.15 -146.07 5.82 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -98.64 -79.82 0.47 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.422 -0.889 . . . . 0.0 111.363 -170.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.35 120.33 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.858 1.263 . . . . 0.0 109.736 -173.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.8 mm100 -66.76 137.34 56.58 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.897 -172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.94 94.8 1.96 Allowed Glycine 0 N--CA 1.479 1.535 0 CA-C-N 113.37 -1.741 . . . . 0.0 112.936 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.475 HG21 HG22 ' A' ' 47' ' ' VAL 0.285 2.6 t -27.91 -71.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 127.898 2.479 . . . . 0.0 117.218 -177.945 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.7 t 64.44 -27.54 0.09 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 119.429 3.122 . . . . 0.0 119.429 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.97 20.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 118.4 2.741 . . . . 0.0 118.4 -177.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -62.86 -73.38 0.11 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.193 1.797 . . . . 0.0 113.452 -166.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.6 mmt -50.21 -46.81 54.87 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -45.88 -58.46 3.51 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.148 1.379 . . . . 0.0 112.872 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HA ' ' HZ2' ' A' ' 64' ' ' TRP . . . -59.09 -49.98 75.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.244 1.418 . . . . 0.0 112.976 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.587 ' HA ' ' HD2' ' A' ' 94' ' ' PHE . 85.8 mt-10 -55.36 -58.46 7.62 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.081 1.353 . . . . 0.0 112.841 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -57.09 -52.82 63.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.607 -1.633 . . . . 0.0 112.228 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.604 ' O ' HG12 ' A' ' 33' ' ' ILE . 47.5 mt-10 -57.99 -57.68 11.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.492 0.717 . . . . 0.0 111.835 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 -45.75 75.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.463 HH21 ' HA ' ' A' ' 95' ' ' SER . 64.9 mtt-85 -53.9 -55.85 23.08 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.524 1.13 . . . . 0.0 111.559 174.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -58.74 -35.02 72.04 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.217 -1.356 . . . . 0.0 113.972 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 29' ' ' GLU . 26.6 pt -107.45 34.98 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.53 33.51 81.96 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 168.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.635 HG22 HG13 ' A' ' 58' ' ' VAL . 89.4 t -124.51 118.78 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 52' ' ' GLN . 15.1 m -127.51 164.46 28.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 114.529 -1.214 . . . . 0.0 114.182 -173.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.58 -120.99 1.3 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.698 1.618 . . . . 0.0 111.013 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -164.04 163.15 23.38 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.38 135.58 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.043 1.737 . . . . 0.0 107.01 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -138.51 137.0 36.68 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.41 0.684 . . . . 0.0 111.592 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.459 ' OD1' ' HG2' ' A' ' 97' ' ' ARG . 5.8 p-10 -88.0 140.81 29.11 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.181 172.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.0 p -77.76 37.22 0.23 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 128.059 2.544 . . . . 0.0 110.892 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . 0.262 25.1 p 65.0 -50.99 0.34 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 128.682 2.793 . . . . 0.0 113.477 -154.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -134.88 132.58 38.71 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -167.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.72 -65.62 3.67 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 114.122 -1.399 . . . . 0.0 116.228 166.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.5 p -90.51 157.71 17.4 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.436 1.894 . . . . 0.0 113.707 -176.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 20' ' ' VAL . 17.7 m -125.15 131.64 72.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 171.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 p -107.8 104.4 13.88 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 110.944 -2.844 . . . . 0.0 107.41 166.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -120.18 176.27 16.14 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.734 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -129.9 132.81 46.52 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 35' ' ' VAL . 15.3 t -116.09 119.16 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.884 2.874 . . . . 0.0 108.209 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HG2' HG22 ' A' ' 36' ' ' VAL . 2.0 pp0? -53.69 157.41 2.27 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.434 1.894 . . . . 0.0 112.738 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.601 ' H ' HD11 ' A' ' 86' ' ' ILE . . . -18.91 96.51 0.01 OUTLIER Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.001 2.238 . . . . 0.0 116.665 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' A' ' 7' ' ' LYS . 33.6 Cg_exo -61.3 86.85 0.09 OUTLIER 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.552 2.168 . . . . 0.0 112.559 164.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.41 101.3 7.54 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 111.015 -2.811 . . . . 0.0 109.419 171.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.445 0.4 OUTLIER 55.53 -88.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 112.209 -2.269 . . . . 0.0 116.766 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -49.25 -50.82 37.01 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.719 1.608 . . . . 0.0 112.404 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.635 HG13 HG22 ' A' ' 35' ' ' VAL . 59.0 t -56.05 -36.57 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.844 1.658 . . . . 0.0 111.821 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -56.61 -35.35 68.19 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.0 p -61.56 -32.81 72.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -67.23 -28.79 68.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.344 1.058 . . . . 0.0 112.94 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -61.73 -37.92 86.02 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.3 m -54.88 -49.21 71.75 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.864 0.866 . . . . 0.0 111.176 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.428 ' HZ2' ' HA ' ' A' ' 26' ' ' ALA . 3.3 t90 -53.15 -59.22 4.83 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.531 1.533 . . . . 0.0 112.79 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 51' ' ' VAL . 14.6 mt -59.99 -17.41 38.2 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.563 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 96.8 p -92.92 -53.83 3.99 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 172.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -71.98 -42.96 65.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -170.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.37 113.86 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 -165.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.74 80.91 0.52 Allowed Glycine 0 CA--C 1.532 1.104 0 CA-C-N 113.323 -1.762 . . . . 0.0 110.777 166.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.581 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 2.2 m -63.87 -45.09 80.95 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-O 117.769 -1.11 . . . . 0.0 113.404 -174.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 22.8 Cg_exo -91.77 102.53 0.22 Allowed 'Trans proline' 0 CA--C 1.53 0.313 0 N-CA-C 106.554 -2.133 . . . . 0.0 106.554 155.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.8 m 67.85 124.04 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.5 p -83.14 53.31 2.42 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.185 -1.825 . . . . 0.0 114.416 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.638 ' NH2' ' H ' ' A' ' 15' ' ' GLY . 1.7 tpm_? -87.47 -10.99 50.3 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.027 -1.897 . . . . 0.0 110.205 165.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.46 96.09 4.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -134.74 -48.79 0.75 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 112.58 -2.1 . . . . 0.0 111.838 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 52.6 ttt-85 -123.27 88.48 2.93 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.389 1.476 . . . . 0.0 108.261 179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.9 m -104.63 124.8 49.97 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 123.708 1.718 . . . . 0.0 112.117 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 11' ' ' TYR . 3.7 m120 -87.81 86.9 7.22 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 110.841 -2.89 . . . . 0.0 112.545 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.563 ' HE2' ' HB3' ' A' ' 66' ' ' SER . 75.0 m-85 -74.44 88.66 2.11 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.141 -1.845 . . . . 0.0 110.731 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.4 t -120.61 -165.7 1.24 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.144 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 23.6 t-20 47.67 74.06 0.18 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.112 2.165 . . . . 0.0 110.75 -178.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.608 ' HG2' HG12 ' A' ' 9' ' ' VAL . 17.7 mt-10 -101.31 102.71 13.61 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.783 -171.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.458 ' HG3' ' HB3' ' A' ' 8' ' ' SER . 0.1 OUTLIER -117.53 113.04 21.42 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 112.147 -2.297 . . . . 0.0 112.718 -177.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.668 HG21 ' HB2' ' A' ' 4' ' ' ARG . 12.5 p -65.53 102.05 0.67 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.755 1.264 . . . . 0.0 113.872 174.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.601 HD11 ' H ' ' A' ' 53' ' ' GLY . 11.3 pt -85.11 77.48 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 112.206 -2.27 . . . . 0.0 113.326 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.2 m -50.09 -34.98 23.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 112.692 -2.049 . . . . 0.0 112.92 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -113.84 108.08 16.58 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 166.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 70.3 tp -67.38 76.94 0.16 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 124.283 1.992 . . . . 0.0 109.513 170.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -96.34 59.29 1.86 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 112.468 -2.151 . . . . 0.0 114.609 -171.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.5 131.27 0.09 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 128.574 2.75 . . . . 0.0 109.143 174.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.2 p -132.69 65.14 1.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 123.182 1.468 . . . . 0.0 109.469 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -174.85 134.7 0.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 111.43 -2.623 . . . . 0.0 109.129 -168.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.587 ' HD2' ' HA ' ' A' ' 27' ' ' GLU . 30.1 t80 -111.31 94.33 4.92 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 168.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.463 ' HA ' HH21 ' A' ' 31' ' ' ARG . 5.9 t -98.03 165.37 11.94 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 118.215 2.672 . . . . 0.0 118.215 -153.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.522 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 7.7 p -53.11 141.06 7.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 127.874 2.47 . . . . 0.0 115.276 -170.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.459 ' HG2' ' OD1' ' A' ' 41' ' ' ASN . 35.4 ttp180 -59.63 104.5 0.28 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.885 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 N--CA 1.477 0.881 0 CA-C-N 113.148 -1.842 . . . . 0.0 112.948 -179.557 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.42 46.57 0.35 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 112.205 -2.27 . . . . 0.0 115.674 174.165 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.91 -51.92 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 121.091 3.737 . . . . 0.0 121.091 170.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.514 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 86.1 mtm180 -45.16 127.87 5.69 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 127.74 2.416 . . . . 0.0 115.965 -166.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 4' ' ' ARG . 64.1 Cg_exo -52.03 -31.35 43.86 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 125.294 3.996 . . . . 0.0 119.342 -161.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.95 117.01 33.65 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.944 1.354 . . . . 0.0 111.273 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.474 ' HZ3' ' HD2' ' A' ' 62' ' ' LYS . 82.2 tttt -85.28 121.5 28.1 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.555 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.5 t -107.87 93.32 4.47 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 123.589 1.662 . . . . 0.0 108.565 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.252 8.0 p -98.3 107.38 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 112.728 -2.033 . . . . 0.0 112.137 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.571 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 11.3 m-20 -85.73 94.18 9.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 112.468 -2.151 . . . . 0.0 110.143 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -70.79 166.61 20.6 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 112.185 -2.28 . . . . 0.0 113.044 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -136.35 113.03 10.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.752 1.621 . . . . 0.0 110.764 167.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.8 124.67 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.35 1.06 . . . . 0.0 113.81 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.58 91.81 3.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 123.085 1.421 . . . . 0.0 108.394 164.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -134.81 87.11 0.25 Allowed Glycine 0 CA--C 1.54 1.597 0 CA-C-N 112.665 -2.061 . . . . 0.0 112.539 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -53.17 -55.72 22.02 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.835 1.254 . . . . 0.0 113.713 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 p -108.75 129.2 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 123.751 0.657 . . . . 0.0 109.824 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 71.84 -30.86 0.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.022 2.129 . . . . 0.0 116.081 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 15' ' ' GLY . . . -22.33 -64.16 0.03 OUTLIER Glycine 0 CA--C 1.53 1.02 0 C-N-CA 129.054 3.216 . . . . 0.0 117.408 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.4 ' C ' HH22 ' A' ' 97' ' ' ARG . 10.0 m -70.39 63.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.8 t -149.04 -85.56 0.09 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.396 1.878 . . . . 0.0 110.104 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.5 ' HA ' ' HB3' ' A' ' 73' ' ' SER 0.364 34.2 p90 58.14 -46.91 0.05 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 119.528 3.158 . . . . 0.0 119.528 179.148 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -12.05 -81.11 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.939 2.895 . . . . 0.0 117.298 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -44.04 -55.51 4.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.057 1.343 . . . . 0.0 114.004 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -57.61 -58.51 7.99 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.828 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.615 ' HA ' ' HH2' ' A' ' 64' ' ' TRP . . . -59.76 -53.03 62.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.477 1.111 . . . . 0.0 113.602 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -52.3 -54.78 27.08 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.864 2.466 . . . . 0.0 113.725 -178.133 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -56.72 -52.66 64.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.328 1.051 . . . . 0.0 111.851 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 33' ' ' ILE . 1.4 mp0 -66.17 -47.57 73.55 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.737 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.04 -47.68 74.47 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -55.9 -50.76 69.78 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.776 0.83 . . . . 0.0 112.522 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -58.12 -37.04 73.82 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.08 1.352 . . . . 0.0 114.274 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 29' ' ' GLU . 24.7 mm -76.13 -36.34 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.981 0.912 . . . . 0.0 111.979 177.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.27 67.85 1.21 Allowed Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.876 1.227 . . . . 0.0 110.56 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.683 HG23 ' HA3' ' A' ' 53' ' ' GLY . 12.3 p -158.34 154.64 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.757 1.623 . . . . 0.0 111.62 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.696 HG13 ' HB2' ' A' ' 94' ' ' PHE 0.473 3.7 p 65.15 152.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 128.929 2.892 . . . . 0.0 115.416 170.271 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.97 -89.29 1.53 Allowed Glycine 0 N--CA 1.477 1.422 0 CA-C-N 112.802 -1.999 . . . . 0.0 113.191 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -135.17 159.69 40.73 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HB ' ' HG2' ' A' ' 97' ' ' ARG . 1.9 t -109.66 136.23 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 113.004 -1.907 . . . . 0.0 108.074 173.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.794 ' HG3' HG23 ' A' ' 48' ' ' THR . 10.7 pttp -118.19 133.01 56.28 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.46 1.904 . . . . 0.0 112.224 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -75.18 146.47 41.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 112.027 -2.351 . . . . 0.0 112.766 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.0 p -123.15 161.47 24.39 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.328 168.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 p -64.57 -22.02 66.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 113.286 -1.779 . . . . 0.0 113.932 169.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -101.8 11.46 38.68 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -168.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.66 -35.94 1.2 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.096 0.855 . . . . 0.0 114.082 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.0 p -61.16 79.97 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.291 2.236 . . . . 0.0 111.728 172.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.51 141.0 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 111.854 -2.43 . . . . 0.0 111.254 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.794 HG23 ' HG3' ' A' ' 40' ' ' LYS . 7.5 t -113.31 131.64 55.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 113.436 -1.711 . . . . 0.0 111.832 -173.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 10' ' ' ASP . . . -133.85 143.03 14.6 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.296 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -98.21 86.94 3.78 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 112.914 -1.643 . . . . 0.0 112.468 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.9 t -86.74 82.75 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 111.86 -2.427 . . . . 0.0 110.534 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.561 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 40.3 tt0 -88.03 115.87 25.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.962 -1.927 . . . . 0.0 109.875 173.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.683 ' HA3' HG23 ' A' ' 35' ' ' VAL . . . 157.89 -82.35 0.15 Allowed Glycine 0 N--CA 1.468 0.827 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.698 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.49 ' HA ' HG13 ' A' ' 58' ' ' VAL . 8.8 Cg_exo -15.18 82.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.327 -0.58 1 C-N-CA 125.343 4.029 . . . . 0.0 118.35 -158.123 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.706 ' H ' HG13 ' A' ' 58' ' ' VAL . 66.9 tt0 -129.24 107.63 9.7 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.467 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 57.91 -88.29 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.487 2.315 . . . . 0.0 114.569 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -57.1 -43.5 82.32 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.299 0.639 . . . . 0.0 111.935 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.706 HG13 ' H ' ' A' ' 55' ' ' GLU 0.33 14.8 p -84.83 2.17 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -60.49 -35.45 75.94 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.487 -0.758 . . . . 0.0 111.517 164.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -51.23 -38.57 53.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.127 1.371 . . . . 0.0 114.023 173.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -53.23 60.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.052 0.541 . . . . 0.0 111.28 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.474 ' HD2' ' HZ3' ' A' ' 7' ' ' LYS . 30.8 ttpt -54.5 -51.62 64.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.728 1.211 . . . . 0.0 112.858 173.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.4 t -57.57 -31.12 65.83 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.051 1.74 . . . . 0.0 115.293 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.615 ' HH2' ' HA ' ' A' ' 26' ' ' ALA . 5.3 t90 -76.9 -50.8 12.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.205 1.802 . . . . 0.0 114.467 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.595 ' HB3' ' HZ ' ' A' ' 80' ' ' PHE . 14.1 tp -51.4 -26.86 8.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.163 2.185 . . . . 0.0 115.482 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.447 ' HA ' ' HB ' ' A' ' 78' ' ' THR . 13.7 p -53.82 -60.3 3.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.158 2.183 . . . . 0.0 113.967 170.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -127.17 70.82 1.31 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.768 2.427 . . . . 0.0 109.5 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -54.95 -29.04 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -177.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.83 -84.5 0.48 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.691 171.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.9 t -128.28 -74.68 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -44.12 102.39 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 124.213 3.275 . . . . 0.0 114.173 -154.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.8 p 42.25 45.91 3.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.655 -2.521 . . . . 0.0 115.303 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 66.1 p -155.38 -66.35 0.12 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 68.4 -61.52 0.4 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.894 2.078 . . . . 0.0 114.158 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.475 HG21 ' OG1' ' A' ' 78' ' ' THR . 14.6 mt 32.05 110.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 128.963 2.905 . . . . 0.0 113.74 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -67.71 -32.28 72.81 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -163.49 110.71 1.17 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.065 0.946 . . . . 0.0 111.686 171.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.475 ' OG1' HG21 ' A' ' 75' ' ' ILE . 63.7 m -88.75 101.11 13.68 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.448 1.594 . . . . 0.0 109.471 166.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -68.24 98.92 0.85 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 111.602 -2.545 . . . . 0.0 111.155 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.595 ' HZ ' ' HB3' ' A' ' 65' ' ' LEU . 58.4 m-85 -79.31 78.72 5.79 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 124.041 1.877 . . . . 0.0 112.42 175.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.5 p -92.67 -69.17 0.76 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 110.977 -2.829 . . . . 0.0 115.302 -169.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.617 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 15.3 m120 -80.75 75.75 7.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 123.686 1.707 . . . . 0.0 110.955 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -87.44 83.41 7.3 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 111.885 -2.416 . . . . 0.0 111.235 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.617 ' HE3' ' HB3' ' A' ' 82' ' ' ASN . 87.9 mttt -96.92 91.85 5.83 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.143 -1.844 . . . . 0.0 109.218 -174.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.1 p -74.6 115.21 13.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.255 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.499 ' CD1' HE21 ' A' ' 52' ' ' GLN . 2.6 pp -122.01 149.49 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 110.618 -2.992 . . . . 0.0 111.658 -174.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.0 p -82.32 101.72 10.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 113.703 -1.589 . . . . 0.0 112.083 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 88' ' ' LYS 0.292 33.8 mmtp 98.55 149.05 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.538 2.335 . . . . 0.0 116.343 168.871 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.6 tp -103.22 130.29 50.41 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.304 -173.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -119.99 -44.32 2.51 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.192 -1.367 . . . . 0.0 112.587 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' TYR . . . . . 0.561 ' HB2' ' HB3' ' A' ' 52' ' ' GLN . 20.5 m-85 -73.95 95.16 2.44 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.885 1.274 . . . . 0.0 113.987 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.9 p -86.21 -22.2 27.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 111.546 -2.57 . . . . 0.0 115.811 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -137.5 108.47 6.72 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.898 0.749 . . . . 0.0 112.539 -162.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.696 ' HB2' HG13 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -66.65 125.79 26.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.815 171.028 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.4 t -149.97 111.28 4.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 97' ' ' ARG 0.31 25.6 m 48.39 -178.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 120.195 3.405 . . . . 0.0 120.195 161.649 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.475 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 46.6 mtt180 -105.97 139.38 40.61 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.841 -1.527 . . . . 0.0 113.662 -176.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 C--O 1.246 0.88 0 CA-C-N 112.4 -2.182 . . . . 0.0 113.446 -179.776 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.9 p . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.7 p -67.37 -31.34 71.51 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 112.592 -2.094 . . . . 0.0 116.024 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.91 69.29 0.95 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 123.255 1.502 . . . . 0.0 110.912 170.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.423 ' HG3' HD13 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -145.83 125.18 6.76 Favored Pre-proline 0 N--CA 1.471 0.594 0 CA-C-N 113.265 -1.788 . . . . 0.0 112.207 -176.055 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.71 33.62 0.43 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.145 2.563 . . . . 0.0 114.556 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.55 ' HB3' HE22 ' A' ' 52' ' ' GLN . 9.9 mp -114.18 97.25 6.24 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.747 ' HG2' HG22 ' A' ' 85' ' ' THR . 63.0 mttm -98.88 113.64 25.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.976 -161.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 t -103.33 101.88 11.81 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.248 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -116.1 142.14 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 112.821 -1.99 . . . . 0.0 112.077 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -100.24 121.79 42.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 123.33 1.538 . . . . 0.0 110.353 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.454 ' HD1' HG23 ' A' ' 13' ' ' VAL . 30.8 p90 -103.02 148.76 25.29 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 111.933 -2.394 . . . . 0.0 111.863 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -124.15 85.94 2.49 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 111.821 -2.445 . . . . 0.0 109.51 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 48.7 t -80.66 110.38 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 123.104 1.43 . . . . 0.0 110.521 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.586 ' HB3' ' HE ' ' A' ' 16' ' ' ARG . 13.6 m-85 -93.84 77.77 4.2 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 111.126 -2.761 . . . . 0.0 106.855 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.66 54.31 0.55 Allowed Glycine 0 N--CA 1.479 1.503 0 CA-C-N 112.015 -2.357 . . . . 0.0 109.991 173.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.586 ' HE ' ' HB3' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -61.4 -36.06 79.25 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -174.236 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.1 m -80.22 52.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 52.68 -110.89 0.55 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 127.012 2.125 . . . . 0.0 112.484 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.75 -56.39 0.35 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 119.087 2.395 . . . . 0.0 119.087 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 m -77.14 100.24 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -171.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.43 64.98 1.02 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 124.582 2.135 . . . . 0.0 107.634 162.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.96 -31.43 50.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 111.702 -2.499 . . . . 0.0 113.709 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -32.7 -59.72 0.32 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.909 2.083 . . . . 0.0 115.538 170.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.1 tpt -54.9 -38.24 67.33 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TYR . . . . . 0.726 ' HB3' ' HZ2' ' A' ' 64' ' ' TRP . 2.5 m-30 -73.36 -53.48 10.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.915 1.686 . . . . 0.0 111.284 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 94' ' ' PHE . . . -54.25 -37.35 64.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.283 1.433 . . . . 0.0 113.143 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.28 -83.42 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.594 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -63.97 -59.62 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.005 1.322 . . . . 0.0 114.209 -170.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 33' ' ' ILE . 43.5 mt-10 -65.24 -43.88 90.0 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 26' ' ' ALA . . . -63.12 -43.38 98.58 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.5 ttp-105 -52.35 -55.72 19.65 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.732 0.813 . . . . 0.0 110.866 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -57.63 -40.78 79.98 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.017 1.727 . . . . 0.0 114.794 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 29' ' ' GLU . 31.8 mm -71.11 -29.76 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.105 0.962 . . . . 0.0 113.418 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.1 38.67 4.77 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 124.568 1.08 . . . . 0.0 112.702 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.3 t -110.62 141.45 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 123.77 1.748 . . . . 0.0 111.736 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 89' ' ' LEU . 3.8 t -126.47 156.18 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 111.002 -2.817 . . . . 0.0 111.125 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.89 -149.61 20.73 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.074 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.604 ' HZ3' ' HB2' ' A' ' 40' ' ' LYS . 55.7 p-90 -153.46 146.36 24.44 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.328 1.451 . . . . 0.0 111.084 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' HD1' ' A' ' 98' ' ' TYR . 2.6 t -117.99 144.52 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.979 0.912 . . . . 0.0 109.583 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.604 ' HB2' ' HZ3' ' A' ' 38' ' ' TRP . 60.4 tttt -132.52 137.49 47.18 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.493 0.717 . . . . 0.0 112.298 175.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . 0.475 ' OD1' ' HG2' ' A' ' 97' ' ' ARG . 1.9 p-10 -94.97 93.35 7.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 122.676 1.227 . . . . 0.0 110.281 168.095 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 46' ' ' THR . 5.7 t -80.53 163.43 23.73 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -168.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.2 p -54.02 -35.03 61.49 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.126 -1.852 . . . . 0.0 113.911 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -66.3 -1.76 3.72 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.46 -41.08 2.62 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 124.952 1.263 . . . . 0.0 111.612 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.55 ' O ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -52.93 140.66 24.06 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.981 2.112 . . . . 0.0 113.804 -178.229 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 13' ' ' VAL . 96.0 t -92.01 103.36 14.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 123.986 1.851 . . . . 0.0 107.278 169.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.7 t -109.77 -164.26 0.92 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 111.738 -2.483 . . . . 0.0 110.156 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.26 -173.79 15.69 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 126.378 1.942 . . . . 0.0 110.89 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -125.74 134.34 51.79 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 112.257 -1.972 . . . . 0.0 111.91 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.454 HG21 ' HG3' ' A' ' 61' ' ' MET . 7.5 p -117.41 117.02 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 111.278 -2.692 . . . . 0.0 109.942 177.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.55 HE22 ' HB3' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -102.15 130.11 48.7 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 112.619 -2.082 . . . . 0.0 107.6 171.443 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.5 149.05 17.41 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.626 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -65.99 145.84 80.82 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 121.554 1.503 . . . . 0.0 109.822 166.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -17.83 -61.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.547 ' HG2' ' HD2' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -61.09 -39.97 91.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HD2' ' HG2' ' A' ' 56' ' ' GLU . 2.7 mptp? -65.92 -39.31 90.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.238 1.015 . . . . 0.0 111.718 174.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.667 HG21 ' HB2' ' A' ' 7' ' ' LYS . 49.2 t -61.69 -42.63 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.244 1.018 . . . . 0.0 112.286 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.594 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 25.2 m120 -55.33 -46.54 76.33 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.7 p -69.02 -47.22 65.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.578 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.655 ' HA ' ' HE3' ' A' ' 64' ' ' TRP . 13.8 tmm? -49.98 -52.58 32.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.695 1.598 . . . . 0.0 114.19 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 59' ' ' ASN . 65.5 pttt -59.17 -38.15 79.08 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.9 m -63.98 -57.69 8.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.055 170.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.726 ' HZ2' ' HB3' ' A' ' 25' ' ' TYR . 13.9 t90 -46.61 -46.06 19.43 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 127.781 2.432 . . . . 0.0 115.262 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.447 ' HB2' ' HZ ' ' A' ' 80' ' ' PHE . 64.6 mt -90.1 13.1 15.84 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 -175.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . 0.265 53.4 p -101.64 -109.23 0.23 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -110.22 75.61 0.94 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.222 2.209 . . . . 0.0 107.911 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.09 -52.1 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 112.426 -2.17 . . . . 0.0 114.698 -166.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.715 ' HA2' ' HA ' ' A' ' 74' ' ' ARG . . . 77.13 -56.8 3.62 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 115.792 1.077 . . . . 0.0 115.792 -173.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.6 m -41.58 145.49 0.66 Allowed Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 127.415 2.286 . . . . 0.0 115.932 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.92 -27.36 8.46 Favored 'Cis proline' 0 CA--C 1.535 0.569 0 N-CA-C 117.774 2.182 . . . . 0.0 117.774 -10.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.5 p -131.19 -43.83 1.04 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.0 m -97.27 121.98 39.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.713 2.005 . . . . 0.0 112.818 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.715 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.84 86.37 0.51 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -172.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.652 HD11 ' HE2' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -75.43 91.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 114.055 -1.429 . . . . 0.0 107.765 167.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.55 -55.25 14.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 110.708 -2.951 . . . . 0.0 115.838 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HD2' ' H ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -163.54 145.6 9.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.745 0.818 . . . . 0.0 110.007 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.44 ' H ' ' HD2' ' A' ' 77' ' ' ARG . 90.3 m -152.22 138.15 18.1 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -98.18 140.23 32.79 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.214 -2.721 . . . . 0.0 109.184 167.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.447 ' HZ ' ' HB2' ' A' ' 65' ' ' LEU . 87.7 m-85 -114.37 109.82 18.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.68 176.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.49 167.67 13.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 113.219 -1.809 . . . . 0.0 111.986 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 22.7 m120 53.82 84.89 0.06 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.909 1.284 . . . . 0.0 113.264 172.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.2 111.76 24.51 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 123.057 1.408 . . . . 0.0 113.728 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -100.03 91.14 4.65 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 111.63 -2.532 . . . . 0.0 107.069 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.747 HG22 ' HG2' ' A' ' 7' ' ' LYS . 12.1 p -74.28 84.31 1.9 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 123.107 1.432 . . . . 0.0 109.034 172.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.1 pt -112.34 154.35 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 112.98 -1.918 . . . . 0.0 114.333 -165.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.1 t -59.15 132.41 53.92 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.229 -1.805 . . . . 0.0 111.864 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp 61.56 149.9 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.468 ' HB3' HG11 ' A' ' 36' ' ' VAL . 90.8 mt -85.51 97.58 10.13 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 113.782 -1.554 . . . . 0.0 111.07 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -84.16 82.03 8.54 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.492 -173.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 154.19 150.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 129.97 3.308 . . . . 0.0 111.965 167.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.3 p -82.07 88.42 6.43 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.504 1.145 . . . . 0.0 110.293 169.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 70.1 m-80 61.42 172.14 0.11 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 111.211 -2.722 . . . . 0.0 113.209 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 8.3 t80 -73.56 69.59 1.25 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.245 1.497 . . . . 0.0 110.807 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.5 110.42 15.95 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 112.585 -2.098 . . . . 0.0 116.078 -166.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.258 27.2 m 54.95 163.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 110.768 -2.924 . . . . 0.0 117.035 165.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.475 ' HG2' ' OD1' ' A' ' 41' ' ' ASN . 52.6 ttp180 -111.66 113.15 25.35 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.215 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.442 ' HD1' ' O ' ' A' ' 39' ' ' VAL . 83.5 m-85 . . . . . 0 C--O 1.246 0.873 0 CA-C-N 111.519 -2.582 . . . . 0.0 111.717 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.413 ' OG ' ' HA ' ' A' ' 84' ' ' LYS . 2.5 t . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.2 p -133.74 -82.13 0.46 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.924 1.289 . . . . 0.0 112.344 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -122.63 -139.54 0.31 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.097 1.359 . . . . 0.0 111.034 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ARG . . . . . 0.572 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 4.9 mpt_? -48.81 132.01 14.5 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 125.7 1.6 . . . . 0.0 115.113 -171.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 4' ' ' ARG . 50.6 Cg_exo -68.14 72.8 0.8 Allowed 'Trans proline' 0 C--N 1.328 -0.522 0 C-N-CA 123.134 2.556 . . . . 0.0 115.434 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.08 127.22 41.06 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 164.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.606 ' HB2' HG21 ' A' ' 58' ' ' VAL . 33.3 mmtp -97.16 115.6 27.84 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.199 1.0 . . . . 0.0 111.598 -163.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.9 t -107.24 122.98 47.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.127 -1.851 . . . . 0.0 110.36 166.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 t -112.98 108.03 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 111.314 -2.675 . . . . 0.0 108.262 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.0 t0 -88.24 97.36 10.98 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 113.106 -1.861 . . . . 0.0 107.715 173.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.461 ' HD2' HG23 ' A' ' 13' ' ' VAL . 33.7 p90 -94.79 150.68 19.95 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 109.122 -3.672 . . . . 0.0 112.56 -171.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 6.0 mp0 -127.8 97.52 4.86 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.008 166.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.461 HG23 ' HD2' ' A' ' 11' ' ' TYR . 94.6 t -68.78 126.58 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.005 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -127.94 137.0 52.1 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.545 0.528 . . . . 0.0 111.515 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 75' ' ' ILE . . . -105.52 121.08 6.68 Favored Glycine 0 N--CA 1.476 1.352 0 O-C-N 124.819 1.324 . . . . 0.0 112.313 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -38.68 -43.56 0.91 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 172.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -121.84 146.98 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.581 163.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -52.83 168.65 0.11 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.6 -78.5 0.28 Allowed Glycine 0 N--CA 1.477 1.377 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.655 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' A' ' 22' ' ' PHE . 12.5 t 66.98 -72.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 128.277 2.631 . . . . 0.0 111.234 175.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.7 m 42.05 38.83 1.16 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.391 1.876 . . . . 0.0 115.316 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.561 ' HB3' HG22 ' A' ' 47' ' ' VAL . 17.3 t80 -63.02 -27.9 69.73 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 112.722 -2.036 . . . . 0.0 113.754 -168.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.517 ' NE ' ' HB3' ' A' ' 97' ' ' ARG . 8.6 mmm180 -21.03 -73.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 67.7 mtm -60.67 -40.59 92.69 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -62.91 -46.89 85.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.894 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.495 ' HA ' ' HZ2' ' A' ' 64' ' ' TRP . . . -50.7 -56.86 10.0 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 125.001 1.438 . . . . 0.0 111.925 173.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.425 ' OE1' HG22 ' A' ' 96' ' ' VAL . 33.0 tt0 -51.43 -60.0 3.62 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.669 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.23 -53.14 61.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.195 1.398 . . . . 0.0 113.468 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.475 ' O ' HG12 ' A' ' 33' ' ' ILE . 1.9 tp10 -65.51 -38.61 90.2 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.549 0.74 . . . . 0.0 112.203 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -55.9 -47.53 77.27 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.017 0.927 . . . . 0.0 112.985 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -52.23 -49.89 63.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.796 1.238 . . . . 0.0 111.196 173.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.97 -51.67 68.26 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.272 1.429 . . . . 0.0 114.444 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 29' ' ' GLU . 29.7 mm -67.8 -25.69 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.4 1.08 . . . . 0.0 112.705 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.28 53.85 1.67 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.33 0.966 . . . . 0.0 111.788 -174.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.546 HG22 ' CE ' ' A' ' 61' ' ' MET . 2.6 t -116.6 140.13 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 123.41 1.576 . . . . 0.0 109.58 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 52' ' ' GLN . 33.5 m -119.98 166.74 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 111.982 -2.372 . . . . 0.0 111.048 173.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.1 -135.3 7.41 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.5 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.434 ' CZ3' ' HB2' ' A' ' 40' ' ' LYS . 39.8 p-90 -162.1 151.07 15.45 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 113.456 -1.372 . . . . 0.0 111.367 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 95' ' ' SER . 10.7 p -114.91 136.4 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.681 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.703 ' HB3' HG23 ' A' ' 48' ' ' THR . 83.8 tttt -117.01 123.3 46.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.202 1.477 . . . . 0.0 112.508 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -64.93 114.73 4.74 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 111.399 -2.637 . . . . 0.0 109.161 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.507 ' OG1' HG22 ' A' ' 48' ' ' THR . 0.2 OUTLIER -104.0 -130.17 0.26 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.995 -175.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.6 m -107.4 108.38 19.7 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.897 -1.127 . . . . 0.0 110.623 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp 49.76 85.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.95 -31.3 1.08 Allowed Glycine 0 N--CA 1.473 1.115 0 CA-C-N 113.086 -1.87 . . . . 0.0 116.319 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.8 p -59.87 147.49 38.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.375 1.07 . . . . 0.0 112.076 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.561 HG22 ' HB3' ' A' ' 22' ' ' PHE . 16.1 m -133.64 124.92 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 112.163 -2.289 . . . . 0.0 113.575 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.703 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.9 t -92.23 -171.91 2.96 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 109.26 -3.609 . . . . 0.0 109.896 159.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 129.5 -155.84 21.04 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.698 2.094 . . . . 0.0 111.191 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -130.94 109.6 10.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.362 1.465 . . . . 0.0 112.659 -173.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 t -94.33 97.65 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.376 171.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.518 ' HB2' HG23 ' A' ' 36' ' ' VAL . 67.7 mt-30 -100.77 107.68 19.31 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.592 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.19 150.87 20.32 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 114.429 -1.26 . . . . 0.0 113.673 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HD3' HD11 ' A' ' 89' ' ' LEU . 74.3 Cg_endo -72.93 153.14 52.68 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.142 1.894 . . . . 0.0 111.147 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.575 ' O ' HG12 ' A' ' 58' ' ' VAL . 40.0 mt-10 -39.84 -49.06 2.36 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -173.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -63.19 -62.91 1.38 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.037 0.381 . . . . 0.0 111.547 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -59.56 -31.34 69.34 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.606 HG21 ' HB2' ' A' ' 7' ' ' LYS 0.287 1.7 p -55.78 -35.41 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -177.368 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.57 -41.07 66.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.9 t -67.55 -54.35 20.65 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.669 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.546 ' CE ' HG22 ' A' ' 35' ' ' VAL . 20.1 ptp -58.13 -36.77 73.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HE3' HG22 ' A' ' 58' ' ' VAL . 88.1 mttt -52.38 -61.63 2.15 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.088 1.355 . . . . 0.0 111.737 171.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.3 m -54.04 -43.5 70.23 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . 0.495 ' HZ2' ' HA ' ' A' ' 26' ' ' ALA . 3.5 t90 -58.11 -53.99 51.99 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 mt -51.57 -29.58 17.69 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -80.02 -69.93 0.55 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.916 -1.493 . . . . 0.0 114.777 167.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -63.86 -27.16 68.97 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.514 HG22 ' HD2' ' A' ' 71' ' ' PRO 0.357 8.1 p 62.01 -70.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 129.394 3.078 . . . . 0.0 118.548 172.376 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.94 -111.67 2.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.88 1.228 . . . . 0.0 111.687 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.1 p -73.18 -30.96 1.33 Allowed Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 118.952 2.945 . . . . 0.0 118.952 -170.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' A' ' 68' ' ' VAL . 38.7 Cg_exo -56.95 109.93 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 CA-C-N 123.075 2.134 . . . . 0.0 112.846 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -43.2 -30.79 0.51 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.222 2.609 . . . . 0.0 114.174 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -49.63 -23.93 1.95 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 74.1 -33.04 0.24 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 127.941 2.496 . . . . 0.0 116.505 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.629 ' HA ' ' HA2' ' A' ' 15' ' ' GLY 0.337 4.1 mp 58.37 -84.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.723 2.009 . . . . 0.0 112.044 178.113 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.31 2.6 p30 57.76 -41.37 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 128.313 2.645 . . . . 0.0 117.928 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 38.9 ttt-85 -110.58 101.69 10.33 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 123.313 1.53 . . . . 0.0 111.116 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.7 m -118.17 127.9 54.2 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 112.784 -2.007 . . . . 0.0 111.584 172.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . 6.4 m120 -82.73 83.57 7.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 111.484 -2.598 . . . . 0.0 110.861 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -72.27 37.8 0.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.682 -2.053 . . . . 0.0 112.953 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 m -59.78 -36.39 76.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.063 2.145 . . . . 0.0 115.887 -163.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.558 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 24.6 t-20 -116.17 88.38 2.88 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.05 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -92.95 102.88 15.24 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.844 169.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HA ' ' OG ' ' A' ' 1' ' ' SER . 39.2 ttmt -108.47 119.99 41.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 111.462 -2.608 . . . . 0.0 110.31 -173.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.6 p -82.8 92.17 7.19 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 123.756 1.741 . . . . 0.0 111.934 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.5 pt -80.64 140.42 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 111.166 -2.743 . . . . 0.0 114.052 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' SER . . . . . 0.572 ' HA ' ' HB2' ' A' ' 4' ' ' ARG . 50.4 m -73.33 87.36 1.51 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.808 -1.996 . . . . 0.0 111.289 171.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 73.08 156.32 0.17 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-N 112.247 -2.251 . . . . 0.0 112.42 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.469 HD11 ' HD3' ' A' ' 54' ' ' PRO . 88.5 mt -75.25 111.15 10.2 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.949 0.881 . . . . 0.0 111.113 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.7 13.58 8.47 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -162.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -148.51 155.21 40.86 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.328 1.051 . . . . 0.0 111.751 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.6 p -68.62 -46.69 68.6 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.519 -1.219 . . . . 0.0 114.056 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.479 ' HA ' HG12 ' A' ' 36' ' ' VAL . 1.9 t-20 -156.54 172.93 17.69 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.429 1.492 . . . . 0.0 111.101 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -72.93 94.98 1.91 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.789 1.28 . . . . 0.0 110.586 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.495 ' O ' HG12 ' A' ' 39' ' ' VAL . 42.4 m -63.06 142.96 58.18 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.305 -2.225 . . . . 0.0 114.496 -173.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.425 HG22 ' OE1' ' A' ' 27' ' ' GLU . 85.3 t -63.75 143.14 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 110.792 -2.913 . . . . 0.0 110.032 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.517 ' HB3' ' NE ' ' A' ' 23' ' ' ARG . 46.1 ptt85 -6.63 123.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 120.306 3.446 . . . . 0.0 120.306 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 112.066 -2.334 . . . . 0.0 112.514 165.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo . . . . . 0 C--O 1.239 0.548 0 CA-C-O 123.03 1.179 . . . . 0.0 114.124 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.888 ' HB3' HE22 ' A' ' 52' ' ' GLN . 5.2 mp -124.63 106.83 10.42 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.576 2.351 . . . . 0.0 107.348 173.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.671 ' HE2' ' HB3' ' A' ' 83' ' ' GLU . 47.9 tttt -107.06 112.11 24.89 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.878 -166.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.612 ' HB3' ' HG2' ' A' ' 52' ' ' GLN . 4.4 p -85.1 104.64 15.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.833 167.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.438 HG22 ' HG3' ' A' ' 83' ' ' GLU . 93.0 t -109.75 143.57 19.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 110.221 -3.172 . . . . 0.0 108.028 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 9.8 m-20 -109.05 142.17 40.13 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.976 171.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -120.33 159.58 24.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.351 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -144.76 116.82 8.34 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.945 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.48 121.74 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 112.467 -2.151 . . . . 0.0 107.054 170.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.31 71.51 10.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.74 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.27 73.15 2.56 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.453 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -33.02 -59.1 0.36 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.78 1.632 . . . . 0.0 115.358 -174.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 t -125.62 72.92 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.664 0.745 . . . . 0.0 109.259 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.468 ' HB3' ' H ' ' A' ' 19' ' ' GLY 0.252 12.9 mt-30 53.33 -139.14 1.05 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 176.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.468 ' H ' ' HB3' ' A' ' 18' ' ' GLN . . . 78.4 -37.73 1.82 Allowed Glycine 0 N--CA 1.474 1.21 0 N-CA-C 116.527 1.371 . . . . 0.0 116.527 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.1 m -54.13 99.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 126.681 1.992 . . . . 0.0 115.718 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.6 m -94.76 75.3 3.66 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 112.396 -2.184 . . . . 0.0 108.519 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -78.78 -29.92 45.28 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 111.103 -2.771 . . . . 0.0 113.106 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.453 ' NH1' ' HG2' ' A' ' 97' ' ' ARG . 53.8 mmm-85 -50.38 155.73 0.98 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.528 1.531 . . . . 0.0 113.82 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 63.9 -57.19 0.21 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.932 2.093 . . . . 0.0 114.968 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -46.26 -55.17 7.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.06 2.144 . . . . 0.0 111.049 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.419 ' HA ' ' HH2' ' A' ' 64' ' ' TRP . . . -53.1 -68.96 0.13 Allowed 'General case' 0 C--N 1.323 -0.58 0 O-C-N 125.167 1.542 . . . . 0.0 112.432 172.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -38.92 -63.55 0.52 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.575 1.95 . . . . 0.0 114.987 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.2 m-20 -63.3 -52.15 63.16 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.876 1.67 . . . . 0.0 113.489 -174.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 33' ' ' ILE . 58.8 mt-10 -69.29 -36.66 77.26 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.517 ' HB1' HG23 ' A' ' 35' ' ' VAL . . . -62.64 -41.39 99.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.864 0.865 . . . . 0.0 112.818 175.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -53.07 -51.69 60.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.778 0.831 . . . . 0.0 110.884 168.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 28' ' ' ASP . 44.8 mmtm -61.27 -40.04 92.65 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 29' ' ' GLU . 37.3 mm -61.65 -34.04 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.883 1.273 . . . . 0.0 111.55 172.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.3 36.88 4.23 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 125.082 1.325 . . . . 0.0 113.119 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.716 HG21 ' HG3' ' A' ' 61' ' ' MET . 29.0 m -123.0 158.56 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 124.37 2.033 . . . . 0.0 115.005 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 93' ' ' ASN . 3.1 t -126.2 155.61 36.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 110.856 -2.883 . . . . 0.0 109.434 -172.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.47 -144.67 13.99 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.108 0.861 . . . . 0.0 111.695 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.492 ' CZ3' ' HB2' ' A' ' 40' ' ' LYS . 65.5 p-90 -166.0 168.16 15.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.356 1.614 . . . . 0.0 115.356 -173.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 47' ' ' VAL . 83.3 t -107.47 136.46 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 112.395 -2.184 . . . . 0.0 108.572 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.637 ' HB3' HG23 ' A' ' 48' ' ' THR . 59.2 tttp -115.12 114.28 25.11 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.639 1.576 . . . . 0.0 109.293 173.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -93.46 119.23 32.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 112.312 -2.222 . . . . 0.0 109.752 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 p -98.67 179.78 4.56 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.893 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.6 p -58.02 -52.66 64.6 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 113.906 -1.497 . . . . 0.0 113.25 171.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.08 49.44 0.84 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.48 3.29 2.89 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 119.576 2.59 . . . . 0.0 119.576 165.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.9 p -64.83 83.52 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 123.0 1.381 . . . . 0.0 111.355 168.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 39' ' ' VAL . 63.2 t -75.25 93.98 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 112.277 -2.238 . . . . 0.0 109.234 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.637 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.5 t -102.61 -169.52 1.67 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 109.987 -3.279 . . . . 0.0 109.69 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.6 -163.99 24.93 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.123 1.344 . . . . 0.0 113.47 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -123.73 131.09 53.53 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 112.021 -2.09 . . . . 0.0 112.646 -168.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.88 108.74 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.229 1.812 . . . . 0.0 107.342 172.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.888 HE22 ' HB3' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -112.01 131.35 55.46 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 170.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.701 ' HA3' HG12 ' A' ' 35' ' ' VAL . . . -168.18 158.77 31.7 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.306 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -59.84 142.64 99.0 Favored 'Trans proline' 0 C--N 1.325 -0.705 0 C-N-CA 121.839 1.692 . . . . 0.0 110.541 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -33.06 -65.95 0.15 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -36.42 48.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -72.74 -41.83 64.74 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.449 1.1 . . . . 0.0 112.487 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 7' ' ' LYS 0.303 8.6 m -65.19 -33.92 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 172.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -57.11 -47.56 80.79 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.16 0.984 . . . . 0.0 112.932 169.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.4 t -60.18 -45.02 94.53 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.815 1.246 . . . . 0.0 112.593 174.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.716 ' HG3' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -58.81 -40.88 85.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.403 1.481 . . . . 0.0 113.937 175.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.61 -40.23 88.72 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 171.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.8 m -58.49 -41.93 86.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.699 0.761 . . . . 0.0 111.093 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.588 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 24.0 t90 -76.23 179.06 5.97 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.447 1.499 . . . . 0.0 110.597 164.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.571 HD12 ' HE1' ' A' ' 80' ' ' PHE . 50.8 mt 71.01 -36.74 0.37 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.469 2.307 . . . . 0.0 114.965 -173.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.7 p -78.85 -42.08 28.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.711 2.004 . . . . 0.0 109.342 162.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 64' ' ' TRP . 0.1 OUTLIER -61.73 99.64 0.12 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 158.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.3 m -108.26 91.41 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 111.426 -2.625 . . . . 0.0 114.53 -169.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.39 158.73 19.91 Favored Glycine 0 N--CA 1.478 1.487 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.583 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.1 t -126.59 139.94 36.09 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 -163.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -102.12 8.21 0.47 Allowed 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 122.342 2.028 . . . . 0.0 116.026 158.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.2 m -178.66 -68.55 0.01 OUTLIER 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.587 2.355 . . . . 0.0 112.187 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 p -114.65 173.07 6.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.635 1.174 . . . . 0.0 113.86 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.469 ' CZ ' ' H ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -78.39 129.07 34.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.093 172.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mp -75.2 85.22 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -76.6 91.16 3.38 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 113.788 -1.551 . . . . 0.0 113.456 -171.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.405 ' CZ ' ' HA ' ' A' ' 77' ' ' ARG . 0.6 OUTLIER 68.39 112.87 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 111.194 -2.73 . . . . 0.0 113.878 172.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.4 m -117.28 117.06 28.51 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.306 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -102.26 140.41 36.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.219 -2.264 . . . . 0.0 109.086 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.571 ' HE1' HD12 ' A' ' 65' ' ' LEU . 68.6 m-85 -115.91 99.06 7.01 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.539 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.9 p -137.74 156.91 47.47 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.492 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 47.0 m-80 69.44 90.35 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.58 1.552 . . . . 0.0 110.749 -165.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.671 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 11.8 mp0 -118.25 111.67 19.09 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.641 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -137.61 110.45 7.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.606 -1.179 . . . . 0.0 113.948 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -68.48 123.42 20.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.919 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 pt -126.07 -159.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.977 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 t -132.03 143.67 50.22 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.482 0.713 . . . . 0.0 109.921 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 59.01 157.34 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.2 mt -97.32 92.73 6.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.856 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -83.04 34.55 0.46 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -168.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.421 ' HB2' HG13 ' A' ' 36' ' ' VAL . 80.2 m-85 -155.64 150.44 26.34 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.887 0.875 . . . . 0.0 111.858 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 p -78.25 85.78 4.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.824 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.424 ' HA ' HG22 ' A' ' 36' ' ' VAL . 3.6 m120 59.83 176.66 0.09 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 112.65 -2.068 . . . . 0.0 114.19 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -78.72 112.48 15.89 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 122.612 1.196 . . . . 0.0 109.06 164.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.7 p -108.7 -139.53 0.38 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 111.68 -2.509 . . . . 0.0 114.978 -163.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.7 m -104.19 -170.81 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.38 1.872 . . . . 0.0 112.162 -164.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.453 ' HG2' ' NH1' ' A' ' 23' ' ' ARG . 11.8 ptt180 -76.77 126.03 30.28 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 174.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.717 177.143 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 N--CA 1.47 0.112 0 N-CA-C 116.465 1.679 . . . . 0.0 116.465 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.5 tp -166.64 38.49 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 129.101 2.96 . . . . 0.0 107.108 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.617 ' O ' ' HD2' ' A' ' 54' ' ' PRO . 20.2 ptmt -104.37 79.51 1.59 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.896 1.814 . . . . 0.0 115.896 -153.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . 0.458 ' HB3' ' HG3' ' A' ' 84' ' ' LYS . 39.1 t -58.53 128.67 38.32 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.935 -176.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.608 HG12 ' HG2' ' A' ' 83' ' ' GLU . 25.8 m -114.94 142.0 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 126.169 2.168 . . . . 0.0 112.344 -173.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.06 120.45 42.56 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.802 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 51.4 p90 -104.34 124.41 49.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.603 -2.089 . . . . 0.0 112.698 -173.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -100.91 113.61 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.522 168.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.1 t -71.34 121.67 21.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 112.313 -2.221 . . . . 0.0 111.12 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -132.43 150.4 52.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.499 166.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.638 ' H ' ' NH2' ' A' ' 74' ' ' ARG . . . -176.15 -146.07 5.82 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -98.64 -79.82 0.47 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.422 -0.889 . . . . 0.0 111.363 -170.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.35 120.33 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.858 1.263 . . . . 0.0 109.736 -173.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.486 HE22 ' CZ ' ' A' ' 74' ' ' ARG . 93.3 mm-40 -66.76 137.34 56.58 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.897 -172.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.94 94.8 1.96 Allowed Glycine 0 N--CA 1.479 1.535 0 CA-C-N 113.37 -1.741 . . . . 0.0 112.936 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.475 HG21 HG22 ' A' ' 47' ' ' VAL 0.285 2.6 t -27.91 -71.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 127.898 2.479 . . . . 0.0 117.218 -177.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.7 t 64.44 -27.54 0.09 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 119.429 3.122 . . . . 0.0 119.429 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.97 20.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 118.4 2.741 . . . . 0.0 118.4 -177.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -62.86 -73.38 0.11 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.193 1.797 . . . . 0.0 113.452 -166.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.6 mmt -50.21 -46.81 54.87 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -45.88 -58.46 3.51 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.148 1.379 . . . . 0.0 112.872 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HA ' ' HZ2' ' A' ' 64' ' ' TRP . . . -59.09 -49.98 75.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.244 1.418 . . . . 0.0 112.976 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.587 ' HA ' ' HD2' ' A' ' 94' ' ' PHE . 85.8 mt-10 -55.36 -58.46 7.62 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.081 1.353 . . . . 0.0 112.841 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -57.09 -52.82 63.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.607 -1.633 . . . . 0.0 112.228 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.604 ' O ' HG12 ' A' ' 33' ' ' ILE . 47.5 mt-10 -57.99 -57.68 11.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.492 0.717 . . . . 0.0 111.835 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 -45.75 75.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . 0.463 HH21 ' HA ' ' A' ' 95' ' ' SER . 64.9 mtt-85 -53.9 -55.85 23.08 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.524 1.13 . . . . 0.0 111.559 174.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -58.74 -35.02 72.04 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.217 -1.356 . . . . 0.0 113.972 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 29' ' ' GLU . 26.6 pt -107.45 34.98 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.53 33.51 81.96 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 168.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.635 HG22 HG13 ' A' ' 58' ' ' VAL . 89.4 t -124.51 118.78 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 52' ' ' GLN . 15.1 m -127.51 164.46 28.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 114.529 -1.214 . . . . 0.0 114.182 -173.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.58 -120.99 1.3 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.698 1.618 . . . . 0.0 111.013 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -164.04 163.15 23.38 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.38 135.58 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.043 1.737 . . . . 0.0 107.01 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -138.51 137.0 36.68 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.41 0.684 . . . . 0.0 111.592 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.459 ' OD1' ' HG2' ' A' ' 97' ' ' ARG . 5.8 p-10 -88.0 140.81 29.11 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.181 172.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.0 p -77.76 37.22 0.23 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 128.059 2.544 . . . . 0.0 110.892 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . 0.262 25.1 p 65.0 -50.99 0.34 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 128.682 2.793 . . . . 0.0 113.477 -154.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -134.88 132.58 38.71 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -167.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.72 -65.62 3.67 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 114.122 -1.399 . . . . 0.0 116.228 166.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.5 p -90.51 157.71 17.4 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.436 1.894 . . . . 0.0 113.707 -176.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 20' ' ' VAL . 17.7 m -125.15 131.64 72.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 171.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 p -107.8 104.4 13.88 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 110.944 -2.844 . . . . 0.0 107.41 166.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -120.18 176.27 16.14 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.734 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -129.9 132.81 46.52 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 35' ' ' VAL . 15.3 t -116.09 119.16 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.884 2.874 . . . . 0.0 108.209 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HG2' HG22 ' A' ' 36' ' ' VAL . 2.0 pp0? -53.69 157.41 2.27 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.434 1.894 . . . . 0.0 112.738 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.601 ' H ' HD11 ' A' ' 86' ' ' ILE . . . -18.91 96.51 0.01 OUTLIER Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.001 2.238 . . . . 0.0 116.665 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' A' ' 7' ' ' LYS . 33.6 Cg_exo -61.3 86.85 0.09 OUTLIER 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.552 2.168 . . . . 0.0 112.559 164.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.41 101.3 7.54 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 111.015 -2.811 . . . . 0.0 109.419 171.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.445 0.4 OUTLIER 55.53 -88.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 112.209 -2.269 . . . . 0.0 116.766 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -49.25 -50.82 37.01 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.719 1.608 . . . . 0.0 112.404 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.635 HG13 HG22 ' A' ' 35' ' ' VAL . 59.0 t -56.05 -36.57 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.844 1.658 . . . . 0.0 111.821 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -56.61 -35.35 68.19 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.0 p -61.56 -32.81 72.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -67.23 -28.79 68.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.344 1.058 . . . . 0.0 112.94 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -61.73 -37.92 86.02 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.3 m -54.88 -49.21 71.75 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.864 0.866 . . . . 0.0 111.176 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.428 ' HZ2' ' HA ' ' A' ' 26' ' ' ALA . 3.3 t90 -53.15 -59.22 4.83 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.531 1.533 . . . . 0.0 112.79 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 51' ' ' VAL . 14.6 mt -59.99 -17.41 38.2 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.563 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 96.8 p -92.92 -53.83 3.99 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 172.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -71.98 -42.96 65.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -170.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.37 113.86 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 -165.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.74 80.91 0.52 Allowed Glycine 0 CA--C 1.532 1.104 0 CA-C-N 113.323 -1.762 . . . . 0.0 110.777 166.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.581 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 2.2 m -63.87 -45.09 80.95 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-O 117.769 -1.11 . . . . 0.0 113.404 -174.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 22.8 Cg_exo -91.77 102.53 0.22 Allowed 'Trans proline' 0 CA--C 1.53 0.313 0 N-CA-C 106.554 -2.133 . . . . 0.0 106.554 155.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.8 m 67.85 124.04 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.5 p -83.14 53.31 2.42 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.185 -1.825 . . . . 0.0 114.416 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.638 ' NH2' ' H ' ' A' ' 15' ' ' GLY . 1.7 tpm_? -87.47 -10.99 50.3 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.027 -1.897 . . . . 0.0 110.205 165.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.46 96.09 4.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -134.74 -48.79 0.75 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 112.58 -2.1 . . . . 0.0 111.838 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.567 ' NH1' HD21 ' A' ' 79' ' ' ASN . 52.6 ttt-85 -123.27 88.48 2.93 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.389 1.476 . . . . 0.0 108.261 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.9 m -104.63 124.8 49.97 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 123.708 1.718 . . . . 0.0 112.117 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.567 HD21 ' NH1' ' A' ' 77' ' ' ARG . 1.4 m-80 -87.81 86.9 7.22 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 110.841 -2.89 . . . . 0.0 112.545 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.563 ' HE2' ' HB3' ' A' ' 66' ' ' SER . 75.0 m-85 -74.44 88.66 2.11 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.141 -1.845 . . . . 0.0 110.731 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.4 t -120.61 -165.7 1.24 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.144 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.481 HD21 ' HE2' ' A' ' 84' ' ' LYS . 7.3 t30 47.67 74.06 0.18 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.112 2.165 . . . . 0.0 110.75 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.608 ' HG2' HG12 ' A' ' 9' ' ' VAL . 17.7 mt-10 -101.31 102.71 13.61 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.783 -171.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.481 ' HE2' HD21 ' A' ' 82' ' ' ASN . 0.1 OUTLIER -117.53 113.04 21.42 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 112.147 -2.297 . . . . 0.0 112.718 -177.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.5 p -65.53 102.05 0.67 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.755 1.264 . . . . 0.0 113.872 174.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.601 HD11 ' H ' ' A' ' 53' ' ' GLY . 11.3 pt -85.11 77.48 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 112.206 -2.27 . . . . 0.0 113.326 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.2 m -50.09 -34.98 23.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 112.692 -2.049 . . . . 0.0 112.92 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -113.84 108.08 16.58 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 166.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 70.3 tp -67.38 76.94 0.16 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 124.283 1.992 . . . . 0.0 109.513 170.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -96.34 59.29 1.86 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 112.468 -2.151 . . . . 0.0 114.609 -171.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.5 131.27 0.09 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 128.574 2.75 . . . . 0.0 109.143 174.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.2 p -132.69 65.14 1.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 123.182 1.468 . . . . 0.0 109.469 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -174.85 134.7 0.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 111.43 -2.623 . . . . 0.0 109.129 -168.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.587 ' HD2' ' HA ' ' A' ' 27' ' ' GLU . 30.1 t80 -111.31 94.33 4.92 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 168.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.463 ' HA ' HH21 ' A' ' 31' ' ' ARG . 5.9 t -98.03 165.37 11.94 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 118.215 2.672 . . . . 0.0 118.215 -153.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.522 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 7.7 p -53.11 141.06 7.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 127.874 2.47 . . . . 0.0 115.276 -170.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.459 ' HG2' ' OD1' ' A' ' 41' ' ' ASN . 35.4 ttp180 -59.63 104.5 0.28 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.885 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 N--CA 1.477 0.881 0 CA-C-N 113.148 -1.842 . . . . 0.0 112.948 -179.557 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo . . . . . 0 CA--C 1.536 0.582 0 N-CA-C 119.342 2.786 . . . . 0.0 119.342 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.95 117.01 33.65 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.944 1.354 . . . . 0.0 111.273 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.474 ' HZ3' ' HD2' ' A' ' 62' ' ' LYS . 82.2 tttt -85.28 121.5 28.1 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.555 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.5 t -107.87 93.32 4.47 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 123.589 1.662 . . . . 0.0 108.565 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.252 8.0 p -98.3 107.38 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 112.728 -2.033 . . . . 0.0 112.137 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.571 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 11.3 m-20 -85.73 94.18 9.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 112.468 -2.151 . . . . 0.0 110.143 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -70.79 166.61 20.6 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 112.185 -2.28 . . . . 0.0 113.044 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -136.35 113.03 10.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.752 1.621 . . . . 0.0 110.764 167.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.8 124.67 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.35 1.06 . . . . 0.0 113.81 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.58 91.81 3.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 123.085 1.421 . . . . 0.0 108.394 164.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -134.81 87.11 0.25 Allowed Glycine 0 CA--C 1.54 1.597 0 CA-C-N 112.665 -2.061 . . . . 0.0 112.539 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -53.17 -55.72 22.02 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.835 1.254 . . . . 0.0 113.713 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 p -108.75 129.2 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 123.751 0.657 . . . . 0.0 109.824 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 71.84 -30.86 0.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.022 2.129 . . . . 0.0 116.081 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 15' ' ' GLY . . . -22.33 -64.16 0.03 OUTLIER Glycine 0 CA--C 1.53 1.02 0 C-N-CA 129.054 3.216 . . . . 0.0 117.408 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.4 ' C ' HH22 ' A' ' 97' ' ' ARG . 10.0 m -70.39 63.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.8 t -149.04 -85.56 0.09 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.396 1.878 . . . . 0.0 110.104 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.5 ' HA ' ' HB3' ' A' ' 73' ' ' SER 0.364 34.2 p90 58.14 -46.91 0.05 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 119.528 3.158 . . . . 0.0 119.528 179.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -12.05 -81.11 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.939 2.895 . . . . 0.0 117.298 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -44.04 -55.51 4.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.057 1.343 . . . . 0.0 114.004 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -57.61 -58.51 7.99 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.828 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.615 ' HA ' ' HH2' ' A' ' 64' ' ' TRP . . . -59.76 -53.03 62.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.477 1.111 . . . . 0.0 113.602 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -52.3 -54.78 27.08 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.864 2.466 . . . . 0.0 113.725 -178.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -56.72 -52.66 64.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.328 1.051 . . . . 0.0 111.851 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 33' ' ' ILE . 1.4 mp0 -66.17 -47.57 73.55 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.737 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.04 -47.68 74.47 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -55.9 -50.76 69.78 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.776 0.83 . . . . 0.0 112.522 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -58.12 -37.04 73.82 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.08 1.352 . . . . 0.0 114.274 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 29' ' ' GLU . 24.7 mm -76.13 -36.34 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.981 0.912 . . . . 0.0 111.979 177.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.27 67.85 1.21 Allowed Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.876 1.227 . . . . 0.0 110.56 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.683 HG23 ' HA3' ' A' ' 53' ' ' GLY . 12.3 p -158.34 154.64 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.757 1.623 . . . . 0.0 111.62 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.696 HG13 ' HB2' ' A' ' 94' ' ' PHE 0.473 3.7 p 65.15 152.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 128.929 2.892 . . . . 0.0 115.416 170.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.97 -89.29 1.53 Allowed Glycine 0 N--CA 1.477 1.422 0 CA-C-N 112.802 -1.999 . . . . 0.0 113.191 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -135.17 159.69 40.73 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HB ' ' HG2' ' A' ' 97' ' ' ARG . 1.9 t -109.66 136.23 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 113.004 -1.907 . . . . 0.0 108.074 173.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.794 ' HG3' HG23 ' A' ' 48' ' ' THR . 10.7 pttp -118.19 133.01 56.28 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.46 1.904 . . . . 0.0 112.224 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -75.18 146.47 41.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 112.027 -2.351 . . . . 0.0 112.766 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.0 p -123.15 161.47 24.39 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.328 168.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 p -64.57 -22.02 66.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 113.286 -1.779 . . . . 0.0 113.932 169.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -101.8 11.46 38.68 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -168.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.66 -35.94 1.2 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.096 0.855 . . . . 0.0 114.082 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.0 p -61.16 79.97 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.291 2.236 . . . . 0.0 111.728 172.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.51 141.0 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 111.854 -2.43 . . . . 0.0 111.254 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.794 HG23 ' HG3' ' A' ' 40' ' ' LYS . 7.5 t -113.31 131.64 55.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 113.436 -1.711 . . . . 0.0 111.832 -173.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 10' ' ' ASP . . . -133.85 143.03 14.6 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.296 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -98.21 86.94 3.78 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 112.914 -1.643 . . . . 0.0 112.468 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.9 t -86.74 82.75 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 111.86 -2.427 . . . . 0.0 110.534 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.561 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 40.3 tt0 -88.03 115.87 25.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.962 -1.927 . . . . 0.0 109.875 173.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.683 ' HA3' HG23 ' A' ' 35' ' ' VAL . . . 157.89 -82.35 0.15 Allowed Glycine 0 N--CA 1.468 0.827 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.698 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.49 ' HA ' HG13 ' A' ' 58' ' ' VAL . 8.8 Cg_exo -15.18 82.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.327 -0.58 1 C-N-CA 125.343 4.029 . . . . 0.0 118.35 -158.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.706 ' H ' HG13 ' A' ' 58' ' ' VAL . 66.9 tt0 -129.24 107.63 9.7 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.467 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 57.91 -88.29 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.487 2.315 . . . . 0.0 114.569 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -57.1 -43.5 82.32 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.299 0.639 . . . . 0.0 111.935 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.706 HG13 ' H ' ' A' ' 55' ' ' GLU 0.33 14.8 p -84.83 2.17 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -60.49 -35.45 75.94 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.487 -0.758 . . . . 0.0 111.517 164.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -51.23 -38.57 53.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.127 1.371 . . . . 0.0 114.023 173.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -53.23 60.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.052 0.541 . . . . 0.0 111.28 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.474 ' HD2' ' HZ3' ' A' ' 7' ' ' LYS . 30.8 ttpt -54.5 -51.62 64.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.728 1.211 . . . . 0.0 112.858 173.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.4 t -57.57 -31.12 65.83 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.051 1.74 . . . . 0.0 115.293 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.615 ' HH2' ' HA ' ' A' ' 26' ' ' ALA . 5.3 t90 -76.9 -50.8 12.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.205 1.802 . . . . 0.0 114.467 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.595 ' HB3' ' HZ ' ' A' ' 80' ' ' PHE . 14.1 tp -51.4 -26.86 8.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.163 2.185 . . . . 0.0 115.482 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.447 ' HA ' ' HB ' ' A' ' 78' ' ' THR . 13.7 p -53.82 -60.3 3.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.158 2.183 . . . . 0.0 113.967 170.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -127.17 70.82 1.31 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.768 2.427 . . . . 0.0 109.5 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -54.95 -29.04 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -177.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.83 -84.5 0.48 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.691 171.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.9 t -128.28 -74.68 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -44.12 102.39 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 124.213 3.275 . . . . 0.0 114.173 -154.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.8 p 42.25 45.91 3.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.655 -2.521 . . . . 0.0 115.303 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 66.1 p -155.38 -66.35 0.12 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 68.4 -61.52 0.4 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.894 2.078 . . . . 0.0 114.158 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.475 HG21 ' OG1' ' A' ' 78' ' ' THR . 14.6 mt 32.05 110.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 128.963 2.905 . . . . 0.0 113.74 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -67.71 -32.28 72.81 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -163.49 110.71 1.17 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.065 0.946 . . . . 0.0 111.686 171.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.475 ' OG1' HG21 ' A' ' 75' ' ' ILE . 63.7 m -88.75 101.11 13.68 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.448 1.594 . . . . 0.0 109.471 166.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -68.24 98.92 0.85 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 111.602 -2.545 . . . . 0.0 111.155 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.595 ' HZ ' ' HB3' ' A' ' 65' ' ' LEU . 58.4 m-85 -79.31 78.72 5.79 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 124.041 1.877 . . . . 0.0 112.42 175.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.5 p -92.67 -69.17 0.76 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 110.977 -2.829 . . . . 0.0 115.302 -169.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.617 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 15.3 m120 -80.75 75.75 7.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 123.686 1.707 . . . . 0.0 110.955 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -87.44 83.41 7.3 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 111.885 -2.416 . . . . 0.0 111.235 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.617 ' HE3' ' HB3' ' A' ' 82' ' ' ASN . 87.9 mttt -96.92 91.85 5.83 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.143 -1.844 . . . . 0.0 109.218 -174.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.1 p -74.6 115.21 13.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.255 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.499 ' CD1' HE21 ' A' ' 52' ' ' GLN . 2.6 pp -122.01 149.49 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 110.618 -2.992 . . . . 0.0 111.658 -174.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.0 p -82.32 101.72 10.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 113.703 -1.589 . . . . 0.0 112.083 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 88' ' ' LYS 0.292 33.8 mmtp 98.55 149.05 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.538 2.335 . . . . 0.0 116.343 168.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.6 tp -103.22 130.29 50.41 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.304 -173.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -119.99 -44.32 2.51 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.192 -1.367 . . . . 0.0 112.587 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . 0.561 ' HB2' ' HB3' ' A' ' 52' ' ' GLN . 20.5 m-85 -73.95 95.16 2.44 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.885 1.274 . . . . 0.0 113.987 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.9 p -86.21 -22.2 27.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 111.546 -2.57 . . . . 0.0 115.811 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -137.5 108.47 6.72 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.898 0.749 . . . . 0.0 112.539 -162.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.696 ' HB2' HG13 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -66.65 125.79 26.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.815 171.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.4 t -149.97 111.28 4.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 97' ' ' ARG 0.31 25.6 m 48.39 -178.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 120.195 3.405 . . . . 0.0 120.195 161.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.475 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 46.6 mtt180 -105.97 139.38 40.61 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.841 -1.527 . . . . 0.0 113.662 -176.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 C--O 1.246 0.88 0 CA-C-N 112.4 -2.182 . . . . 0.0 113.446 -179.776 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo . . . . . 0 CA--C 1.539 0.75 0 N-CA-C 114.556 0.944 . . . . 0.0 114.556 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.55 ' HB3' HE22 ' A' ' 52' ' ' GLN . 9.9 mp -114.18 97.25 6.24 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.747 ' HG2' HG22 ' A' ' 85' ' ' THR . 63.0 mttm -98.88 113.64 25.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.976 -161.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 t -103.33 101.88 11.81 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.248 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -116.1 142.14 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 112.821 -1.99 . . . . 0.0 112.077 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -100.24 121.79 42.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 123.33 1.538 . . . . 0.0 110.353 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.454 ' HD1' HG23 ' A' ' 13' ' ' VAL . 30.8 p90 -103.02 148.76 25.29 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 111.933 -2.394 . . . . 0.0 111.863 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -124.15 85.94 2.49 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 111.821 -2.445 . . . . 0.0 109.51 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 48.7 t -80.66 110.38 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 123.104 1.43 . . . . 0.0 110.521 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.586 ' HB3' ' HE ' ' A' ' 16' ' ' ARG . 13.6 m-85 -93.84 77.77 4.2 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 111.126 -2.761 . . . . 0.0 106.855 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.66 54.31 0.55 Allowed Glycine 0 N--CA 1.479 1.503 0 CA-C-N 112.015 -2.357 . . . . 0.0 109.991 173.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.586 ' HE ' ' HB3' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -61.4 -36.06 79.25 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -174.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.1 m -80.22 52.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 52.68 -110.89 0.55 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 127.012 2.125 . . . . 0.0 112.484 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.75 -56.39 0.35 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 119.087 2.395 . . . . 0.0 119.087 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 m -77.14 100.24 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -171.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.43 64.98 1.02 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 124.582 2.135 . . . . 0.0 107.634 162.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.96 -31.43 50.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 111.702 -2.499 . . . . 0.0 113.709 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -32.7 -59.72 0.32 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.909 2.083 . . . . 0.0 115.538 170.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.1 tpt -54.9 -38.24 67.33 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . 0.726 ' HB3' ' HZ2' ' A' ' 64' ' ' TRP . 2.5 m-30 -73.36 -53.48 10.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.915 1.686 . . . . 0.0 111.284 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 94' ' ' PHE . . . -54.25 -37.35 64.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.283 1.433 . . . . 0.0 113.143 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.28 -83.42 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.594 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -63.97 -59.62 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.005 1.322 . . . . 0.0 114.209 -170.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 33' ' ' ILE . 43.5 mt-10 -65.24 -43.88 90.0 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 26' ' ' ALA . . . -63.12 -43.38 98.58 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.5 ttp-105 -52.35 -55.72 19.65 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.732 0.813 . . . . 0.0 110.866 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -57.63 -40.78 79.98 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.017 1.727 . . . . 0.0 114.794 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 29' ' ' GLU . 31.8 mm -71.11 -29.76 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.105 0.962 . . . . 0.0 113.418 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.1 38.67 4.77 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 124.568 1.08 . . . . 0.0 112.702 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.3 t -110.62 141.45 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 123.77 1.748 . . . . 0.0 111.736 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 89' ' ' LEU . 3.8 t -126.47 156.18 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 111.002 -2.817 . . . . 0.0 111.125 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.89 -149.61 20.73 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.074 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.604 ' HZ3' ' HB2' ' A' ' 40' ' ' LYS . 55.7 p-90 -153.46 146.36 24.44 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.328 1.451 . . . . 0.0 111.084 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' HD1' ' A' ' 98' ' ' TYR . 2.6 t -117.99 144.52 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.979 0.912 . . . . 0.0 109.583 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.604 ' HB2' ' HZ3' ' A' ' 38' ' ' TRP . 60.4 tttt -132.52 137.49 47.18 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.493 0.717 . . . . 0.0 112.298 175.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . 0.475 ' OD1' ' HG2' ' A' ' 97' ' ' ARG . 1.9 p-10 -94.97 93.35 7.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 122.676 1.227 . . . . 0.0 110.281 168.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 46' ' ' THR . 5.7 t -80.53 163.43 23.73 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -168.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.2 p -54.02 -35.03 61.49 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.126 -1.852 . . . . 0.0 113.911 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -66.3 -1.76 3.72 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.46 -41.08 2.62 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 124.952 1.263 . . . . 0.0 111.612 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.55 ' O ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -52.93 140.66 24.06 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.981 2.112 . . . . 0.0 113.804 -178.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 13' ' ' VAL . 96.0 t -92.01 103.36 14.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 123.986 1.851 . . . . 0.0 107.278 169.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.7 t -109.77 -164.26 0.92 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 111.738 -2.483 . . . . 0.0 110.156 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.26 -173.79 15.69 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 126.378 1.942 . . . . 0.0 110.89 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -125.74 134.34 51.79 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 112.257 -1.972 . . . . 0.0 111.91 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.454 HG21 ' HG3' ' A' ' 61' ' ' MET . 7.5 p -117.41 117.02 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 111.278 -2.692 . . . . 0.0 109.942 177.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.55 HE22 ' HB3' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -102.15 130.11 48.7 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 112.619 -2.082 . . . . 0.0 107.6 171.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.5 149.05 17.41 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.626 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -65.99 145.84 80.82 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 121.554 1.503 . . . . 0.0 109.822 166.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -17.83 -61.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.547 ' HG2' ' HD2' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -61.09 -39.97 91.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HD2' ' HG2' ' A' ' 56' ' ' GLU . 2.7 mptp? -65.92 -39.31 90.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.238 1.015 . . . . 0.0 111.718 174.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.667 HG21 ' HB2' ' A' ' 7' ' ' LYS . 49.2 t -61.69 -42.63 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.244 1.018 . . . . 0.0 112.286 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.594 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 25.2 m120 -55.33 -46.54 76.33 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.7 p -69.02 -47.22 65.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.578 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.655 ' HA ' ' HE3' ' A' ' 64' ' ' TRP . 13.8 tmm? -49.98 -52.58 32.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.695 1.598 . . . . 0.0 114.19 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 59' ' ' ASN . 65.5 pttt -59.17 -38.15 79.08 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.9 m -63.98 -57.69 8.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.055 170.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.726 ' HZ2' ' HB3' ' A' ' 25' ' ' TYR . 13.9 t90 -46.61 -46.06 19.43 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 127.781 2.432 . . . . 0.0 115.262 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.447 ' HB2' ' HZ ' ' A' ' 80' ' ' PHE . 64.6 mt -90.1 13.1 15.84 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 -175.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . 0.265 53.4 p -101.64 -109.23 0.23 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -110.22 75.61 0.94 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.222 2.209 . . . . 0.0 107.911 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.09 -52.1 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 112.426 -2.17 . . . . 0.0 114.698 -166.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.715 ' HA2' ' HA ' ' A' ' 74' ' ' ARG . . . 77.13 -56.8 3.62 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 115.792 1.077 . . . . 0.0 115.792 -173.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.6 m -41.58 145.49 0.66 Allowed Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 127.415 2.286 . . . . 0.0 115.932 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.92 -27.36 8.46 Favored 'Cis proline' 0 CA--C 1.535 0.569 0 N-CA-C 117.774 2.182 . . . . 0.0 117.774 -10.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.5 p -131.19 -43.83 1.04 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.0 m -97.27 121.98 39.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.713 2.005 . . . . 0.0 112.818 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.715 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.84 86.37 0.51 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -172.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.652 HD11 ' HE2' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -75.43 91.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 114.055 -1.429 . . . . 0.0 107.765 167.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.55 -55.25 14.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 110.708 -2.951 . . . . 0.0 115.838 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HD2' ' H ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -163.54 145.6 9.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.745 0.818 . . . . 0.0 110.007 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.44 ' H ' ' HD2' ' A' ' 77' ' ' ARG . 90.3 m -152.22 138.15 18.1 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -98.18 140.23 32.79 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.214 -2.721 . . . . 0.0 109.184 167.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.447 ' HZ ' ' HB2' ' A' ' 65' ' ' LEU . 87.7 m-85 -114.37 109.82 18.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.68 176.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.49 167.67 13.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 113.219 -1.809 . . . . 0.0 111.986 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 53.82 84.89 0.06 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.909 1.284 . . . . 0.0 113.264 172.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.2 111.76 24.51 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 123.057 1.408 . . . . 0.0 113.728 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -100.03 91.14 4.65 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 111.63 -2.532 . . . . 0.0 107.069 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.747 HG22 ' HG2' ' A' ' 7' ' ' LYS . 12.1 p -74.28 84.31 1.9 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 123.107 1.432 . . . . 0.0 109.034 172.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.1 pt -112.34 154.35 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 112.98 -1.918 . . . . 0.0 114.333 -165.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.1 t -59.15 132.41 53.92 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.229 -1.805 . . . . 0.0 111.864 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp 61.56 149.9 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.468 ' HB3' HG11 ' A' ' 36' ' ' VAL . 90.8 mt -85.51 97.58 10.13 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 113.782 -1.554 . . . . 0.0 111.07 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -84.16 82.03 8.54 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.492 -173.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 154.19 150.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 129.97 3.308 . . . . 0.0 111.965 167.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.3 p -82.07 88.42 6.43 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.504 1.145 . . . . 0.0 110.293 169.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.2 m120 61.42 172.14 0.11 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 111.211 -2.722 . . . . 0.0 113.209 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 8.3 t80 -73.56 69.59 1.25 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.245 1.497 . . . . 0.0 110.807 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.5 110.42 15.95 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 112.585 -2.098 . . . . 0.0 116.078 -166.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.258 27.2 m 54.95 163.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 110.768 -2.924 . . . . 0.0 117.035 165.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.475 ' HG2' ' OD1' ' A' ' 41' ' ' ASN . 52.6 ttp180 -111.66 113.15 25.35 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.215 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.442 ' HD1' ' O ' ' A' ' 39' ' ' VAL . 83.5 m-85 . . . . . 0 C--O 1.246 0.873 0 CA-C-N 111.519 -2.582 . . . . 0.0 111.717 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 CA--C 1.534 0.515 0 N-CA-C 115.434 1.282 . . . . 0.0 115.434 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.08 127.22 41.06 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 164.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.606 ' HB2' HG21 ' A' ' 58' ' ' VAL . 33.3 mmtp -97.16 115.6 27.84 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.199 1.0 . . . . 0.0 111.598 -163.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.9 t -107.24 122.98 47.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.127 -1.851 . . . . 0.0 110.36 166.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 t -112.98 108.03 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 111.314 -2.675 . . . . 0.0 108.262 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.0 t0 -88.24 97.36 10.98 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 113.106 -1.861 . . . . 0.0 107.715 173.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.461 ' HD2' HG23 ' A' ' 13' ' ' VAL . 33.7 p90 -94.79 150.68 19.95 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 109.122 -3.672 . . . . 0.0 112.56 -171.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 6.0 mp0 -127.8 97.52 4.86 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.008 166.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.461 HG23 ' HD2' ' A' ' 11' ' ' TYR . 94.6 t -68.78 126.58 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.005 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -127.94 137.0 52.1 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.545 0.528 . . . . 0.0 111.515 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 75' ' ' ILE . . . -105.52 121.08 6.68 Favored Glycine 0 N--CA 1.476 1.352 0 O-C-N 124.819 1.324 . . . . 0.0 112.313 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -38.68 -43.56 0.91 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 172.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -121.84 146.98 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.581 163.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -52.83 168.65 0.11 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.6 -78.5 0.28 Allowed Glycine 0 N--CA 1.477 1.377 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.655 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' A' ' 22' ' ' PHE . 12.5 t 66.98 -72.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 128.277 2.631 . . . . 0.0 111.234 175.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.7 m 42.05 38.83 1.16 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.391 1.876 . . . . 0.0 115.316 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.561 ' HB3' HG22 ' A' ' 47' ' ' VAL . 17.3 t80 -63.02 -27.9 69.73 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 112.722 -2.036 . . . . 0.0 113.754 -168.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.517 ' NE ' ' HB3' ' A' ' 97' ' ' ARG . 8.6 mmm180 -21.03 -73.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 67.7 mtm -60.67 -40.59 92.69 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -62.91 -46.89 85.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.894 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.495 ' HA ' ' HZ2' ' A' ' 64' ' ' TRP . . . -50.7 -56.86 10.0 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 125.001 1.438 . . . . 0.0 111.925 173.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.425 ' OE1' HG22 ' A' ' 96' ' ' VAL . 33.0 tt0 -51.43 -60.0 3.62 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.669 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.23 -53.14 61.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.195 1.398 . . . . 0.0 113.468 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.475 ' O ' HG12 ' A' ' 33' ' ' ILE . 1.9 tp10 -65.51 -38.61 90.2 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.549 0.74 . . . . 0.0 112.203 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -55.9 -47.53 77.27 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.017 0.927 . . . . 0.0 112.985 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -52.23 -49.89 63.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.796 1.238 . . . . 0.0 111.196 173.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.97 -51.67 68.26 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.272 1.429 . . . . 0.0 114.444 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 29' ' ' GLU . 29.7 mm -67.8 -25.69 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.4 1.08 . . . . 0.0 112.705 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.28 53.85 1.67 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.33 0.966 . . . . 0.0 111.788 -174.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.546 HG22 ' CE ' ' A' ' 61' ' ' MET . 2.6 t -116.6 140.13 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 123.41 1.576 . . . . 0.0 109.58 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 52' ' ' GLN . 33.5 m -119.98 166.74 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 111.982 -2.372 . . . . 0.0 111.048 173.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.1 -135.3 7.41 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.5 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.434 ' CZ3' ' HB2' ' A' ' 40' ' ' LYS . 39.8 p-90 -162.1 151.07 15.45 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 113.456 -1.372 . . . . 0.0 111.367 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 95' ' ' SER . 10.7 p -114.91 136.4 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.681 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.703 ' HB3' HG23 ' A' ' 48' ' ' THR . 83.8 tttt -117.01 123.3 46.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.202 1.477 . . . . 0.0 112.508 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -64.93 114.73 4.74 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 111.399 -2.637 . . . . 0.0 109.161 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.507 ' OG1' HG22 ' A' ' 48' ' ' THR . 0.2 OUTLIER -104.0 -130.17 0.26 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.995 -175.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.6 m -107.4 108.38 19.7 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.897 -1.127 . . . . 0.0 110.623 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp 49.76 85.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.95 -31.3 1.08 Allowed Glycine 0 N--CA 1.473 1.115 0 CA-C-N 113.086 -1.87 . . . . 0.0 116.319 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.8 p -59.87 147.49 38.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.375 1.07 . . . . 0.0 112.076 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.561 HG22 ' HB3' ' A' ' 22' ' ' PHE . 16.1 m -133.64 124.92 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 112.163 -2.289 . . . . 0.0 113.575 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.703 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.9 t -92.23 -171.91 2.96 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 109.26 -3.609 . . . . 0.0 109.896 159.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 129.5 -155.84 21.04 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.698 2.094 . . . . 0.0 111.191 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -130.94 109.6 10.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.362 1.465 . . . . 0.0 112.659 -173.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 t -94.33 97.65 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.376 171.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.518 ' HB2' HG23 ' A' ' 36' ' ' VAL . 67.7 mt-30 -100.77 107.68 19.31 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.592 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.19 150.87 20.32 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 114.429 -1.26 . . . . 0.0 113.673 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HD3' HD11 ' A' ' 89' ' ' LEU . 74.3 Cg_endo -72.93 153.14 52.68 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.142 1.894 . . . . 0.0 111.147 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.575 ' O ' HG12 ' A' ' 58' ' ' VAL . 40.0 mt-10 -39.84 -49.06 2.36 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -173.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -63.19 -62.91 1.38 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.037 0.381 . . . . 0.0 111.547 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -59.56 -31.34 69.34 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.606 HG21 ' HB2' ' A' ' 7' ' ' LYS 0.287 1.7 p -55.78 -35.41 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -177.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.57 -41.07 66.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.9 t -67.55 -54.35 20.65 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.669 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.546 ' CE ' HG22 ' A' ' 35' ' ' VAL . 20.1 ptp -58.13 -36.77 73.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HE3' HG22 ' A' ' 58' ' ' VAL . 88.1 mttt -52.38 -61.63 2.15 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.088 1.355 . . . . 0.0 111.737 171.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.3 m -54.04 -43.5 70.23 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . 0.495 ' HZ2' ' HA ' ' A' ' 26' ' ' ALA . 3.5 t90 -58.11 -53.99 51.99 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 mt -51.57 -29.58 17.69 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -80.02 -69.93 0.55 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.916 -1.493 . . . . 0.0 114.777 167.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -63.86 -27.16 68.97 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.514 HG22 ' HD2' ' A' ' 71' ' ' PRO 0.357 8.1 p 62.01 -70.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 129.394 3.078 . . . . 0.0 118.548 172.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.94 -111.67 2.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.88 1.228 . . . . 0.0 111.687 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.1 p -73.18 -30.96 1.33 Allowed Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 118.952 2.945 . . . . 0.0 118.952 -170.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' A' ' 68' ' ' VAL . 38.7 Cg_exo -56.95 109.93 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 CA-C-N 123.075 2.134 . . . . 0.0 112.846 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -43.2 -30.79 0.51 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.222 2.609 . . . . 0.0 114.174 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -49.63 -23.93 1.95 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 74.1 -33.04 0.24 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 127.941 2.496 . . . . 0.0 116.505 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.629 ' HA ' ' HA2' ' A' ' 15' ' ' GLY 0.337 4.1 mp 58.37 -84.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.723 2.009 . . . . 0.0 112.044 178.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.31 2.6 p30 57.76 -41.37 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 128.313 2.645 . . . . 0.0 117.928 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.498 ' NH1' HD21 ' A' ' 79' ' ' ASN . 38.9 ttt-85 -110.58 101.69 10.33 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 123.313 1.53 . . . . 0.0 111.116 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.7 m -118.17 127.9 54.2 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 112.784 -2.007 . . . . 0.0 111.584 172.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . 2.4 m-80 -82.73 83.57 7.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 111.484 -2.598 . . . . 0.0 110.861 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -72.27 37.8 0.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.682 -2.053 . . . . 0.0 112.953 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 m -59.78 -36.39 76.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.063 2.145 . . . . 0.0 115.887 -163.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.558 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 24.6 t-20 -116.17 88.38 2.88 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.05 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -92.95 102.88 15.24 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.844 169.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -108.47 119.99 41.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 111.462 -2.608 . . . . 0.0 110.31 -173.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.6 p -82.8 92.17 7.19 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 123.756 1.741 . . . . 0.0 111.934 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.5 pt -80.64 140.42 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 111.166 -2.743 . . . . 0.0 114.052 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 50.4 m -73.33 87.36 1.51 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.808 -1.996 . . . . 0.0 111.289 171.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 73.08 156.32 0.17 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-N 112.247 -2.251 . . . . 0.0 112.42 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.469 HD11 ' HD3' ' A' ' 54' ' ' PRO . 88.5 mt -75.25 111.15 10.2 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.949 0.881 . . . . 0.0 111.113 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.7 13.58 8.47 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -162.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -148.51 155.21 40.86 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.328 1.051 . . . . 0.0 111.751 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.6 p -68.62 -46.69 68.6 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.519 -1.219 . . . . 0.0 114.056 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.479 ' HA ' HG12 ' A' ' 36' ' ' VAL . 1.9 t-20 -156.54 172.93 17.69 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.429 1.492 . . . . 0.0 111.101 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -72.93 94.98 1.91 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.789 1.28 . . . . 0.0 110.586 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . 0.495 ' O ' HG12 ' A' ' 39' ' ' VAL . 42.4 m -63.06 142.96 58.18 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.305 -2.225 . . . . 0.0 114.496 -173.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . 0.425 HG22 ' OE1' ' A' ' 27' ' ' GLU . 85.3 t -63.75 143.14 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 110.792 -2.913 . . . . 0.0 110.032 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.517 ' HB3' ' NE ' ' A' ' 23' ' ' ARG . 46.1 ptt85 -6.63 123.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 120.306 3.446 . . . . 0.0 120.306 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 112.066 -2.334 . . . . 0.0 112.514 165.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.0 p . . . . . 0 N--CA 1.471 0.596 0 N-CA-C 114.461 1.282 . . . . 0.0 114.461 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.5 p -50.38 -33.06 19.24 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 116.79 2.144 . . . . 0.0 116.79 -177.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -51.9 -23.34 4.79 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 mpp_? -96.5 119.19 64.5 Favored Pre-proline 0 N--CA 1.476 0.864 0 C-N-CA 124.541 1.136 . . . . 0.0 111.294 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -71.92 59.97 2.93 Favored 'Trans proline' 0 C--N 1.323 -0.794 0 C-N-CA 123.428 2.752 . . . . 0.0 114.124 176.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.888 ' HB3' HE22 ' A' ' 52' ' ' GLN . 5.2 mp -124.63 106.83 10.42 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.576 2.351 . . . . 0.0 107.348 173.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.671 ' HE2' ' HB3' ' A' ' 83' ' ' GLU . 47.9 tttt -107.06 112.11 24.89 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-N 114.484 -1.235 . . . . 0.0 112.878 -166.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.612 ' HB3' ' HG2' ' A' ' 52' ' ' GLN . 4.4 p -85.1 104.64 15.18 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 113.817 -1.538 . . . . 0.0 111.833 167.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.438 HG22 ' HG3' ' A' ' 83' ' ' GLU . 93.0 t -109.75 143.57 19.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-N 110.221 -3.172 . . . . 0.0 108.028 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.417 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 9.8 m-20 -109.05 142.17 40.13 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 114.224 -1.353 . . . . 0.0 110.976 171.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -120.33 159.58 24.74 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.351 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -144.76 116.82 8.34 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 113.908 -1.496 . . . . 0.0 111.945 168.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 30.4 t -89.48 121.74 40.0 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 112.467 -2.151 . . . . 0.0 107.054 170.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -85.31 71.51 10.83 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 113.973 -1.467 . . . . 0.0 111.74 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.27 73.15 2.56 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 113.412 -1.722 . . . . 0.0 110.453 174.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.6 mpt_? -33.02 -59.1 0.36 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 125.78 1.632 . . . . 0.0 115.358 -174.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.6 t -125.62 72.92 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.664 0.745 . . . . 0.0 109.259 173.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.468 ' HB3' ' H ' ' A' ' 19' ' ' GLY 0.252 12.9 mt-30 53.33 -139.14 1.05 Allowed 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 176.72 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.468 ' H ' ' HB3' ' A' ' 18' ' ' GLN . . . 78.4 -37.73 1.82 Allowed Glycine 0 N--CA 1.474 1.21 0 N-CA-C 116.527 1.371 . . . . 0.0 116.527 176.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.1 m -54.13 99.91 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 C-N-CA 126.681 1.992 . . . . 0.0 115.718 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 86.6 m -94.76 75.3 3.66 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 112.396 -2.184 . . . . 0.0 108.519 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -78.78 -29.92 45.28 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 111.103 -2.771 . . . . 0.0 113.106 177.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.453 ' NH1' ' HG2' ' A' ' 97' ' ' ARG . 53.8 mmm-85 -50.38 155.73 0.98 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.528 1.531 . . . . 0.0 113.82 176.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 1.6 mpt? 63.9 -57.19 0.21 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 126.932 2.093 . . . . 0.0 114.968 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -46.26 -55.17 7.57 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 127.06 2.144 . . . . 0.0 111.049 173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.419 ' HA ' ' HH2' ' A' ' 64' ' ' TRP . . . -53.1 -68.96 0.13 Allowed 'General case' 0 C--N 1.323 -0.58 0 O-C-N 125.167 1.542 . . . . 0.0 112.432 172.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -38.92 -63.55 0.52 Allowed 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 126.575 1.95 . . . . 0.0 114.987 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' O ' ' HG2' ' A' ' 32' ' ' LYS . 5.2 m-20 -63.3 -52.15 63.16 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 125.876 1.67 . . . . 0.0 113.489 -174.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 33' ' ' ILE . 58.8 mt-10 -69.29 -36.66 77.26 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.936 1.088 . . . . 0.0 113.936 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.517 ' HB1' HG23 ' A' ' 35' ' ' VAL . . . -62.64 -41.39 99.02 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.864 0.865 . . . . 0.0 112.818 175.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 45.4 ttt180 -53.07 -51.69 60.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 123.778 0.831 . . . . 0.0 110.884 168.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 28' ' ' ASP . 44.8 mmtm -61.27 -40.04 92.65 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 178.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 29' ' ' GLU . 37.3 mm -61.65 -34.04 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.883 1.273 . . . . 0.0 111.55 172.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.3 36.88 4.23 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 125.082 1.325 . . . . 0.0 113.119 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.716 HG21 ' HG3' ' A' ' 61' ' ' MET . 29.0 m -123.0 158.56 27.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-O 124.37 2.033 . . . . 0.0 115.005 -179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.424 HG22 ' HA ' ' A' ' 93' ' ' ASN . 3.1 t -126.2 155.61 36.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 110.856 -2.883 . . . . 0.0 109.434 -172.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 143.47 -144.67 13.99 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 124.108 0.861 . . . . 0.0 111.695 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.492 ' CZ3' ' HB2' ' A' ' 40' ' ' LYS . 65.5 p-90 -166.0 168.16 15.89 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 115.356 1.614 . . . . 0.0 115.356 -173.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 47' ' ' VAL . 83.3 t -107.47 136.46 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-N 112.395 -2.184 . . . . 0.0 108.572 177.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.637 ' HB3' HG23 ' A' ' 48' ' ' THR . 59.2 tttp -115.12 114.28 25.11 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.639 1.576 . . . . 0.0 109.293 173.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -93.46 119.23 32.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 112.312 -2.222 . . . . 0.0 109.752 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.8 p -98.67 179.78 4.56 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.788 -1.551 . . . . 0.0 109.893 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.6 p -58.02 -52.66 64.6 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 113.906 -1.497 . . . . 0.0 113.25 171.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -110.08 49.44 0.84 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 -173.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 60.48 3.29 2.89 Favored Glycine 0 CA--C 1.534 1.255 0 N-CA-C 119.576 2.59 . . . . 0.0 119.576 165.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.9 p -64.83 83.52 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 123.0 1.381 . . . . 0.0 111.355 168.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.467 HG13 HG13 ' A' ' 39' ' ' VAL . 63.2 t -75.25 93.98 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 112.277 -2.238 . . . . 0.0 109.234 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.637 HG23 ' HB3' ' A' ' 40' ' ' LYS . 7.5 t -102.61 -169.52 1.67 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 109.987 -3.279 . . . . 0.0 109.69 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 135.6 -163.99 24.93 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 125.123 1.344 . . . . 0.0 113.47 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -123.73 131.09 53.53 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 112.021 -2.09 . . . . 0.0 112.646 -168.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.4 t -119.88 108.74 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 126.229 1.812 . . . . 0.0 107.342 172.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.888 HE22 ' HB3' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -112.01 131.35 55.46 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 170.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.701 ' HA3' HG12 ' A' ' 35' ' ' VAL . . . -168.18 158.77 31.7 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-N 115.12 -0.945 . . . . 0.0 112.306 178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -59.84 142.64 99.0 Favored 'Trans proline' 0 C--N 1.325 -0.705 0 C-N-CA 121.839 1.692 . . . . 0.0 110.541 168.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -33.06 -65.95 0.15 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.88 -36.42 48.57 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 179.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -72.74 -41.83 64.74 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 124.449 1.1 . . . . 0.0 112.487 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.427 HG21 ' HB3' ' A' ' 7' ' ' LYS 0.303 8.6 m -65.19 -33.92 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 N-CA-C 114.402 1.26 . . . . 0.0 114.402 172.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -57.11 -47.56 80.79 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 124.16 0.984 . . . . 0.0 112.932 169.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.4 t -60.18 -45.02 94.53 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.815 1.246 . . . . 0.0 112.593 174.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.716 ' HG3' HG21 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -58.81 -40.88 85.4 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.403 1.481 . . . . 0.0 113.937 175.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -66.61 -40.23 88.72 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 114.922 1.452 . . . . 0.0 114.922 171.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 67.8 m -58.49 -41.93 86.45 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.699 0.761 . . . . 0.0 111.093 170.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.588 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 24.0 t90 -76.23 179.06 5.97 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 125.447 1.499 . . . . 0.0 110.597 164.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.571 HD12 ' HE1' ' A' ' 80' ' ' PHE . 50.8 mt 71.01 -36.74 0.37 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 127.469 2.307 . . . . 0.0 114.965 -173.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 82.7 p -78.85 -42.08 28.39 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.711 2.004 . . . . 0.0 109.342 162.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.588 ' HB3' ' HA ' ' A' ' 64' ' ' TRP . 0.1 OUTLIER -61.73 99.64 0.12 Allowed 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 158.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 18.3 m -108.26 91.41 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 CA-C-N 111.426 -2.625 . . . . 0.0 114.53 -169.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.39 158.73 19.91 Favored Glycine 0 N--CA 1.478 1.487 0 CA-C-N 112.523 -2.126 . . . . 0.0 108.583 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.1 t -126.59 139.94 36.09 Favored Pre-proline 0 N--CA 1.472 0.662 0 N-CA-C 117.298 2.333 . . . . 0.0 117.298 -163.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -102.12 8.21 0.47 Allowed 'Trans proline' 0 C--N 1.328 -0.5 0 C-N-CA 122.342 2.028 . . . . 0.0 116.026 158.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 2.2 m -178.66 -68.55 0.01 OUTLIER 'General case' 0 C--O 1.237 0.398 0 C-N-CA 127.587 2.355 . . . . 0.0 112.187 -179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 44.8 p -114.65 173.07 6.65 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.635 1.174 . . . . 0.0 113.86 -173.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.469 ' CZ ' ' H ' ' A' ' 74' ' ' ARG . 0.0 OUTLIER -78.39 129.07 34.53 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 114.382 -1.281 . . . . 0.0 112.093 172.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.2 mp -75.2 85.22 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 170.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -76.6 91.16 3.38 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 113.788 -1.551 . . . . 0.0 113.456 -171.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.405 ' CZ ' ' HA ' ' A' ' 77' ' ' ARG . 0.6 OUTLIER 68.39 112.87 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 111.194 -2.73 . . . . 0.0 113.878 172.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 24.4 m -117.28 117.06 28.51 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 112.603 -2.09 . . . . 0.0 110.306 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -102.26 140.41 36.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 112.219 -2.264 . . . . 0.0 109.086 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.571 ' HE1' HD12 ' A' ' 65' ' ' LEU . 68.6 m-85 -115.91 99.06 7.01 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.717 -1.583 . . . . 0.0 109.539 -177.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 83.9 p -137.74 156.91 47.47 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 114.263 -1.335 . . . . 0.0 110.492 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.417 ' HB2' ' HB2' ' A' ' 10' ' ' ASP . 47.0 m-80 69.44 90.35 0.1 Allowed 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.58 1.552 . . . . 0.0 110.749 -165.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.671 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 11.8 mp0 -118.25 111.67 19.09 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.641 -179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 18.0 pttm -137.61 110.45 7.65 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 114.606 -1.179 . . . . 0.0 113.948 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.2 p -68.48 123.42 20.78 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 113.94 -1.482 . . . . 0.0 112.919 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 5.4 pt -126.07 -159.93 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.977 -176.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 2.7 t -132.03 143.67 50.22 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 123.482 0.713 . . . . 0.0 109.921 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? 59.01 157.34 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 116.83 2.159 . . . . 0.0 116.83 -178.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 65.2 mt -97.32 92.73 6.13 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.856 -178.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -83.04 34.55 0.46 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 117.605 2.446 . . . . 0.0 117.605 -168.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.421 ' HB2' HG13 ' A' ' 36' ' ' VAL . 80.2 m-85 -155.64 150.44 26.34 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 123.887 0.875 . . . . 0.0 111.858 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.4 p -78.25 85.78 4.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.479 -1.237 . . . . 0.0 111.824 173.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.424 ' HA ' HG22 ' A' ' 36' ' ' VAL . 3.6 m120 59.83 176.66 0.09 Allowed 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 112.65 -2.068 . . . . 0.0 114.19 -176.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 19.3 t80 -78.72 112.48 15.89 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 122.612 1.196 . . . . 0.0 109.06 164.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.7 p -108.7 -139.53 0.38 Allowed 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 111.68 -2.509 . . . . 0.0 114.978 -163.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 24.7 m -104.19 -170.81 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 126.38 1.872 . . . . 0.0 112.162 -164.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.453 ' HG2' ' NH1' ' A' ' 23' ' ' ARG . 11.8 ptt180 -76.77 126.03 30.28 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 113.572 0.953 . . . . 0.0 113.572 174.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.3 m-30 . . . . . 0 C--O 1.247 0.97 0 CA-C-N 112.667 -2.06 . . . . 0.0 110.717 177.143 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.7 t . . . . . 0 N--CA 1.473 0.689 0 CA-C-O 122.383 1.087 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . 0.307 28.7 p 59.75 -43.82 0.09 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 128.572 2.749 . . . . 0.0 118.062 -174.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 69.41 -36.83 0.35 Allowed 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 119.785 3.254 . . . . 0.0 119.785 171.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.668 ' HB2' HG21 ' A' ' 85' ' ' THR . 16.6 mmm180 -56.1 144.11 60.69 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 125.125 1.37 . . . . 0.0 112.005 -175.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.82 72.89 2.5 Favored 'Trans proline' 0 C--N 1.334 -0.19 0 C-N-CA 123.092 2.528 . . . . 0.0 116.465 -178.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 19.5 tp -166.64 38.49 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 129.101 2.96 . . . . 0.0 107.108 173.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.617 ' O ' ' HD2' ' A' ' 54' ' ' PRO . 20.2 ptmt -104.37 79.51 1.59 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.896 1.814 . . . . 0.0 115.896 -153.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.458 ' HB3' ' HG3' ' A' ' 84' ' ' LYS . 39.1 t -58.53 128.67 38.32 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.935 -176.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.608 HG12 ' HG2' ' A' ' 83' ' ' GLU . 25.8 m -114.94 142.0 29.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 126.169 2.168 . . . . 0.0 112.344 -173.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -109.06 120.45 42.56 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 113.424 -1.716 . . . . 0.0 107.802 170.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 79' ' ' ASN . 51.4 p90 -104.34 124.41 49.13 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.603 -2.089 . . . . 0.0 112.698 -173.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -100.91 113.61 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.522 168.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.1 t -71.34 121.67 21.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 112.313 -2.221 . . . . 0.0 111.12 177.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -132.43 150.4 52.16 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 112.992 -1.913 . . . . 0.0 109.499 166.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.638 ' H ' ' NH2' ' A' ' 74' ' ' ARG . . . -176.15 -146.07 5.82 Favored Glycine 0 N--CA 1.466 0.652 0 N-CA-C 115.535 0.974 . . . . 0.0 115.535 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -98.64 -79.82 0.47 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.422 -0.889 . . . . 0.0 111.363 -170.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 96.7 t -77.35 120.33 27.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 124.858 1.263 . . . . 0.0 109.736 -173.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.486 HE22 ' CZ ' ' A' ' 74' ' ' ARG . 93.3 mm-40 -66.76 137.34 56.58 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.897 -172.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 97.94 94.8 1.96 Allowed Glycine 0 N--CA 1.479 1.535 0 CA-C-N 113.37 -1.741 . . . . 0.0 112.936 175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.475 HG21 HG22 ' A' ' 47' ' ' VAL 0.285 2.6 t -27.91 -71.77 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 C-N-CA 127.898 2.479 . . . . 0.0 117.218 -177.945 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 9.7 t 64.44 -27.54 0.09 Allowed 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 119.429 3.122 . . . . 0.0 119.429 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -63.97 20.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 118.4 2.741 . . . . 0.0 118.4 -177.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 3.4 tmm_? -62.86 -73.38 0.11 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 126.193 1.797 . . . . 0.0 113.452 -166.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 11.6 mmt -50.21 -46.81 54.87 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 176.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -45.88 -58.46 3.51 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 125.148 1.379 . . . . 0.0 112.872 175.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.428 ' HA ' ' HZ2' ' A' ' 64' ' ' TRP . . . -59.09 -49.98 75.8 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.244 1.418 . . . . 0.0 112.976 179.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.587 ' HA ' ' HD2' ' A' ' 94' ' ' PHE . 85.8 mt-10 -55.36 -58.46 7.62 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.081 1.353 . . . . 0.0 112.841 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -57.09 -52.82 63.75 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.607 -1.633 . . . . 0.0 112.228 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.604 ' O ' HG12 ' A' ' 33' ' ' ILE . 47.5 mt-10 -57.99 -57.68 11.75 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 123.492 0.717 . . . . 0.0 111.835 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.13 -45.75 75.6 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.463 HH21 ' HA ' ' A' ' 95' ' ' SER . 64.9 mtt-85 -53.9 -55.85 23.08 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.524 1.13 . . . . 0.0 111.559 174.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -58.74 -35.02 72.04 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.217 -1.356 . . . . 0.0 113.972 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.604 HG12 ' O ' ' A' ' 29' ' ' GLU . 26.6 pt -107.45 34.98 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 -178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 60.53 33.51 81.96 Favored Glycine 0 CA--C 1.536 1.391 0 N-CA-C 117.308 1.683 . . . . 0.0 117.308 168.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.635 HG22 HG13 ' A' ' 58' ' ' VAL . 89.4 t -124.51 118.78 54.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.429 HG22 ' HG2' ' A' ' 52' ' ' GLN . 15.1 m -127.51 164.46 28.51 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 114.529 -1.214 . . . . 0.0 114.182 -173.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 147.58 -120.99 1.3 Allowed Glycine 0 CA--C 1.529 0.945 0 C-N-CA 125.698 1.618 . . . . 0.0 111.013 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 59.2 p-90 -164.04 163.15 23.38 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -172.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.4 t -122.38 135.58 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 C-N-CA 126.043 1.737 . . . . 0.0 107.01 169.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.0 tttt -138.51 137.0 36.68 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.41 0.684 . . . . 0.0 111.592 174.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.459 ' OD1' ' HG2' ' A' ' 97' ' ' ARG . 5.8 p-10 -88.0 140.81 29.11 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 114.829 -1.078 . . . . 0.0 112.181 172.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 51.0 p -77.76 37.22 0.23 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 128.059 2.544 . . . . 0.0 110.892 177.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . 0.262 25.1 p 65.0 -50.99 0.34 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 128.682 2.793 . . . . 0.0 113.477 -154.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -134.88 132.58 38.71 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 114.914 1.45 . . . . 0.0 114.914 -167.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.72 -65.62 3.67 Favored Glycine 0 CA--C 1.532 1.116 0 CA-C-N 114.122 -1.399 . . . . 0.0 116.228 166.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.5 p -90.51 157.71 17.4 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 126.436 1.894 . . . . 0.0 113.707 -176.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.475 HG22 HG21 ' A' ' 20' ' ' VAL . 17.7 m -125.15 131.64 72.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 171.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 p -107.8 104.4 13.88 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 110.944 -2.844 . . . . 0.0 107.41 166.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -120.18 176.27 16.14 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 113.487 -1.688 . . . . 0.0 111.734 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.7 tt0 -129.9 132.81 46.52 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 113.509 0.929 . . . . 0.0 113.509 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.488 HG13 HG13 ' A' ' 35' ' ' VAL . 15.3 t -116.09 119.16 61.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.884 2.874 . . . . 0.0 108.209 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.429 ' HG2' HG22 ' A' ' 36' ' ' VAL . 2.0 pp0? -53.69 157.41 2.27 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.434 1.894 . . . . 0.0 112.738 175.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.601 ' H ' HD11 ' A' ' 86' ' ' ILE . . . -18.91 96.51 0.01 OUTLIER Glycine 0 CA--C 1.536 1.397 0 C-N-CA 127.001 2.238 . . . . 0.0 116.665 -178.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.617 ' HD2' ' O ' ' A' ' 7' ' ' LYS . 33.6 Cg_exo -61.3 86.85 0.09 OUTLIER 'Trans proline' 0 CA--C 1.535 0.556 0 C-N-CA 122.552 2.168 . . . . 0.0 112.559 164.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.41 101.3 7.54 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 111.015 -2.811 . . . . 0.0 109.419 171.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . 0.445 0.4 OUTLIER 55.53 -88.87 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 112.209 -2.269 . . . . 0.0 116.766 179.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.4 ttpt -49.25 -50.82 37.01 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 125.719 1.608 . . . . 0.0 112.404 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.635 HG13 HG22 ' A' ' 35' ' ' VAL . 59.0 t -56.05 -36.57 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 125.844 1.658 . . . . 0.0 111.821 -177.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -56.61 -35.35 68.19 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.0 p -61.56 -32.81 72.91 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 178.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 2.2 mpt? -67.23 -28.79 68.35 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.344 1.058 . . . . 0.0 112.94 176.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -61.73 -37.92 86.02 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 173.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.3 m -54.88 -49.21 71.75 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.864 0.866 . . . . 0.0 111.176 173.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.428 ' HZ2' ' HA ' ' A' ' 26' ' ' ALA . 3.3 t90 -53.15 -59.22 4.83 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.531 1.533 . . . . 0.0 112.79 171.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.413 HD13 HG21 ' A' ' 51' ' ' VAL . 14.6 mt -59.99 -17.41 38.2 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 117.038 2.236 . . . . 0.0 117.038 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.563 ' HB3' ' HE2' ' A' ' 80' ' ' PHE . 96.8 p -92.92 -53.83 3.99 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 172.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -71.98 -42.96 65.89 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -170.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.7 m -121.37 113.86 41.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 117.184 2.29 . . . . 0.0 117.184 -165.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -99.74 80.91 0.52 Allowed Glycine 0 CA--C 1.532 1.104 0 CA-C-N 113.323 -1.762 . . . . 0.0 110.777 166.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.581 ' HB2' ' HD3' ' A' ' 71' ' ' PRO . 2.2 m -63.87 -45.09 80.95 Favored Pre-proline 0 N--CA 1.473 0.701 0 CA-C-O 117.769 -1.11 . . . . 0.0 113.404 -174.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.581 ' HD3' ' HB2' ' A' ' 70' ' ' SER . 22.8 Cg_exo -91.77 102.53 0.22 Allowed 'Trans proline' 0 CA--C 1.53 0.313 0 N-CA-C 106.554 -2.133 . . . . 0.0 106.554 155.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 66.8 m 67.85 124.04 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.5 p -83.14 53.31 2.42 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 113.185 -1.825 . . . . 0.0 114.416 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.638 ' NH2' ' H ' ' A' ' 15' ' ' GLY . 1.7 tpm_? -87.47 -10.99 50.3 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 113.027 -1.897 . . . . 0.0 110.205 165.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.7 mp -106.46 96.09 4.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -134.74 -48.79 0.75 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 112.58 -2.1 . . . . 0.0 111.838 177.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.567 ' NH1' HD21 ' A' ' 79' ' ' ASN . 52.6 ttt-85 -123.27 88.48 2.93 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.389 1.476 . . . . 0.0 108.261 179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 62.9 m -104.63 124.8 49.97 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 123.708 1.718 . . . . 0.0 112.117 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.567 HD21 ' NH1' ' A' ' 77' ' ' ARG . 1.4 m-80 -87.81 86.9 7.22 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 110.841 -2.89 . . . . 0.0 112.545 -171.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.563 ' HE2' ' HB3' ' A' ' 66' ' ' SER . 75.0 m-85 -74.44 88.66 2.11 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.141 -1.845 . . . . 0.0 110.731 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 25.4 t -120.61 -165.7 1.24 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 113.501 -1.681 . . . . 0.0 110.144 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.481 HD21 ' HE2' ' A' ' 84' ' ' LYS . 7.3 t30 47.67 74.06 0.18 Allowed 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 127.112 2.165 . . . . 0.0 110.75 -178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.608 ' HG2' HG12 ' A' ' 9' ' ' VAL . 17.7 mt-10 -101.31 102.71 13.61 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.134 -1.848 . . . . 0.0 110.783 -171.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.481 ' HE2' HD21 ' A' ' 82' ' ' ASN . 0.1 OUTLIER -117.53 113.04 21.42 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 112.147 -2.297 . . . . 0.0 112.718 -177.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.668 HG21 ' HB2' ' A' ' 4' ' ' ARG . 12.5 p -65.53 102.05 0.67 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 122.755 1.264 . . . . 0.0 113.872 174.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.601 HD11 ' H ' ' A' ' 53' ' ' GLY . 11.3 pt -85.11 77.48 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 112.206 -2.27 . . . . 0.0 113.326 -174.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 11.2 m -50.09 -34.98 23.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 112.692 -2.049 . . . . 0.0 112.92 174.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -113.84 108.08 16.58 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 166.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 70.3 tp -67.38 76.94 0.16 Allowed 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 124.283 1.992 . . . . 0.0 109.513 170.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -96.34 59.29 1.86 Allowed 'General case' 0 N--CA 1.472 0.657 0 CA-C-N 112.468 -2.151 . . . . 0.0 114.609 -171.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 179.5 131.27 0.09 Allowed 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 128.574 2.75 . . . . 0.0 109.143 174.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.2 p -132.69 65.14 1.59 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 123.182 1.468 . . . . 0.0 109.469 177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -174.85 134.7 0.36 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 111.43 -2.623 . . . . 0.0 109.129 -168.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.587 ' HD2' ' HA ' ' A' ' 27' ' ' GLU . 30.1 t80 -111.31 94.33 4.92 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 106.134 -1.802 . . . . 0.0 106.134 168.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.463 ' HA ' HH21 ' A' ' 31' ' ' ARG . 5.9 t -98.03 165.37 11.94 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 118.215 2.672 . . . . 0.0 118.215 -153.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.522 ' HA ' ' OE2' ' A' ' 27' ' ' GLU . 7.7 p -53.11 141.06 7.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 127.874 2.47 . . . . 0.0 115.276 -170.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.459 ' HG2' ' OD1' ' A' ' 41' ' ' ASN . 35.4 ttp180 -59.63 104.5 0.28 Allowed 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 113.813 -1.54 . . . . 0.0 112.885 179.008 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 . . . . . 0 N--CA 1.477 0.881 0 CA-C-N 113.148 -1.842 . . . . 0.0 112.948 -179.557 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.9 t . . . . . 0 N--CA 1.47 0.54 0 N-CA-C 115.598 1.703 . . . . 0.0 115.598 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -75.42 46.57 0.35 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 112.205 -2.27 . . . . 0.0 115.674 174.165 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 54.91 -51.92 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.949 0 N-CA-C 121.091 3.737 . . . . 0.0 121.091 170.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.514 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 86.1 mtm180 -45.16 127.87 5.69 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 127.74 2.416 . . . . 0.0 115.965 -166.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.514 ' HD3' ' HA ' ' A' ' 4' ' ' ARG . 64.1 Cg_exo -52.03 -31.35 43.86 Favored 'Trans proline' 0 CA--C 1.536 0.582 0 C-N-CA 125.294 3.996 . . . . 0.0 119.342 -161.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -102.95 117.01 33.65 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-O 122.944 1.354 . . . . 0.0 111.273 -175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.474 ' HZ3' ' HD2' ' A' ' 62' ' ' LYS . 82.2 tttt -85.28 121.5 28.1 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.555 -175.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 10.5 t -107.87 93.32 4.47 Favored 'General case' 0 N--CA 1.478 0.95 0 CA-C-O 123.589 1.662 . . . . 0.0 108.565 170.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.252 8.0 p -98.3 107.38 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 CA-C-N 112.728 -2.033 . . . . 0.0 112.137 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.571 ' HB2' ' HB2' ' A' ' 82' ' ' ASN . 11.3 m-20 -85.73 94.18 9.04 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 112.468 -2.151 . . . . 0.0 110.143 172.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -70.79 166.61 20.6 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 112.185 -2.28 . . . . 0.0 113.044 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -136.35 113.03 10.15 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 125.752 1.621 . . . . 0.0 110.764 167.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.2 t -73.8 124.67 31.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 124.35 1.06 . . . . 0.0 113.81 -175.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -112.58 91.81 3.79 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 123.085 1.421 . . . . 0.0 108.394 164.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 19' ' ' GLY . . . -134.81 87.11 0.25 Allowed Glycine 0 CA--C 1.54 1.597 0 CA-C-N 112.665 -2.061 . . . . 0.0 112.539 -179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 45.1 mtp180 -53.17 -55.72 22.02 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.835 1.254 . . . . 0.0 113.713 -177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 13.6 p -108.75 129.2 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 O-C-N 123.751 0.657 . . . . 0.0 109.824 174.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 18.6 tp60 71.84 -30.86 0.21 Allowed 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.022 2.129 . . . . 0.0 116.081 176.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.429 ' HA3' ' HA3' ' A' ' 15' ' ' GLY . . . -22.33 -64.16 0.03 OUTLIER Glycine 0 CA--C 1.53 1.02 0 C-N-CA 129.054 3.216 . . . . 0.0 117.408 -178.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.4 ' C ' HH22 ' A' ' 97' ' ' ARG . 10.0 m -70.39 63.54 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 53.8 t -149.04 -85.56 0.09 Allowed 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 126.396 1.878 . . . . 0.0 110.104 175.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.5 ' HA ' ' HB3' ' A' ' 73' ' ' SER 0.364 34.2 p90 58.14 -46.91 0.05 Allowed 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 119.528 3.158 . . . . 0.0 119.528 179.148 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -12.05 -81.11 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 128.939 2.895 . . . . 0.0 117.298 -177.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 2.1 mpt? -44.04 -55.51 4.65 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 125.057 1.343 . . . . 0.0 114.004 -174.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -57.61 -58.51 7.99 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.132 -1.849 . . . . 0.0 111.828 -178.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.615 ' HA ' ' HH2' ' A' ' 64' ' ' TRP . . . -59.76 -53.03 62.75 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.477 1.111 . . . . 0.0 113.602 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.592 ' HG3' ' O ' ' A' ' 94' ' ' PHE . 0.4 OUTLIER -52.3 -54.78 27.08 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.864 2.466 . . . . 0.0 113.725 -178.133 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 68.6 m-20 -56.72 -52.66 64.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.328 1.051 . . . . 0.0 111.851 -177.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 33' ' ' ILE . 1.4 mp0 -66.17 -47.57 73.55 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-N 114.81 -1.086 . . . . 0.0 112.737 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -55.04 -47.68 74.47 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -55.9 -50.76 69.78 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.776 0.83 . . . . 0.0 112.522 175.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -58.12 -37.04 73.82 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.08 1.352 . . . . 0.0 114.274 178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 29' ' ' GLU . 24.7 mm -76.13 -36.34 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 123.981 0.912 . . . . 0.0 111.979 177.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.27 67.85 1.21 Allowed Glycine 0 N--CA 1.471 0.972 0 C-N-CA 124.876 1.227 . . . . 0.0 110.56 -173.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.683 HG23 ' HA3' ' A' ' 53' ' ' GLY . 12.3 p -158.34 154.64 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 125.757 1.623 . . . . 0.0 111.62 -173.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.696 HG13 ' HB2' ' A' ' 94' ' ' PHE 0.473 3.7 p 65.15 152.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 128.929 2.892 . . . . 0.0 115.416 170.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -115.97 -89.29 1.53 Allowed Glycine 0 N--CA 1.477 1.422 0 CA-C-N 112.802 -1.999 . . . . 0.0 113.191 -176.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 22.1 p-90 -135.17 159.69 40.73 Favored 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 -169.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' HB ' ' HG2' ' A' ' 97' ' ' ARG . 1.9 t -109.66 136.23 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-N 113.004 -1.907 . . . . 0.0 108.074 173.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.794 ' HG3' HG23 ' A' ' 48' ' ' THR . 10.7 pttp -118.19 133.01 56.28 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 126.46 1.904 . . . . 0.0 112.224 176.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.6 m-20 -75.18 146.47 41.22 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 112.027 -2.351 . . . . 0.0 112.766 -172.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 29.0 p -123.15 161.47 24.39 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.328 168.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.5 p -64.57 -22.02 66.86 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 113.286 -1.779 . . . . 0.0 113.932 169.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -101.8 11.46 38.68 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -168.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.66 -35.94 1.2 Allowed Glycine 0 CA--C 1.53 1.01 0 C-N-CA 124.096 0.855 . . . . 0.0 114.082 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 16.0 p -61.16 79.97 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.291 2.236 . . . . 0.0 111.728 172.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.0 p -72.51 141.0 17.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 CA-C-N 111.854 -2.43 . . . . 0.0 111.254 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.794 HG23 ' HG3' ' A' ' 40' ' ' LYS . 7.5 t -113.31 131.64 55.87 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 113.436 -1.711 . . . . 0.0 111.832 -173.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.461 ' O ' ' HA ' ' A' ' 10' ' ' ASP . . . -133.85 143.03 14.6 Favored Glycine 0 N--CA 1.474 1.178 0 CA-C-N 115.284 -0.871 . . . . 0.0 113.296 -175.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -98.21 86.94 3.78 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 112.914 -1.643 . . . . 0.0 112.468 -173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 23.9 t -86.74 82.75 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 111.86 -2.427 . . . . 0.0 110.534 179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.561 ' HB3' ' HB2' ' A' ' 91' ' ' TYR . 40.3 tt0 -88.03 115.87 25.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 112.962 -1.927 . . . . 0.0 109.875 173.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.683 ' HA3' HG23 ' A' ' 35' ' ' VAL . . . 157.89 -82.35 0.15 Allowed Glycine 0 N--CA 1.468 0.827 0 CA-C-N 112.338 -2.21 . . . . 0.0 110.698 -176.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.49 ' HA ' HG13 ' A' ' 58' ' ' VAL . 8.8 Cg_exo -15.18 82.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.327 -0.58 1 C-N-CA 125.343 4.029 . . . . 0.0 118.35 -158.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.706 ' H ' HG13 ' A' ' 58' ' ' VAL . 66.9 tt0 -129.24 107.63 9.7 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 113.466 -1.697 . . . . 0.0 110.467 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.8 mt-10 57.91 -88.29 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 127.487 2.315 . . . . 0.0 114.569 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -57.1 -43.5 82.32 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 123.299 0.639 . . . . 0.0 111.935 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.706 HG13 ' H ' ' A' ' 55' ' ' GLU 0.33 14.8 p -84.83 2.17 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 115.011 1.486 . . . . 0.0 115.011 -179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -60.49 -35.45 75.94 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.487 -0.758 . . . . 0.0 111.517 164.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 19.7 m -51.23 -38.57 53.26 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.127 1.371 . . . . 0.0 114.023 173.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -53.23 60.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 123.052 0.541 . . . . 0.0 111.28 176.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.474 ' HD2' ' HZ3' ' A' ' 7' ' ' LYS . 30.8 ttpt -54.5 -51.62 64.51 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.728 1.211 . . . . 0.0 112.858 173.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.4 t -57.57 -31.12 65.83 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 126.051 1.74 . . . . 0.0 115.293 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.615 ' HH2' ' HA ' ' A' ' 26' ' ' ALA . 5.3 t90 -76.9 -50.8 12.49 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 126.205 1.802 . . . . 0.0 114.467 170.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.595 ' HB3' ' HZ ' ' A' ' 80' ' ' PHE . 14.1 tp -51.4 -26.86 8.62 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 127.163 2.185 . . . . 0.0 115.482 -174.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.447 ' HA ' ' HB ' ' A' ' 78' ' ' THR . 13.7 p -53.82 -60.3 3.5 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.158 2.183 . . . . 0.0 113.967 170.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -127.17 70.82 1.31 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.768 2.427 . . . . 0.0 109.5 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.43 HG13 ' HA ' ' A' ' 65' ' ' LEU . 1.0 OUTLIER -54.95 -29.04 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 116.766 2.136 . . . . 0.0 116.766 -177.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 102.83 -84.5 0.48 Allowed Glycine 0 CA--C 1.531 1.065 0 CA-C-N 114.723 -1.126 . . . . 0.0 111.691 171.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.9 t -128.28 -74.68 0.01 OUTLIER Pre-proline 0 N--CA 1.469 0.484 0 N-CA-C 116.757 2.132 . . . . 0.0 116.757 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -44.12 102.39 0.04 OUTLIER 'Trans proline' 0 CA--C 1.534 0.52 0 C-N-CA 124.213 3.275 . . . . 0.0 114.173 -154.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 89.8 p 42.25 45.91 3.73 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 111.655 -2.521 . . . . 0.0 115.303 178.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.5 ' HB3' ' HA ' ' A' ' 22' ' ' PHE . 66.1 p -155.38 -66.35 0.12 Allowed 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 -176.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 53.4 mtt85 68.4 -61.52 0.4 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.894 2.078 . . . . 0.0 114.158 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.475 HG21 ' OG1' ' A' ' 78' ' ' THR . 14.6 mt 32.05 110.57 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 128.963 2.905 . . . . 0.0 113.74 -178.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -67.71 -32.28 72.81 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 30.8 ttm180 -163.49 110.71 1.17 Allowed 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.065 0.946 . . . . 0.0 111.686 171.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.475 ' OG1' HG21 ' A' ' 75' ' ' ILE . 63.7 m -88.75 101.11 13.68 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 123.448 1.594 . . . . 0.0 109.471 166.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 29.6 t30 -68.24 98.92 0.85 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 111.602 -2.545 . . . . 0.0 111.155 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.595 ' HZ ' ' HB3' ' A' ' 65' ' ' LEU . 58.4 m-85 -79.31 78.72 5.79 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 124.041 1.877 . . . . 0.0 112.42 175.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.5 p -92.67 -69.17 0.76 Allowed 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 110.977 -2.829 . . . . 0.0 115.302 -169.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.617 ' HB3' ' HE3' ' A' ' 84' ' ' LYS . 15.3 m120 -80.75 75.75 7.66 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 123.686 1.707 . . . . 0.0 110.955 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 58.3 mt-10 -87.44 83.41 7.3 Favored 'General case' 0 C--O 1.239 0.53 0 CA-C-N 111.885 -2.416 . . . . 0.0 111.235 -176.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.617 ' HE3' ' HB3' ' A' ' 82' ' ' ASN . 87.9 mttt -96.92 91.85 5.83 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 113.143 -1.844 . . . . 0.0 109.218 -174.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 4.1 p -74.6 115.21 13.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.255 175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.499 ' CD1' HE21 ' A' ' 52' ' ' GLN . 2.6 pp -122.01 149.49 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 110.618 -2.992 . . . . 0.0 111.658 -174.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 6.0 p -82.32 101.72 10.75 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 113.703 -1.589 . . . . 0.0 112.083 173.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 88' ' ' LYS 0.292 33.8 mmtp 98.55 149.05 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 127.538 2.335 . . . . 0.0 116.343 168.871 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 66.6 tp -103.22 130.29 50.41 Favored 'General case' 0 N--CA 1.469 0.475 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.304 -173.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 12.8 mp0 -119.99 -44.32 2.51 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 114.192 -1.367 . . . . 0.0 112.587 175.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . 0.561 ' HB2' ' HB3' ' A' ' 52' ' ' GLN . 20.5 m-85 -73.95 95.16 2.44 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.885 1.274 . . . . 0.0 113.987 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.9 p -86.21 -22.2 27.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 111.546 -2.57 . . . . 0.0 115.811 176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -137.5 108.47 6.72 Favored 'General case' 0 N--CA 1.463 0.183 0 O-C-N 123.898 0.749 . . . . 0.0 112.539 -162.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.696 ' HB2' HG13 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -66.65 125.79 26.91 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 114.46 -1.245 . . . . 0.0 110.815 171.028 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 34.4 t -149.97 111.28 4.42 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 115.361 1.615 . . . . 0.0 115.361 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.426 ' HB ' ' H ' ' A' ' 97' ' ' ARG 0.31 25.6 m 48.39 -178.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 N-CA-C 120.195 3.405 . . . . 0.0 120.195 161.649 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.475 ' HG2' ' HB ' ' A' ' 39' ' ' VAL . 46.6 mtt180 -105.97 139.38 40.61 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.841 -1.527 . . . . 0.0 113.662 -176.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 . . . . . 0 C--O 1.246 0.88 0 CA-C-N 112.4 -2.182 . . . . 0.0 113.446 -179.776 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 66.9 p . . . . . 0 N--CA 1.469 0.523 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.7 p -67.37 -31.34 71.51 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 112.592 -2.094 . . . . 0.0 116.024 -179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -72.91 69.29 0.95 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 123.255 1.502 . . . . 0.0 110.912 170.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.423 ' HG3' HD13 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -145.83 125.18 6.76 Favored Pre-proline 0 N--CA 1.471 0.594 0 CA-C-N 113.265 -1.788 . . . . 0.0 112.207 -176.055 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.71 33.62 0.43 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 123.145 2.563 . . . . 0.0 114.556 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.55 ' HB3' HE22 ' A' ' 52' ' ' GLN . 9.9 mp -114.18 97.25 6.24 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.747 ' HG2' HG22 ' A' ' 85' ' ' THR . 63.0 mttm -98.88 113.64 25.87 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 112.73 -2.032 . . . . 0.0 110.976 -161.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.6 t -103.33 101.88 11.81 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 113.433 -1.712 . . . . 0.0 110.248 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.1 p -116.1 142.14 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 112.821 -1.99 . . . . 0.0 112.077 -176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -100.24 121.79 42.02 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 123.33 1.538 . . . . 0.0 110.353 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.454 ' HD1' HG23 ' A' ' 13' ' ' VAL . 30.8 p90 -103.02 148.76 25.29 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 111.933 -2.394 . . . . 0.0 111.863 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 22.9 mp0 -124.15 85.94 2.49 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 111.821 -2.445 . . . . 0.0 109.51 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 47' ' ' VAL . 48.7 t -80.66 110.38 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-O 123.104 1.43 . . . . 0.0 110.521 -179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.586 ' HB3' ' HE ' ' A' ' 16' ' ' ARG . 13.6 m-85 -93.84 77.77 4.2 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 111.126 -2.761 . . . . 0.0 106.855 177.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.66 54.31 0.55 Allowed Glycine 0 N--CA 1.479 1.503 0 CA-C-N 112.015 -2.357 . . . . 0.0 109.991 173.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.586 ' HE ' ' HB3' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -61.4 -36.06 79.25 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -174.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.1 m -80.22 52.83 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 175.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 52.68 -110.89 0.55 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 127.012 2.125 . . . . 0.0 112.484 -178.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.75 -56.39 0.35 Allowed Glycine 0 CA--C 1.528 0.89 0 N-CA-C 119.087 2.395 . . . . 0.0 119.087 172.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 m -77.14 100.24 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -171.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 42.3 t -101.43 64.98 1.02 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 124.582 2.135 . . . . 0.0 107.634 162.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -53.96 -31.43 50.59 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 111.702 -2.499 . . . . 0.0 113.709 -172.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 13.5 mmm180 -32.7 -59.72 0.32 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.909 2.083 . . . . 0.0 115.538 170.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 16.1 tpt -54.9 -38.24 67.33 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 -177.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . 0.726 ' HB3' ' HZ2' ' A' ' 64' ' ' TRP . 2.5 m-30 -73.36 -53.48 10.67 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 125.915 1.686 . . . . 0.0 111.284 -178.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.483 ' HB1' ' O ' ' A' ' 94' ' ' PHE . . . -54.25 -37.35 64.58 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 125.283 1.433 . . . . 0.0 113.143 176.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -73.28 -83.42 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.192 -0.913 . . . . 0.0 112.594 170.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -63.97 -59.62 4.27 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.005 1.322 . . . . 0.0 114.209 -170.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.527 ' O ' HG12 ' A' ' 33' ' ' ILE . 43.5 mt-10 -65.24 -43.88 90.0 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -172.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 26' ' ' ALA . . . -63.12 -43.38 98.58 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 113.331 0.863 . . . . 0.0 113.331 178.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.5 ttp-105 -52.35 -55.72 19.65 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.732 0.813 . . . . 0.0 110.866 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 70.9 tttt -57.63 -40.78 79.98 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 126.017 1.727 . . . . 0.0 114.794 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.527 HG12 ' O ' ' A' ' 29' ' ' GLU . 31.8 mm -71.11 -29.76 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.105 0.962 . . . . 0.0 113.418 176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.1 38.67 4.77 Favored Glycine 0 N--CA 1.473 1.115 0 C-N-CA 124.568 1.08 . . . . 0.0 112.702 -171.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 19.3 t -110.62 141.45 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-O 123.77 1.748 . . . . 0.0 111.736 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 89' ' ' LEU . 3.8 t -126.47 156.18 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-N 111.002 -2.817 . . . . 0.0 111.125 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.89 -149.61 20.73 Favored Glycine 0 N--CA 1.471 0.979 0 CA-C-N 115.297 -0.865 . . . . 0.0 113.074 172.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.604 ' HZ3' ' HB2' ' A' ' 40' ' ' LYS . 55.7 p-90 -153.46 146.36 24.44 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.328 1.451 . . . . 0.0 111.084 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.442 ' O ' ' HD1' ' A' ' 98' ' ' TYR . 2.6 t -117.99 144.52 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.979 0.912 . . . . 0.0 109.583 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.604 ' HB2' ' HZ3' ' A' ' 38' ' ' TRP . 60.4 tttt -132.52 137.49 47.18 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.493 0.717 . . . . 0.0 112.298 175.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . 0.475 ' OD1' ' HG2' ' A' ' 97' ' ' ARG . 1.9 p-10 -94.97 93.35 7.35 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 122.676 1.227 . . . . 0.0 110.281 168.095 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.55 HG22 ' O ' ' A' ' 46' ' ' THR . 5.7 t -80.53 163.43 23.73 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -168.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.2 p -54.02 -35.03 61.49 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 113.126 -1.852 . . . . 0.0 113.911 176.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.3 mmtm -66.3 -1.76 3.72 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 116.094 1.887 . . . . 0.0 116.094 174.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.46 -41.08 2.62 Favored Glycine 0 N--CA 1.479 1.514 0 C-N-CA 124.952 1.263 . . . . 0.0 111.612 -177.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.55 ' O ' HG22 ' A' ' 42' ' ' THR . 0.2 OUTLIER -52.93 140.66 24.06 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.981 2.112 . . . . 0.0 113.804 -178.229 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.522 ' HB ' ' HB ' ' A' ' 13' ' ' VAL . 96.0 t -92.01 103.36 14.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 123.986 1.851 . . . . 0.0 107.278 169.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 11.7 t -109.77 -164.26 0.92 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 111.738 -2.483 . . . . 0.0 110.156 -176.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 121.26 -173.79 15.69 Favored Glycine 0 N--CA 1.469 0.872 0 C-N-CA 126.378 1.942 . . . . 0.0 110.89 -177.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -125.74 134.34 51.79 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 112.257 -1.972 . . . . 0.0 111.91 -177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.454 HG21 ' HG3' ' A' ' 61' ' ' MET . 7.5 p -117.41 117.02 53.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 CA-C-N 111.278 -2.692 . . . . 0.0 109.942 177.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.55 HE22 ' HB3' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -102.15 130.11 48.7 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 112.619 -2.082 . . . . 0.0 107.6 171.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -161.5 149.05 17.41 Favored Glycine 0 CA--C 1.527 0.82 0 CA-C-N 113.592 -1.64 . . . . 0.0 110.626 176.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -65.99 145.84 80.82 Favored 'Trans proline' 0 CA--C 1.532 0.416 0 C-N-CA 121.554 1.503 . . . . 0.0 109.822 166.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -17.83 -61.87 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 116.945 2.202 . . . . 0.0 116.945 178.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.547 ' HG2' ' HD2' ' A' ' 57' ' ' LYS . 0.9 OUTLIER -61.09 -39.97 91.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -179.526 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HD2' ' HG2' ' A' ' 56' ' ' GLU . 2.7 mptp? -65.92 -39.31 90.44 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.238 1.015 . . . . 0.0 111.718 174.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.667 HG21 ' HB2' ' A' ' 7' ' ' LYS . 49.2 t -61.69 -42.63 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 C-N-CA 124.244 1.018 . . . . 0.0 112.286 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.594 ' HA ' ' HE2' ' A' ' 62' ' ' LYS . 25.2 m120 -55.33 -46.54 76.33 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 116.01 1.856 . . . . 0.0 116.01 -179.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 21.7 p -69.02 -47.22 65.98 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.578 173.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.655 ' HA ' ' HE3' ' A' ' 64' ' ' TRP . 13.8 tmm? -49.98 -52.58 32.66 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.695 1.598 . . . . 0.0 114.19 176.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.594 ' HE2' ' HA ' ' A' ' 59' ' ' ASN . 65.5 pttt -59.17 -38.15 79.08 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.165 1.172 . . . . 0.0 114.165 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 66.9 m -63.98 -57.69 8.96 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.055 170.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.726 ' HZ2' ' HB3' ' A' ' 25' ' ' TYR . 13.9 t90 -46.61 -46.06 19.43 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 127.781 2.432 . . . . 0.0 115.262 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.447 ' HB2' ' HZ ' ' A' ' 80' ' ' PHE . 64.6 mt -90.1 13.1 15.84 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 116.918 2.192 . . . . 0.0 116.918 -175.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . 0.265 53.4 p -101.64 -109.23 0.23 Allowed 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 114.56 1.318 . . . . 0.0 114.56 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -110.22 75.61 0.94 Allowed 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 127.222 2.209 . . . . 0.0 107.911 -177.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.7 t -128.09 -52.1 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-N 112.426 -2.17 . . . . 0.0 114.698 -166.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.715 ' HA2' ' HA ' ' A' ' 74' ' ' ARG . . . 77.13 -56.8 3.62 Favored Glycine 0 CA--C 1.527 0.836 0 N-CA-C 115.792 1.077 . . . . 0.0 115.792 -173.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.6 m -41.58 145.49 0.66 Allowed Pre-proline 0 CA--C 1.536 0.409 0 C-N-CA 127.415 2.286 . . . . 0.0 115.932 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -78.92 -27.36 8.46 Favored 'Cis proline' 0 CA--C 1.535 0.569 0 N-CA-C 117.774 2.182 . . . . 0.0 117.774 -10.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 71.5 p -131.19 -43.83 1.04 Allowed 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 117.307 2.336 . . . . 0.0 117.307 -171.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.0 m -97.27 121.98 39.78 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 126.713 2.005 . . . . 0.0 112.818 -178.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.715 ' HA ' ' HA2' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -69.84 86.37 0.51 Allowed 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 116.007 1.854 . . . . 0.0 116.007 -172.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.652 HD11 ' HE2' ' A' ' 25' ' ' TYR . 0.5 OUTLIER -75.43 91.82 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.507 0 CA-C-N 114.055 -1.429 . . . . 0.0 107.765 167.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -67.55 -55.25 14.17 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 110.708 -2.951 . . . . 0.0 115.838 -173.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.44 ' HD2' ' H ' ' A' ' 78' ' ' THR . 0.0 OUTLIER -163.54 145.6 9.61 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.745 0.818 . . . . 0.0 110.007 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.44 ' H ' ' HD2' ' A' ' 77' ' ' ARG . 90.3 m -152.22 138.15 18.1 Favored 'General case' 0 N--CA 1.477 0.876 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -176.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -98.18 140.23 32.79 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-N 111.214 -2.721 . . . . 0.0 109.184 167.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.447 ' HZ ' ' HB2' ' A' ' 65' ' ' LEU . 87.7 m-85 -114.37 109.82 18.93 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 114.264 -1.335 . . . . 0.0 109.68 176.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.49 167.67 13.58 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 113.219 -1.809 . . . . 0.0 111.986 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 40.8 m-80 53.82 84.89 0.06 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.909 1.284 . . . . 0.0 113.264 172.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -106.2 111.76 24.51 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 123.057 1.408 . . . . 0.0 113.728 177.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -100.03 91.14 4.65 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 111.63 -2.532 . . . . 0.0 107.069 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.747 HG22 ' HG2' ' A' ' 7' ' ' LYS . 12.1 p -74.28 84.31 1.9 Allowed 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 123.107 1.432 . . . . 0.0 109.034 172.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 9.1 pt -112.34 154.35 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 112.98 -1.918 . . . . 0.0 114.333 -165.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . . . . . . . . . 16.1 t -59.15 132.41 53.92 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 113.229 -1.805 . . . . 0.0 111.864 167.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp 61.56 149.9 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.468 ' HB3' HG11 ' A' ' 36' ' ' VAL . 90.8 mt -85.51 97.58 10.13 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 113.782 -1.554 . . . . 0.0 111.07 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -84.16 82.03 8.54 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.492 -173.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 154.19 150.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 129.97 3.308 . . . . 0.0 111.965 167.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.3 p -82.07 88.42 6.43 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-O 122.504 1.145 . . . . 0.0 110.293 169.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.2 m120 61.42 172.14 0.11 Allowed 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 111.211 -2.722 . . . . 0.0 113.209 -171.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' O ' ' HB1' ' A' ' 26' ' ' ALA . 8.3 t80 -73.56 69.59 1.25 Allowed 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 123.245 1.497 . . . . 0.0 110.807 177.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.5 110.42 15.95 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 112.585 -2.098 . . . . 0.0 116.078 -166.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . 0.258 27.2 m 54.95 163.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 110.768 -2.924 . . . . 0.0 117.035 165.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.475 ' HG2' ' OD1' ' A' ' 41' ' ' ASN . 52.6 ttp180 -111.66 113.15 25.35 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-N 112.966 -1.925 . . . . 0.0 111.215 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.442 ' HD1' ' O ' ' A' ' 39' ' ' VAL . 83.5 m-85 . . . . . 0 C--O 1.246 0.873 0 CA-C-N 111.519 -2.582 . . . . 0.0 111.717 -177.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.413 ' OG ' ' HA ' ' A' ' 84' ' ' LYS . 2.5 t . . . . . 0 N--CA 1.471 0.613 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 10.2 p -133.74 -82.13 0.46 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.924 1.289 . . . . 0.0 112.344 -178.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -122.63 -139.54 0.31 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.097 1.359 . . . . 0.0 111.034 -179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . 0.572 ' HB2' ' HA ' ' A' ' 87' ' ' SER . 4.9 mpt_? -48.81 132.01 14.5 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 125.7 1.6 . . . . 0.0 115.113 -171.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 4' ' ' ARG . 50.6 Cg_exo -68.14 72.8 0.8 Allowed 'Trans proline' 0 C--N 1.328 -0.522 0 C-N-CA 123.134 2.556 . . . . 0.0 115.434 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mp -129.08 127.22 41.06 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 164.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.606 ' HB2' HG21 ' A' ' 58' ' ' VAL . 33.3 mmtp -97.16 115.6 27.84 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.199 1.0 . . . . 0.0 111.598 -163.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 9.9 t -107.24 122.98 47.62 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 113.127 -1.851 . . . . 0.0 110.36 166.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.9 t -112.98 108.03 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-N 111.314 -2.675 . . . . 0.0 108.262 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.558 ' HB3' ' HB3' ' A' ' 82' ' ' ASN . 6.0 t0 -88.24 97.36 10.98 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 113.106 -1.861 . . . . 0.0 107.715 173.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.461 ' HD2' HG23 ' A' ' 13' ' ' VAL . 33.7 p90 -94.79 150.68 19.95 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 109.122 -3.672 . . . . 0.0 112.56 -171.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.566 ' HB2' ' HB2' ' A' ' 79' ' ' ASN . 6.0 mp0 -127.8 97.52 4.86 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 114.06 -1.427 . . . . 0.0 108.008 166.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.461 HG23 ' HD2' ' A' ' 11' ' ' TYR . 94.6 t -68.78 126.58 29.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.005 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -127.94 137.0 52.1 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 123.545 0.528 . . . . 0.0 111.515 173.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.629 ' HA2' ' HA ' ' A' ' 75' ' ' ILE . . . -105.52 121.08 6.68 Favored Glycine 0 N--CA 1.476 1.352 0 O-C-N 124.819 1.324 . . . . 0.0 112.313 -175.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -38.68 -43.56 0.91 Allowed 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 172.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 9.8 p -121.84 146.98 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.581 163.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -52.83 168.65 0.11 Allowed 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 117.01 2.226 . . . . 0.0 117.01 179.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 115.6 -78.5 0.28 Allowed Glycine 0 N--CA 1.477 1.377 0 CA-C-N 113.606 -1.634 . . . . 0.0 109.655 -175.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' HB2' ' A' ' 22' ' ' PHE . 12.5 t 66.98 -72.44 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 128.277 2.631 . . . . 0.0 111.234 175.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.7 m 42.05 38.83 1.16 Allowed 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 126.391 1.876 . . . . 0.0 115.316 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.561 ' HB3' HG22 ' A' ' 47' ' ' VAL . 17.3 t80 -63.02 -27.9 69.73 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 112.722 -2.036 . . . . 0.0 113.754 -168.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.517 ' NE ' ' HB3' ' A' ' 97' ' ' ARG . 8.6 mmm180 -21.03 -73.82 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 117.941 2.571 . . . . 0.0 117.941 174.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' MET . . . . . . . . . . . . . 67.7 mtm -60.67 -40.59 92.69 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.076 1.139 . . . . 0.0 114.076 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -62.91 -46.89 85.66 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.1 -0.954 . . . . 0.0 111.894 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.495 ' HA ' ' HZ2' ' A' ' 64' ' ' TRP . . . -50.7 -56.86 10.0 Favored 'General case' 0 N--CA 1.475 0.82 0 O-C-N 125.001 1.438 . . . . 0.0 111.925 173.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.425 ' OE1' HG22 ' A' ' 96' ' ' VAL . 33.0 tt0 -51.43 -60.0 3.62 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-N 113.395 -1.73 . . . . 0.0 112.669 177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -60.23 -53.14 61.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.195 1.398 . . . . 0.0 113.468 -177.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.475 ' O ' HG12 ' A' ' 33' ' ' ILE . 1.9 tp10 -65.51 -38.61 90.2 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.549 0.74 . . . . 0.0 112.203 -178.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.48 ' HB1' ' HB ' ' A' ' 35' ' ' VAL . . . -55.9 -47.53 77.27 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.017 0.927 . . . . 0.0 112.985 175.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -52.23 -49.89 63.08 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.796 1.238 . . . . 0.0 111.196 173.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -60.97 -51.67 68.26 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 125.272 1.429 . . . . 0.0 114.444 178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 29' ' ' GLU . 29.7 mm -67.8 -25.69 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.4 1.08 . . . . 0.0 112.705 -176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 94.28 53.85 1.67 Allowed Glycine 0 CA--C 1.536 1.351 0 C-N-CA 124.33 0.966 . . . . 0.0 111.788 -174.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.546 HG22 ' CE ' ' A' ' 61' ' ' MET . 2.6 t -116.6 140.13 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-O 123.41 1.576 . . . . 0.0 109.58 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.518 HG23 ' HB2' ' A' ' 52' ' ' GLN . 33.5 m -119.98 166.74 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.375 0 CA-C-N 111.982 -2.372 . . . . 0.0 111.048 173.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 138.1 -135.3 7.41 Favored Glycine 0 N--CA 1.473 1.162 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.5 175.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.434 ' CZ3' ' HB2' ' A' ' 40' ' ' LYS . 39.8 p-90 -162.1 151.07 15.45 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 113.456 -1.372 . . . . 0.0 111.367 -177.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 95' ' ' SER . 10.7 p -114.91 136.4 51.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.681 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.703 ' HB3' HG23 ' A' ' 48' ' ' THR . 83.8 tttt -117.01 123.3 46.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 123.202 1.477 . . . . 0.0 112.508 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 54.5 m-20 -64.93 114.73 4.74 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 111.399 -2.637 . . . . 0.0 109.161 177.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.507 ' OG1' HG22 ' A' ' 48' ' ' THR . 0.2 OUTLIER -104.0 -130.17 0.26 Allowed 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.995 -175.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 64.6 m -107.4 108.38 19.7 Favored 'General case' 0 CA--C 1.535 0.388 0 O-C-N 120.897 -1.127 . . . . 0.0 110.623 -173.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.7 mmtp 49.76 85.91 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 115.839 1.792 . . . . 0.0 115.839 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.95 -31.3 1.08 Allowed Glycine 0 N--CA 1.473 1.115 0 CA-C-N 113.086 -1.87 . . . . 0.0 116.319 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.8 p -59.87 147.49 38.24 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.375 1.07 . . . . 0.0 112.076 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.561 HG22 ' HB3' ' A' ' 22' ' ' PHE . 16.1 m -133.64 124.92 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-N 112.163 -2.289 . . . . 0.0 113.575 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.703 HG23 ' HB3' ' A' ' 40' ' ' LYS . 8.9 t -92.23 -171.91 2.96 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 109.26 -3.609 . . . . 0.0 109.896 159.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 129.5 -155.84 21.04 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 126.698 2.094 . . . . 0.0 111.191 -175.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 10.2 mm-40 -130.94 109.6 10.65 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 125.362 1.465 . . . . 0.0 112.659 -173.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 t -94.33 97.65 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 113.89 -1.504 . . . . 0.0 109.376 171.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.518 ' HB2' HG23 ' A' ' 36' ' ' VAL . 67.7 mt-30 -100.77 107.68 19.31 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.592 -178.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -135.19 150.87 20.32 Favored Glycine 0 CA--C 1.534 1.261 0 CA-C-N 114.429 -1.26 . . . . 0.0 113.673 -179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' HD3' HD11 ' A' ' 89' ' ' LEU . 74.3 Cg_endo -72.93 153.14 52.68 Favored 'Trans proline' 0 CA--C 1.533 0.465 0 C-N-CA 122.142 1.894 . . . . 0.0 111.147 175.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.575 ' O ' HG12 ' A' ' 58' ' ' VAL . 40.0 mt-10 -39.84 -49.06 2.36 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 117.887 2.551 . . . . 0.0 117.887 -173.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -63.19 -62.91 1.38 Allowed 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 118.037 0.381 . . . . 0.0 111.547 178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -59.56 -31.34 69.34 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -175.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.606 HG21 ' HB2' ' A' ' 7' ' ' LYS 0.287 1.7 p -55.78 -35.41 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -177.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.57 -41.07 66.12 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 177.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.9 t -67.55 -54.35 20.65 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.171 -1.377 . . . . 0.0 113.669 177.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.546 ' CE ' HG22 ' A' ' 35' ' ' VAL . 20.1 ptp -58.13 -36.77 73.44 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -178.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.486 ' HE3' HG22 ' A' ' 58' ' ' VAL . 88.1 mttt -52.38 -61.63 2.15 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 125.088 1.355 . . . . 0.0 111.737 171.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 64.3 m -54.04 -43.5 70.23 Favored 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 178.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . 0.495 ' HZ2' ' HA ' ' A' ' 26' ' ' ALA . 3.5 t90 -58.11 -53.99 51.99 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 175.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 14.3 mt -51.57 -29.58 17.69 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 179.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 m -80.02 -69.93 0.55 Allowed 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 113.916 -1.493 . . . . 0.0 114.777 167.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -63.86 -27.16 68.97 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 116.997 2.221 . . . . 0.0 116.997 -171.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.514 HG22 ' HD2' ' A' ' 71' ' ' PRO 0.357 8.1 p 62.01 -70.02 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 C-N-CA 129.394 3.078 . . . . 0.0 118.548 172.376 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.94 -111.67 2.45 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.88 1.228 . . . . 0.0 111.687 -173.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 60.1 p -73.18 -30.96 1.33 Allowed Pre-proline 0 N--CA 1.469 0.482 0 N-CA-C 118.952 2.945 . . . . 0.0 118.952 -170.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.514 ' HD2' HG22 ' A' ' 68' ' ' VAL . 38.7 Cg_exo -56.95 109.93 0.52 Allowed 'Trans proline' 0 CA--C 1.536 0.624 0 CA-C-N 123.075 2.134 . . . . 0.0 112.846 175.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -43.2 -30.79 0.51 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.222 2.609 . . . . 0.0 114.174 177.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.7 m -49.63 -23.93 1.95 Allowed 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 116.381 1.993 . . . . 0.0 116.381 171.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 30.3 mtm180 74.1 -33.04 0.24 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 127.941 2.496 . . . . 0.0 116.505 176.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.629 ' HA ' ' HA2' ' A' ' 15' ' ' GLY 0.337 4.1 mp 58.37 -84.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 126.723 2.009 . . . . 0.0 112.044 178.113 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . 0.31 2.6 p30 57.76 -41.37 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 128.313 2.645 . . . . 0.0 117.928 -178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.498 ' NH1' HD21 ' A' ' 79' ' ' ASN . 38.9 ttt-85 -110.58 101.69 10.33 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 123.313 1.53 . . . . 0.0 111.116 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 20.7 m -118.17 127.9 54.2 Favored 'General case' 0 C--O 1.24 0.602 0 CA-C-N 112.784 -2.007 . . . . 0.0 111.584 172.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.566 ' HB2' ' HB2' ' A' ' 12' ' ' GLU . 2.4 m-80 -82.73 83.57 7.63 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 111.484 -2.598 . . . . 0.0 110.861 -172.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -72.27 37.8 0.07 Allowed 'General case' 0 N--CA 1.471 0.596 0 CA-C-N 112.682 -2.053 . . . . 0.0 112.953 176.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 m -59.78 -36.39 76.58 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.063 2.145 . . . . 0.0 115.887 -163.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.558 ' HB3' ' HB3' ' A' ' 10' ' ' ASP . 24.6 t-20 -116.17 88.38 2.88 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.05 177.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -92.95 102.88 15.24 Favored 'General case' 0 C--O 1.237 0.447 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.844 169.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.413 ' HA ' ' OG ' ' A' ' 1' ' ' SER . 39.2 ttmt -108.47 119.99 41.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 111.462 -2.608 . . . . 0.0 110.31 -173.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 30.6 p -82.8 92.17 7.19 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 123.756 1.741 . . . . 0.0 111.934 174.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 15.5 pt -80.64 140.42 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 111.166 -2.743 . . . . 0.0 114.052 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' SER . . . . . 0.572 ' HA ' ' HB2' ' A' ' 4' ' ' ARG . 50.4 m -73.33 87.36 1.51 Allowed 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.808 -1.996 . . . . 0.0 111.289 171.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp 73.08 156.32 0.17 Allowed 'General case' 0 C--O 1.237 0.42 0 CA-C-N 112.247 -2.251 . . . . 0.0 112.42 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.469 HD11 ' HD3' ' A' ' 54' ' ' PRO . 88.5 mt -75.25 111.15 10.2 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-O 121.949 0.881 . . . . 0.0 111.113 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -86.7 13.58 8.47 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.895 1.813 . . . . 0.0 115.895 -162.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' TYR . . . . . . . . . . . . . 85.3 m-85 -148.51 155.21 40.86 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.328 1.051 . . . . 0.0 111.751 -177.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 20.6 p -68.62 -46.69 68.6 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 114.519 -1.219 . . . . 0.0 114.056 174.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.479 ' HA ' HG12 ' A' ' 36' ' ' VAL . 1.9 t-20 -156.54 172.93 17.69 Favored 'General case' 0 N--CA 1.465 0.305 0 C-N-CA 125.429 1.492 . . . . 0.0 111.101 174.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 44.4 t80 -72.93 94.98 1.91 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 122.789 1.28 . . . . 0.0 110.586 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.495 ' O ' HG12 ' A' ' 39' ' ' VAL . 42.4 m -63.06 142.96 58.18 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 112.305 -2.225 . . . . 0.0 114.496 -173.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.425 HG22 ' OE1' ' A' ' 27' ' ' GLU . 85.3 t -63.75 143.14 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 CA-C-N 110.792 -2.913 . . . . 0.0 110.032 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.517 ' HB3' ' NE ' ' A' ' 23' ' ' ARG . 46.1 ptt85 -6.63 123.67 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 120.306 3.446 . . . . 0.0 120.306 178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 112.066 -2.334 . . . . 0.0 112.514 165.995 . . . . . . . . 0 0 . 1 stop_ save_